var title_f22_55_23408="Atopic dermatitis infantile I";
var content_f22_55_23408=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F77457&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F77457&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Atopic dermatitis: infantile",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 327px; height: 419px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAGjAUcDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5mkRT8xVTn2qPYv8AdX8qmfrUZFUWN2KOij8qcMDpRilxQAopw6U3FKBTAUCngVHTgaAJAgNSCMU2L5mxVooAuaRSIfKp4hGKUOB1NSxkMRimPQks7VdwdxlR2rbsoSTkjr0+lVraAYXPJrZsoxkY7VLNIRuX7WIdhV+NMe5pLVQBkir1uqFhxWLZ0qJEkTMQSKv2sGTyOlTJHknavNXLeLBHB9z2qGzZRHQptXkfL71J5OR8nSrAXAwRxTkAOQKlspQIEjVW6fjTXgDEgjI61c8vAycHNKYiR7UrlOBmizJUAdM+nSnSWZGeM1fgjYkDGOxzVp4h6UXJcbGC1sdoGOnrUP2fHUbSO4610DwgjIA4qoUBzlaBqKsYMtqcMduSRVWSLaDgV0skakDYPrVC4t8HIFNMnkOZliAPvVWaEPwwrpbu3U/w1Rmt1UZA/OrTuZyjY5S+sV2lWQMp6ZFcTq1q1tcFSu1e2BXqk8QYbeprnfEOmG5tmwMSKMjitYS6M5qsLq6PPTSq2DmlkQo5BBBHY0gGT0rU5DQgm3RnPbpXZeD7NMK0/wDEd3NcPEQGArvPO+yaZFKv93FRPax0UN7sz9dm87UGCnI3cU2JdxAXoKz4pTLMXNbWnx8ZIqXojWPvyLtrD04q+kPyg44otI+lasSAgVzyZ2xjoYE0RU9MZorS1GDa3HT1ooTIlDU8ikHWo+tSyCo+9dh5IYpQKUUvagQ3FLS0YpgMoFLilApAS25+cVfc/u6z4uDmrgbK4plIrBS8mBWlYwEv06d6baRBQZD+FX7BDyTmgcUaVvGBwBxWxZRjG0c5rNtRzkdq3tOiLc1lNnXSiXYIflGelaVvAABmq0KgH5hxWtaRkqCfyrBs61Gw5IOME4z6VbgjMYAIp0ce3r61YUbjkjntUNmyiN28cdaWMdj1NShGPbFPjQlueSKCkhghOwFuTT4k5O84zUxU/wD6u9N2AcknmlYW4iw4BPJpWBUdeKcGAAwaSSLenU+xpitrqNVQo68elIVHHy8+9PEXydefWlClSM7iD3oE0VvLAJwoqCe3LNwMGtEqCCO9NaMqORigVzFmhGBntVC6gAGMA5rcnQnOOuaz5ozuoTsDjc56aPZJwOKr3kQPzAc1r3UW7NZ0yHoa1izmnGx5p4t0o21z9pjH7qTrjsa55RzXqur2SXlq8TDgjAPoa8zvLWS0uHikBDKcV0xdzgqx5XcjhGWJPTrXSS34uNMt4VPI6iubQkJWjo0ZcknoKbVyYSa2LtmmGI966TTovlArFt1/f7ccCujshtHpxWVRnXQRp2qDjI+laEajt+VUIMkZrQt1JI+lcsjviEtv5i8jNFaCphelFQDPn96YBT3PNNr0TwgHFKelAo7UAJ3ozS4ooATtSUGimBJH16VODyKhi5qdB84zQNGnAv7se9XoRsQY5NV7Fd5AzxV2VRGRSNkjRsBk+tdRajy4xtGTXPaUoKg8V01rg8YrCbO2ii3Am4gY5Peta3QqoGKr2cS/e9K1YhkAdjWDOtIUA+XkjmpYE7461JhduO1SxgYXFLQvWwpA4pDhMmp8KW6ZNBjQkk0xLzIWywAHSnHJTjBqZtowKQbdxAHFFhlYttTnr61LGcjnnIzVkxI2BgdM0rxKqBgPyoE2mUEVixz3qQgoevan7lGCQck0kpyRwMUA1camWAB7U2UnGBU4AVSvY9DSYwvIzmixJm3CHbuPUVVkXK571pzgBTxVRkDducVJXQxrhcN0rLu0xkgVv3Iwc4HNZV7tIOBWkTCaMRsB9pGQetc34x0oz2wuYly0fU98V1MgA5b1on2NGQygxuMMD3raLsck4J6M8bbOdtdPpNukenrIT87HpWdqOn/ZdWeNcmPdlD6itWD5YzjgVs3ocsI2eotoczseOtdBabmGBXP2P+sJ45NdNYj5OKxqHZQRpW/yr71o2mcjiqUIHGetatnyfauZnckWecYoqVCu08UUkhM+dH602lakr0DwhRS44pBS9qYBSHrS0h6UAMNHeilFAieEdanHUDvUERxU0HzTr60FI39Jj4BPSrV0nzjA6U3T/lQZ6VZxmUZ5qTdLQ0dKAABrqtOTzHA7fSucsYwqr6102msEGT1rGep2UjbtYQq45qwuc4zgCqcMrsMZGKtRFj94cCsXodcVcuQAMoDZqz5eHXB4xVRWOQFFWfMwwxkmoLsPB+c46U7nPNKseRuGc0ijD464/SqHoSmP061IsIODigsCMD05qaMrt5znHHNMzkRlQoBwfSnMPkwc4bpU4VWHuegoaIgDPAFFiW0ZbRMJACRinTR4Xg8GrU0YJ3Z5Wq7/ADDGaTNE7kQUeX8zdKcmG4pdoxjOKEXnGcCmJoguQCNuc4qnJGMDJxzVqfG/rzUUvzDjr3qQZn3CA5B7Vj3ygI1bVzyT7isS/PBqoozkjHk5BHanS4+ygYBpNmXPoaSc4jK44A5FbI5ZHGauA044GR0pgX9zzTbgl7l884bip5hthGfStdjntq2Q2I/e11Onr8lcxp4OSa6myG2NeKzqHRQRpxpucA8CtK2XGFHTNUbYFuTV6IFcYNcrO5ItsOODxRTQCR2xRTtcl2Pnh+tNFOcdaaOtegeCPGKSjpR1FACmkGME96CaRQTkCgQhOKF60hoXk0ATLVqwXdMKqAcVoaUP3mR1BoKW50douExVuJgJAeeKpwSYX61btRuc8HNSzqjqa0AJI9MZrWs9zMME1UtoCeevvW1p0QVgWFYSZ2Uo6mnZRE4yce1asEYXANUoWVRkCriz/L15rI7VFJFpUXkjrSsjId3XNQRTjcNx+tW/tKbQeKVhPQFyrDnpUjDPJOPU1GGDBiOoqN5drfNS2J9CcyYG31p0cnGCOPWqRkJJP6VYiJK/L0oTL5dDTiJKDJGfekcvlRkcVEr425HvmnSTbcE96oxaGM/zEH1qMgEgdKguJlUA5Jqqk7ySY9KTLjHQnlbDn0pckdSce1QvKC/XtT45V9uaBshk5Yc9+lLkbSOlNuNxbI5HtVbziOCeBzRYUitePjvkVh6i4OFOea2b9wwLAADrWBcnLgk9elXBGFV6EQjwPc1R1aURxnn5sYraICx5J6VzniSRFh3A/MeDWiOZs5mBd8rE+tTXz/Lj8Kba4C570kvzygVq9zJLQsafGNq/WuitBhfbtWNZKAwz07VvW4HFY1Dqoqxp22Sgq/GQpGeTVG3HYHFaEeARk1zs7EKzkcDpRTsDP0opiZ87t1pBzSt1pBXefPC0lKab2oELSUvbmimA00qDmkNOTrQBJ2rS0wlVzxg1ndqs2bcGgqO50Fu248Vt6VHubGOawdNBbv14rtdDsyMdves5ux20I8xr2MQFscgg1ehOGHBxV6G1UwDscAGmyQLHjJFc8j0aS1GGdYlyxwKz73VZo3xEhPGfqKt3USsCFIz6mqV/5UGh3S26f6SYyN3U/hTpQU3Zuwq9aUI3ijNh8QySS4Z2PONqitePV4YzH9onnhXk5deBz3rgxHM+nSPbZEwXCjoc1oJD9jtQq3kt4jxo7GZNpRyPmX3APeuz6vDY8z65V3PR4rh127XWRG/iU8YqaRyPeue8OoU0fTpFPzSkp5fqOxraf93Jg9utclWn7N2Z6OHre1jcnQknJFaEBGM1RiJZhirMav2GOxrBHTcutIQoxUE8vKjtUbl1YbicUydwV7ZxT8iWkgkIYkU1Qq4PQ1ASVTIPJ96x9W1WKxcI/myTMMhU9K0jTctjOVSMNzfaMZzTUIBxniuOk1yVIjKWkXecBXGdv1qex15GYCcgA9CpzVSpyjuhU68J7M615ECbcVSm2K5wOahSdZl3xtlW6VKFLjmoNWjJvpMAjkA9qx5TkAe9bWoxFeOv9KxbhSGA5xVROaqieVwISR6YrjvE0wZkVSeT09K6eYkqV/hxXEa0zPfBP7tax3OSeiEiwsYqSBdz5pignCirlvFxk8U2xRRPbgCQVtW+CKx7cZYketbEPAFZSOmmaVsRjHer6FTg1mW7EEDrxVtHIOf0rI6osuEjk5BFFU3kwnPWikDPBW6mm5/WlfrTa7z54Umk7UpoA4oEAxnnpTmGM4OaaKcOnvTAaRTkHNIa0dCtDe6lDDjILc/Shuw0ruyLum+Hr2/h8xFCJ2Lnr9KiutMuNMujHcgdOxr0mcf2dZxsF+QYGB2rj/FVyLjUAV5BA6VnGbbOudGMI+YaImSD2r0TRIzhGPQVwuirhF7V2dhOUQYPAqKjOjDqyOnu7uOOHYOtZLzSyyDLcUi5mbJzVqO3y47D3rGR2UkluLDuAyeamLoQAYRn605Y9vQ0xy24YFRdo6OVMabOzlP763ULnn1pL600+YKFtgVVdvzc04hyQMU9Y+hI5q1VklYylh4N3sPs1ESqkEYUAYGB0qdEO4luc0sIOBsHJqS7ItoTJKduOnvSb5haR0Q9WVMZOPep1u0J+bmsKCSW7+YZCmrq2zhehqb2DkuajSJIuVPSqtyN447VVWVoWw/Sp5WwAw6Gi/UpJrQkiEfybxlF6iuA16SSTxDdSMpAHCFhgdOMV2rPnnOKjYxN8s0auD1DDOa6qNfkVrHJiML7V3vqeYzrcQ3Mey+luY5Yd06vHtEb5+6PUY71o+FrRbu/vImb7se8E9A1dffaTp9z8xhIz2DcU2z0uys8m1UIW+971q68eWz1OaODqKV9iPTgUj3JuLKcMM9feteJyy8d6ijVAOAtWbd40ODwa4up6eqViCa3LHJHHpWBqoCFj029BXWXDKi4znNczrIUA+pppmck2jJlcsBn061wurOp1VwPXrXcyEGP0wPzrz3UZg2rSYHG6t4bnnVXoatkMy5IzWk6YjAx1qlpoDPntWsQHdABSk9TSGw2GPYoJq6h4BprrvlSJeg61prbokWT2rKTNoogjLAA+lWYmO3moACThBUyxlcD86g1UhzguoPSip4wuPaipsXdngj9aQU5+tIBzXoHgARRSsCODSDjFMQtL2pD1pw5GKAGHrXcfCe2jufELebyEjziuJOOldb8Lb1bXxbAjkBbgGLPv2qZ/CzWi7TVz1HxfDDBo6rGnzOCT6mvILoEz5PY969b8cOXuLe1GdyxnOPrXkuoqUu2HoaypHdidkbWin7p9+a6u0IJHpXIaQwEYBxnP411GnsGwMilMqgdBbOFUZ61bWfc5BFUolAQE8jrViONuGrGTO+CuTiQjoangjDcseveoYlAIHc8VbRMcHgVm2b2ZIqjOQMgVJGi9hyfWiIBUY57YFWLZUz8wzjnNLcT03LCiK1hMkxAULnpWMsMmrXBeYYiHKJUmsX8EsfkWrNM5IyEGRVmystRubcJBZTLkclRWvLJ7I5HNLVsntrSOHAGMVqxx2/kkMCH7Vh2Ph7xDZOTKJ5oCchXTJX6Gpp5Z7f5ZonR/wDaGKmUJRew41IzW4upWfmIxUVWtY/OtirHDocVUh1TVHvCkttGttngg5LCtTaEutyg4cZIqVozRPQoSxbQR3qsQWB3A57GtCdSznbzzUXlnnFCbRvZNFABg2D0p4TIOO9SujBjioxI0ZIYcU7jsgWLc23PWpjFtHvUke11BFK5Zuh6UIwnuRSDIBxWJrSArxng1txnkhuKxta4Dj0HFWjNvoc5qLiO3Zt2cDgV53KSb5z3zXr8WjxXUUMkqlvlztzwahuPDumT7lNsik/xAcitY1FHc454aU9mcZpP+r3YrXVgibsjJ6CoJ7D+zrh7fO4L90n0p8Q+0X0UQHC9aG76kJcujNrSbPpLJ1PNWbphJI0aYwKViIowueg7VBAcknPNYNnSl0ImjnU/LjHoajS6ZZRHN8rkcZ6VozNiI9zWBqHzn+R9KcXfRg4djbWQY5OfpRXORak9s3l3GSnaTHBop8rFc8wem0rHmmk12njCk0YzTakjUsQPU0ANHFKOnFad/p/2O0idyC8gzj0rMP3cinYVwxjk1d0O4+y6xZT5x5cytn8az80qHDA+hzQC01PoHXFM/iJGTDBoNwryjXk26lKG4IY16toTi6vrSaTndbr/ACrzPxbGU1m5wOA5rCnuepX1gN0xgjfhxXT6a+FB6k1yVs2Nv97v7102kn5TVVERh3qdXakCMcZB9avH7vX8qybckqgJxVxHODg/j7Vys9SCRdiPORnNPEjM/P5VHbYCsJCRkfLUsDDzFLEBCcE+lZG+hLLOtuhlmbaqdc96saHo+o+J5/lDW9kPXj86raNZP4m15bdSPsUDZYgcHFezaXaIkS2tonlW8fDEd/auyjSXxM8rG4zk9yG5n6H4a0vSIVS3thdXA6swzg10kC3gHyiKIHoB2qxEqwptRQoA7d6mjYtnjFdNjxXNyd2V1F4ORMh+oqvewpdIyahZRTLjqBWkBikYYyaVhqbR5zrfhAbWuNDb3aBv6Vy0b7XZJFZZ14ZWHIr2WeEZ3w/LKPTvXIeM9ETULZtSsk23kI/eKBjeKxq0VLVbndhsW0+WT0OIC7t2cktVd1MZKjmp7a5VkBxjsfrTJnQk+v04riPchqUWVic9s02aP5c1bJAUdz1FRuwKjPGaDS7KERdXJzwO1WVkyCe/akZVEZqIMqsOapGVTUc8oCndwawNSkyzZPBNbF/Kgi46/wBawpl825ijzguwzWsTlnobcZZoVjhGAqjJ9OKZ9llt3jnJLxtwQe3vVqSP7NAIxzk4J9a1bhV3QQEfdG5qzZTueb+JmB1cKPvBORVHQ2/0mSRuucA1X1zU47zxHfSRMCivsGPbijSpgN3ua35bROPmvI6S4bdFgVHbny2wfTOaLcFosk9e1OKEsc+lYs6EPmctjB4rPvYyw9wKvKRtIPUVAxDYyOnBpIrZmKsCzRskgJwc4z0oq3cxCOYMo+Vic0VqmzSyZ5O9Mpz9TTRXUfPjlXcwA71rGGOyhG/bLKegHQGqVjCzyHau4gZFdV4Z0E39vc/aUIdx+6LcAGriiZO2rOZeK6uYmkwzpH1PpVIjjmvQF0xtO0iZXwc5DccZrgpDuY4oaFF3I8cUrLtYqSD9KMU2kM9X8L67Gvhy1lzm4hHlBe5Iqtrmmu+nm5mYGVmLFR1Ga5/4fW4nu5S54XG0ds+tenzaek1oykjO09e/FYSaiz06alWgmzyiE4kC44rqtLGEQg43CuZukMN5x2aun0n5oiO+MiqnsTSVpNHTWrAhc9R0qZZ1DjABBODmqUR2hSp7cinIASPX3rlkj1aT7mosm5dv8P15qLUbgQ2LFSA5G0e5qAzR28O+VgMVr+CvC9/47ut4JtdFgky8x6uw/hWlCm5MdfERpRbZ3nw70+PS/DcMpws122AxP616VaG3igRIizBR1x1qlo3h+x0u1iht4ywj6M53GtXysDjpXoKyVj5ic3N3FVlYDgj60/fGByQMetVbu5jsrWS4fJCdh/Koo0kukV5ztUjOwf1otcnzL6PG/wB1gTSuuRVX7Mg+4SpqWCRm3RsfmXp70rWFuKFHcVSu4hFMsoHyH5XHrWgeKrXwzA2PTNMS3PGvE2m/2b4ku7dCFjdvOjGOoNZ/3kLdPeun+JYxqGnTngvGUJ+lcas7EsCfoMVwV1yzPpsDJzpJserFJMMc1ZlT5RnpVQqX5J+gqyhPlAE5rJI6ptFacYQDp9KpyOFXNT3Ug3be1Z8r4OG61SJktCK+lzsHY81VgRpNQTaSCBmknkDTE+gq3oCebcTSMOBhQa1ekTj3mjWkST9yXBK7gfrTfEd29jp0pVv9MnUhf9ketXr6SPfCgOAPmbPauP1a6a+v5JnJKnhfYUoruKpLseWwu9vqEkcnViTz61t6TKWlxnvVDxlCINSEicZGaXQ5d0ikGup6q55sfdnynoVmD5Q78VbVP3Z9TVCwb90Oc5FaSsMe9ccj0oFQpjIqpMuxwy52963IoQ2cjg1GdP8ANjIFSmW0Y8qq8YIPXqPSii7gmtHw6naehoq0TzSWh4y/JoRSSAKc1beh6Qbhkkkx5Z5wK7keE3Y3PCmmPHbmZgCTztI7Vv2Gq2r6i1iJAUZcxkH7relYev6rFZWEdpZyAyEZLL29jXJ213Lb3SXCNiQNkE1pexly82rO18Z6m0FuYSvzSgggdveuS8O2A1Gd4WAJI+X1zUOs382oXjSzEZPYdKu+EhMmsxGIHcuXI6ZwKW7HbliJr2lizgWRFIydpB7EVz9eha4ragrkpguOF64auDuImhlZHHIODUjhK6LWiarPpN2JocEHhlPQiu7/AOFh2xtTm1l87bjGRj8680b2oqXBS3OinWnTVos2G1F729ZnAVScgCuz0OTKKSeoxXnFs2yZD6Gu30OcqAM9OOaU1obYeblLU7WBWeIkYp06FGTnk/pUNhIRFk/hVqUhot+DuHeuSR68HZHM6vPLd30VnCSWdwgHuTivrXwhpMeg+HrHToECrCg3e7Ecn86+SfDJEvjvSFl5BvI85/3q+z45BkZGK64K0TxsZUcp2EkYpnAznoB60gEjkFzj/ZFQahKYzHKvCocsPUVejcOFI5B71Zx2MXxT5n9lKyqdiTIz/TNaVvzECTwQMVYlSOaJ4po90bDawPeqdnaS2kZjhfzYQflVuGA9M96V7Dauixzmi2G64dh0UY/GobiSaNkUR4Zzgc9PerFunlBh17n3p3JSsPYDPFQXTBYH3elSFxyT0qhqEgwEzgtz9BTEtzzb4kyb9Q0yFSPkRmP0rjiuCSQN2eua2vEt19v1q7uVJ8uLEMfoQOv61jFt5G7jH6152Id5n0+Ai40kIzsMZwBUkcoHzbvwqnITwG4IojX5jzx2rNanZJIJ8sSccVn3BwD0zWhM27jtWbekBSQfpVpGM5aGdI+0n3rd8P8AlxQIJXCF23En9KwoLd727hiT+I4J9B3rcu7QxHCD5BxWknZHJBOTuibVptqSydSwwtYEYXp1qxM7BvLdsjsDUUK4bFPoRUbb1OJ8f2+JIpAOCK5/w/N5dxtJ716B4rsftWmsVGXTn8K8yjJtrwHpg810Qd42OCsuSfMep6fKDGPWtm1Ut1FchotyJApB4IrrrGZdmCa5qisd9GXMjThjJTgZq5DEFXJJBPvUNu4AHPFOMwz04H61mjoYXUKTJsZQR6GipZGzGCp5op2uSfN9uiyTbX3YIPTsa249VFlavFCMyY+V/Sse3GJAc4qWWNSS245HQetegkfPvUhyZZC8mSScmro0q4bTXvVU+QjBScdzW94Y8K3N9cwyyr5dq2DuPQ+1ejvpUUWmtZiNRbn5HXt7NWijcxnVUXY8RsbV7y6SGP7zHFd3dafHayQzRALNsEZx3KjB/OpPDvh6bTdWupZkyi5VGPTB71Pfo0mqGHOSCBkVL0RMp3dkT6XYxzHzJnGXJZB6EDpXnfiiaCfU3e2DAH7wIxzXY+Lr+KxsY7O23Au28Nn7vrXO6b4dnv4mmlR1Un5Wxw3407aWQ6envM5Y9aOlWdQtmtLuSFxhlPSqtQbC5ya6rw/ckgZPXr9a5UCtLRpjHchezUpbGlOXLI9OsJv3aqx4rZyGQDAHGa5jTJAQm8gjpW4p4wCSPrXHNWZ7FKV0clDP/Z/ie1uc8Q3KOSPQMK+2LGWO4top0IKSIGB+or4s8UWWybzIwdjjrX0h8C/Eqa94Ojt5HH2ywxDIvfbjhq64O6PLxcbSuej3EaywMvc1V06f7PiCYAIOFb09jVpV565qpqFnJLmS3ZRKB91hkN7GqscqZq4XrxUc8yWse4/MzHCr3JrnotZNqjRTW1wLlfuweWW3/wC6w4x9a1bOKSST7VdqEkYfLGDkRj/GpK21ZYt42XLSndM5yx/pUisBvY9OlNlkEcbO3QCsy61OKC3+Z0j4yWkYCmTZsvTyRxplvwHrXB+Ndf8AsSPb2zA3koxxzsWq+ueKzLvj0vM0nQzH7ifT1rhXdjcO8rtLK5yzN1NZVaygrI9DCYOU3zTWhbglQWWwjcRnt1PeshyQ52DANW1cKOmOfWqcrHzCeorgk76nu00o7CSjvUbHaAMc05m4OeTUByWxQi29NRXyFLd6y7ts/LnPPNaV0WEexcD3rHupFjV3c4VV3E1tBHJWnoTaUzfa5DburXEfPl552mteS8LJiSOTf6YrxseIrq311760kKgtyv8AeX0Ner6JrdtrVn9ot8jHDK3UGtqlNrU4aGKveJHKpeTewxx09KVUGc4qS45c1Lbx5H4VkaXu7siuIA8TDGQwwa8p8WaU1neMVB2E5BFewY+XBrE1vTo723dHHzdjVwnysitT54nm3h2/8mURyH6V6Hp04IUjBHavNNW0uawuGyCADwa2fDetbGEU7YYdM1pUjzK6OehUdN8sj1G2mOPrVkn34rAsr9XVSCCK0BcBlb5sZrksz04yTNBX+Q80Vnfaig+9RVJg7HiNuhJwBnNacNzFCYHjt1ZkIL7+Qfb6Vlr8pCq3XuKk3OV29h3Femj55nuGgXVvcaYjw7QqLiREGAD6/rVqRSsLb2LsvysAeqnvXmXgTXP7LuTDdyO0E4CgHgDJ7V6U8kgRsREugAAJ+8hrVO6OCpDlkZt4wtbfAyzRpgZ/iWuesTuuJZXI+UhgxrR126WSQJGQVVRsIOc+xrntYke00GWQPtMuFGPTNZN3l6FwVzDKyeIPEHlKHZC5wo/hFdhq15FommRqg3pImxoi3KOB1xWP4Gsmt7a5vJj5Ujr+7djjBHPU+tYOqXh1fU5HSHbPKwwFOR05q1ojZrmfkjEv90szSkliepPNUzXpbeFFj8NS3bxstx5WWQ9AfUV5s4wxrOUbM0jJS2G1LbuUnRs9DUeOacBjmpLR2umXRUrjhvX1rqLS4/dhXBBIrltHhW5tI2744rctbh4JFW6XhRgHFYzimehSk0jbktFurXZMMqensazvD2pal4G8Qpf2YLRn5ZY+0iehq9bvvkURyHHv0rQkRJUKSKGU+orNScGdE4RqqzPoHwh4r07xPpqXWmTq5x88X8aH0IroFyec18li2utIvRe6FdTWs687kOPzHevRfDnxh1OKNIdbsIrojjzoW8tj9R0rdVIs82phJxfu6nuHNSIc9egrzu1+KWnzjJtLhD6HB/WqOseP7i7hMVjF9nVhguTlse1KVWK3YU8FWm7KJq+PvEDEiwsJduDmWRe3tXHpLDJBI15I88pOPnJOB6isua4YAs5yT196h8/92fU1xyqtu57lHCRpwUUWrm7EcfygAdBiqCTfvMnnI702SQFeagBJYADmsr3Z0cqSLocHJIH41Wmb25p4BK+9IIcjB5oGtCBiVAAHWmScDgVZdADx1qrPnoO1NIUpFe6lIG0HOa4/xvem10wRI2JJzg+u0V1ki4Vmf5VAJJ9q8l8Uan/aeqySKT5KfLH9BXXRjdnlYypyxt3Mck+la2iatPpF3HPA5KA/MmeGHoayGyeT0oDdMGutq+jPJTad0ewaNrVtqsKyKwSQ8GMnkV0dpyK8CtZ5La4WaF9rocg13ugePBDHHFqMRZs48xPT3rmnRe6O6liVtI9DnAyfQ1SnA3ADqKZbanbak5+yTLKFGTtPT61Jj5icdKwtZnbdNaGRf2UF6jLKgyeM+lcTrPhmaBzJbAkdRivRbmLHK9e9VypK4IzVxnymM6Sluef6XqN5Yny7mJig7iumg1qFgMHH1FaUlnFIeY15qFtOgHIiBP0obUt0KKnDRMibU42PDcdsUUrWSY/1Q/KiptEv2kzyx9quVRtyjocVIGx0P4VW4L4I4zUh+9gV3Jnkl63uWNxEZAZDH9xfSvRdB8USX1jIhGy5RsIB6eleYwuy5249M1bsbo2dzDKgI2nLc9aq7toZ1IKSPQo4VuJlUNkO2Rz0Peub8aOLnUrSytj8vA29gc11lnNaxaQL9tsazAsrdNrdq5Dw08N5e3t3djzJ1O9ST6elKMbIyhpdlzxhfC002PTolQ741WTnlSO4+tS+AtIEkbXt3GjpGQygnBxXLzXP9q64kkuAu4bsf3RXU6r4oh0yA2+nbFlj4BUZDL71aet2VJNR5UdF4s1m3ttHltY5IykicFWzj2rxd8bzVm8vZ76ZnkYnceF7Cr+leH7u+cZQoh7kVnKV3dmlKlyqyMmKJ5ZAkalmPQCt+18Nzm2aeUcgZ2+1dvonhmCxjB8sFyOXI5rce0UJsAGD1rF1Ox2Qo9WcT4WUHMRHK9BXWGySSMhhlT19qwbC2+xa9JER8p5Wu4t4cgFRnjmomzopq2hyz2k9iS0OZY/7vcCr1jfxuoXHOe5relsGZS8Az3K/4VSn06C65YGKcdGXg59xUOV9zaN1sSwSJN8pAB9PUVHd6PEX86B8E/w+pql9nu7LDToXj/vrzV23vVJHzbqz1Wx0RtLcihZrZisqsD79K0bedSAd4NSRypMuCMrjnNC2cAyQuCfQ1DszaN4j2lUrjORUJkOcZzj0qZbSHaPvc+9TRrHEBtUZ6VNka8zIEt5ZVBC7R6mpBbCE/e3E96tGQjGehqGVwSMUbBvuO2YUe9MHFOL7R14poYMcDk0EylYZKcDjr7VB5TOdx4Bq6sIzl/wFOnjY4UYBPQVSMJTMDWrR7yynto2Kq67WdeoFeS654eu9LYkqZIezgfzr6AFmqxBT0/nWXqGnxSoyuoYEd+a6KdRwOGtSVXV7nz3xjBFR4AOK9F8Q+DcO0tgNrddh6GuGvLOa0kKTxMjjsRXXGalsedOnKG5UwcnAqQg4FJjAxnrSkfuxz71RmS2l3cWjFraV4XPUocZrrtN8dXMWyO8iWVQOXHDGuJzxRk1MoKW5cKkobM9Sh8ZaZcoplZoWJxhhWxFe2ky/up4m47MK8WbBxSozLkBiue4OKydBPY6I4uS3Patu4HaQfbNIF28nAHvXjCXt0hBW4lGOB8xpz396wAa6lP8AwM1PsH3L+trseyvJCI97yIFHHUUV4r58x3gyvg84LGil9X8xfW/IaOp4Oc0/nJPr1pqjk08AlgOefSuhHKKvHOeKl3kYJ6gVG/y/e6VBNKTgL0p3sIvz6rO+n/YmdjCG3AE9KfFqRstO8m2YeZJ94+nbFY+STzUlvBJcSiOJSzHoBS5hcokUjqTsJBPHFaum6Fe6g4LKY4z/ABN1P0rqvDHhIArLcjdIegPQV6DpmjJG4JUcetYyqW2Oulh76yOT0DwZFAFd497+rc12FtpCwY2KK3oLZVXAXpU4iADYFYuTZ0KCWxiNbhSBjAxVSRCWwo5FbN4gCZFUY4/m96RVjnNcsSpt7qJf3kZJbHcVp6VcgEA1rfZt6hiuVB5z6VkXVm1jc/KP3Tcr7e1Ve6BKzOltvLdAVGDUlzpaXCgt8r44daztNn2oAa3bWbcBkjFZsuz6GHJp93bttAEyew/pVKeztZ2O6IxSdCRwa7RCpbIHzU+W0gn/ANbGrfWp9C1O26OAFlLASIp9yH1qZEuFGCufoa62bQLZvus6/Q03/hH1CYWVvqaGmaxqxOa/fkDcmOKerSKDmM1unROQPOc/hUseiqGyXZgOvNTymntF3OeDORyp+mKclvI7ZxgV1sOlQKo+XJ9zmpDbRxk7VH4UcpDq9jmotPZuqsx9+lW47ARgFiFHoK1Xbaxqlc3AQhSck9FHeiyRLk5FdlhiUNt57Z60kEDM5duCensKmjgZn3TcnsOwq2E2IWNC1JehVeMLx6VTmjznNXptxyR+VVJWKpnpV3JsZV5ECCDXOanpdvdxskqBwfUV1jqXB4/Oqr2uckDNNSE4J7nk+r+DmVi1mxx/cb/GuVurWa1k8q4RkI9RXvUthu7VlatoMF3EVniDA9K3jWfU5KmFT1joeIsv40h4rpvEvhubS2MkYMlvnr3WubPHJrpTTV0cMouLsyMnmkJ5680pAPNIw6CmIQ9DTTwafjGfWm7evagQ0dee9FPBwc4/OigCVBkk1L9zkEg/yq0tg/2Xzhghn2AZ5zXUeJdL0zSfDVrEWWTUnUSNhuRnsR7UktBuSTscNM5Y4JqFqU+9GCeBUjH20L3EyxxjLNxXqPhDwytvHvkUGQ9WrI8C6HlhPKnzt69hXrmnWQjCgADisKk+iOyhSt7zG2GnKgXCitZbbYOnAqe2hHGe1WAoLHisTqK6Jhc1FISBVxwApA/Gq8oXZmkUrGXeH9ySfWoreLc3I4NWrhN8TDuKW0QDrTAsW8Q2FSODVW8tRKpVuorRUdCKbJhjzwaaJOdiiaGXBrXtM4FRXMPzbsU+2DK4FKSKVzRjYgYzVpJOefyqmDjHHNWoyMY9alDZaVzkAVNuGRVUEk8ZxUsSknmhsEiVmB5GBTSwxgCpPLCjNRF8npxU3GPLDGaqzzBVPIpZGxnnC9zVN8S58v8A76NK40iG4mduFHJptrbbX8xxuc96uQwhck9T1NWPlUbulCQ3K2iK+3ByRxUTHc3sKdLJk+1REfKfXtTFqMmkAB9KoNljuJJHpVplLE7hTfLHHp6UFbFcKSal2Y7VOsa7cqBUojzyaYij5QHrUE8S7fY1qSIO1VbiIDnNMErnOalZLPE6OgZWBGDXjnivRm0m9wgzbufkPp7V73JErr1rlfFOix6jaSRMOeqn0Na0qnKznr0OdabniHBbApDgsTn8K3rvwtqECuwj3qvUpzVCXRb+KPe9rKEz12mu08l6Oxn7smmuMgdqna1nGcxuPwNNaCZjxE+R7UARgc0VMLS4c/LE5P0ophc9Q8FrbwabLcXUKPtZiCwz0NcJ4s1VtU1WWU/d+6B7CprjxBNHposYjhMct3Nc8Tk5PU1DelgjGzbG1teHdON1OsjrlFPHuazLK3a5uo4l6scfSvTvDumqgRVX5V4zjrWU5WR0UafM7nW+F9PWKBMjnrXXRxAYwOtUNLhVIwMDpWqv3Rz9K5bnoJWRMoAUYqULkGmIMoPWnu2FHFMCByMnmq0xqaY8iqzkFsA1JaIJASCM4p1uR0NKw3tgCliUo59KoLFscKTTHTI3U9TkAdqWQgZGeKYiscMMY5pVj+cHpS7ccg0oYAjNJsaRIE5znrU6ofXgVEGBbORVmE+9ICaJQOc1MqnH8qjjZcHJwKcZOAFPFIZP0Xk9qqyPhtqinyNlRzVcnkE0gBkDL+8OeelIUJB28KKcSD9KCwCgD71Kw7ibcLk0w5cDPTtQ0h5ye1MXIXJIA+tMQxhjIzURyD7VNL0FQAEtnvSKVgKE8+lM8slhz1qwMgc9KcgOQe9AXIkh9+lWRF8oFIuASe9PST8aZNxrRgjHGBWbfx4P3sCtKVjk5HWqN0hJPy8CkzSnuZzblXgZFVZ42cnIxWmCNuDg1WnG4nAqbm3KmctqkE8auYG2se3ZvauQuvGlzbz3MWoWZ3Z2qm7gCvSruHK4NcfrWi2d1cq96pCqOXUcmuvD12nys8vHYOLXtEtTJi8X6W9w/m22LeOP92u0Es3vTG8XaUskAWwAjVCSdoyx9KsnwhpktwrbjGpTeyg8gUg8HabIIn811R88E849a9Bcx4n7sor4vsf3AFlsUlmkIAz7AUVcm8IafLbrJEzqAxUAn7w9c0UveC9M8zk5PNIOlKRmkAwcHrXOdh0XhG133Bkxz0Fep6DbldoI4FcT4HgU7Aem3Nel6SgGOK5qjuzvoxtFG7Zphc1aDktjsKpiUKnA4oSfLfKRnpWR0ctzTic4OKXzOuecVBGwEZajzBTuTYWVtwHHNVzmld+D2po569qCkhyggg1KY93zc1GjZbHpVyIgLg0IorplTzTypZac/XmnZAX3piZXxjHtTWY7hx+lSlsH2JqFnw2eCKVxpEq56t61YWQqMqMVT3fJx1zU8UhYnJ4xSuVysuRy4XmnPMoUYGaplsKNueO9RlicDmk2NQLbSgnB+tAcE5Kmq6Aq2SMjFPwTnnjFIGiTzlwdopUZSvvUMadRRg5piFJG7J5FKzrgg9qhYnJx0oiU5P0pDsx28HPpT4ym7JGaYEI5NWYY92SBxQSxjsrbVGMGp2RcDHWnRRfvRx0onO2XaOcc8UEXd7EGFyeKUFBwKbuO8bhxmjawYDtTY1ceSCRxxTGRGJHWpDtBPB5pMfe7c0DV7mfcQKrZxVaRFzmtWTG4EjcKqTwkLu2461DRvGT2ZmSxrg8DNZOoWySRscc1uvGXbJHeqV1DuyOhpFvXQ4C8gkhlk8tyHfCj2FVZPMDytk7o1CKT6mupvoRDcpK6BgrZoezjnntxInU+awC/eA6fSvSoJ1I3ufMY6l7GrotGc7bu4eOOZyRGueD1Jorof7PWWMEKAXckk9x2orb2UjgbR4YwwoNMX5mGfWpJT8qj0FPs4Gkbfj5AetZHprU9D8IxiNU7cV6JpwXauea4Tw4o+zxHjGK7fTxmMMGrkm9T0qa0L14+2NQveqzTGKPdjBJAH1q1ND5kaEckday9abyYrfn/AJajisep2RsonQGUJAoJ5PanKd1YkFy80nJHHFa1u3qe1WYk5GRg0+NdoxTUOc59anTFFxoFTJFWkAqqDhxUyvzjpSuVYlkj+XNQsBgAjmrIbMfNQleeTTuSQTABB61GqbsCpp0yfaomO3GDSbNIajioAAojAB5pqHIFSEYHB61JqkOJBXg0RYPXtTU7jNO4UHbQJjySoPTFM381Hv3UoG3k0IlslQnJNNZvmo3goR3qMMPWgS1HgVNCh696rRud/NWY3PagB7R5A5yaniT5QAcVED74NWEOV96CWPjUqTnpVDzQZ5Nx5zV8Njnsaxbh1Se4bOD1FJiir3LDMW6HnNSkgAMxxxWfaSAsCzVPJIGO1cY70y+XUsRyE4Ap2WZzuyAKigXBDE4zVlSM0dBNK4hjL52jApsqfK26pwwUcce5pkhBUikwTMyRGGGB4qjLGdx78VryoNhHUVTKAqxFSa30Oa1VN0Rx6Y+lc4L64hMw+YsyiNfQDPWuxv4gEbHBNcpJA0l55QOC33frXVhptSsjzMzpc9PmXQn/ALTfaEJVmAAzngUVBJp0xARkweuB6UV389Q+c0PFVVpJAo5J4rrLbT/Ks1XHvWLoUHm3BcjO2u6SHzIRtx0rmnKx7lGF1cdobGEAHoBXW2ExAVQcA1ytqoVcHgjpW7p02CCawmd9FLY7PThuU55A61zPjGfGp2sIxtRS/wDhXS6bdLFGO5NcN4muBP4nnwflXC/pUQWpc+praQW256mugjB2gisbRUPlg1vQjAoYktB+SAAOpqUenSmgd6DKc4x9TSGkTIvvUyJux7VUSY56DFW7Z8ucnFIbViyMgYPAqGRcNwaczN6jApjSZJJ6HpTFuRSeh71EyZ74xT3k+YHApZGJAwKTNIqxEqMM1KsJxmmKeTg9KnEny4oKbIgjAnnAqCWYr8oPJqa6mWKMs7AADk1lQStKxf8AKkK5owNgc4qdsACq9v05qZhuPTAHei4rXYgcg9eDSfx8dDSiJmPA49alKAA44NK5rZLYaGA/GrELgjA6VWWMOCBmpolKuB2xQJotxgFgKsqQqmq6qAcjqKRmOG9R2oMmrllJFKHmuX8TSmErJGM5IVvoTW8oJ6dKzNYtvPgdTjJFN2FC6kU7V8oCODVmJhvG498GqOngvAM8Hpn0q7EuxwX6A0Gty+HCnA5X3qaORWAPGKoghuQeKtRp8oIHFMxdyxvTfhcEVHPKP4cY/nQIyVbt9KgK/e4O2kyo6iNJvDYGD0qFipU1IUBHBwKgaM8gc1BbKF8qsTuHbiuX1WLY4ZDhgetddMhIwRkmsPUrXOcZIq4u2qIl7y5Wcbf+N4rG8ljmtXWRAFX39TRVPxL4eGp3KbCqSgYJJ6iivXp1JTjdHztbD06U3FnPaBamO2R+u7k11Wn4IZMj6GsXSbecRop44HyjtXR2mlbiHdiG68GuKbPWpRaQxYhlgv3hzVm0YBxzinvppT50uApH949aoTytBJuyjEd1bINZ7mqdmdfYXHygE9K5G+fzfE1z6bq1NPv0dRlgv1rl7i7jh8QTN5gZGbqKcI6sdSWh6Po5yv4YrZjYZAzXHabqMzYFtAxX+83ArSivL2TkoqDOMetQ9Ny4xctkdKWAXiqks3zZzWcj3kjctgewpXhuyGIIOPUVDaNo02tzSifcBVyAn1rCsZZCCkgKup5FXZr4W0WBzI/CCkDWhqPcZcRL174qcIGUDvWZpkbEZOSzHJJ71tLGQoI60yLFcQj0pTCMc1cWPpxSToQAwNA7lDZtHSn4yoH6U7aWPNUNduzY2DyR8Sv8kf1PejcTZjarcNd3xgiJEURwxHc1etoSFGKo6XbbY+ck9SfU1u20eAuabZSQRocZwevNXI4iRnB21MkaDHTntWNr2tixIt7fBmYZ+lSo3FzdjXG0Iu7A5qCdd7Zj6Vyqz3cpLyzue/tWpYXsm4Ryt9GNDRUTWgBLEAYqc8dR7VVtnxJyeau7gQCaLDluDqcg/rTguT168UFvl4IIxSK3PFKxFxrgx8A5zUExBU9zVrdkHcvSqcg5z60mFrmJbN5F1NFyDuyB7GrIf881V1b91NHKvrtY1H5xxnPAoRpa+pqCTBAXrir9s2QAeBWDaz7mz2rUjkA2gHk0xSXQ01ODgYxUUrY3YHy0iOHXHepVH7rDL9KTJVluZshOepFLjau45qy8Y7jIqNsHPZfSpsy3JFSRgRxzWZdjcSO5rXICfNj5TWdf4B4BqlsRpc5PVbXccHII70Vq30e9ckH8KK1jNpWRnOlCbvJHJWESrFvJwo70y91sxqUtcFh1cj9BVDUb3cvkxHbGOCR3qLTog0hcqD/CoxWyXVnM30RZtoJ71t91I5B7Zrp9K0JXxuUBfpTdIst7qNvArR1m9a2jFnanErD527qPT61m5X0RrGNkVtVbTbCJoyqyzDqiDOPqa5XStNS71YXDRjaDkL2FaLW+Uxgk9Sa0NLh8kHA5NNOy0Ha71OmsYI41QELj2q6baJckFTnkYrOhzgbjye1OaLaMgkMDkVlZG8W0y/G6KRjHWrsRiaNlBG7FcuZnjZir5PXBNQ2uuAjCgtN02e9JJmrSfUm1O5FlfIFG+STICjvjvVnS7Ge5uBcXWC54A7KKNLsy8huJ+ZXJ59PauggTGNvWrSMZzLVrblFXABq5tYNzgj0pLcNgcgYqVsjOcE0NGXMMG7uMUjgsvIpy7jySBTwDtosJyKaqQMY61yfiOZrnV47fjbCMke5rtLg+VG0nZRXn0TNPrV07/eLnmi1kEZXZt2ilQBtFasS8At6VltcR2sDSSuqKo5JNZkvigyrs02IynpvbhRSsaKV9jqZZQqcnGPWvNbrUBd+IbsxneqvgHtitRzf34IvLltrcFU4GKWx0W3tWPloEBOc+tCaSNFBslh85xljtHoKtKpIyHyRU4jjC9fapEii5IPPvUXuaOEUizZT7owD97oa0ElJTHesa1CpcqpbCvxk+taixlTjdzVIhsto2FIB56UpIUcnkVVLYzzzUXnFuCcYoIdy08mT14pkhB6nNUpmcDOePaot0kmMMPxqLlJE15Es8LI3RgRXNTXHk27xucSKdhz9a6ErIFwWUZ9647xhHLbXNlIGXZI+1+OtVFXYr2N+yPyLj0rWtky4OeKxNNfKLg8CtqEkYbpSKbNSFVQZPWpww9TVGJuhJ79+1S+aMnPQ0EWbJ2CsDnBHpVe4QAfJ3pscisxGCBUig9+e+Km5fJYqFCOG5HUVTul35J/GtdlGMnFUbgjacYyD0oBbmHLGGOwjiipZRmQk5op3G4nkRXcwXsBk1saZH8ygd6yID8zH1NbmkczjrxXXPY8+G52Gmj7OjSdlXj61lBWlmklflmJJNagc/YiOgHJqgjAQgCsEdT7ERQbh2zVqBNrADvVYn5+eKvW+DyDzQwjuadqoDc9qn3rKSO3TNVYWIU55q5HHi2TAwWOc1mdFktWV57FHToCPpVO10qGC6Z1/i7nrWyAQADSGHJziqTsTuX7WFVjUDpV2KPaOlZltO0XyOeOxNStqUKHDSrnOAM9apMxcXexso4HXikMyvnHUVjSX5zuOQPpTorok8DrRzXBwsbIKlQelTKVZRzWUs/GTk1aikJGSadzJi3YDnaf8AVjk+9edfa4rW7vJ5mCoHJ5713d7IVicjrivFPGNw4vDbgkDOSPeqiruxN7K5qSXdz4hvMtlLFD8q9mrp7GyWOMBQAPTFZ+h26x2cKgD5VAroY8DAFTNm9IekC4wF5FOEJckHgVYiATJzmj5nY9hWZupEMVluwSwxVn7GqggDPvSr8vFOMrBBtzQiJSbKV3agghc56iozqUcTLFOQkh7E9fpT7q5deFUsx7VnRWLSymac739+30p3Ek2aBvYnPEiZ9M0+NXcFlKt9DVA2wAxjimm22gFcqfY4pXK5DSPmY5U4FOXIH3W9elUI7q5hQ8+ap/vdakTVWAw0LZ9jQK1iwxZjyp/KuV8enZZW0hRgElH0q/qOs6gMCzgXnu5rDv7fU9YXZqFyfJznYgq4JLVmc7s1dFlV4lOetb6zADGenvXLWOmGFdgd8D1NaUdqRwSSPrS0K33NxJ+xYD2zVjzgUByPSsVLQA5wealEDBsoSMds1Fik0bcL87h0HarUWWwRx9a59LmaD7yhh+tadrerPxwGpAy9LGWwc4AqlcxYXK85q6WLqAG5zioJfvNuwSDjFUTExJ0bPfNFXJ8bjxiikjW66nhVtLyPcZroNKk/eg5rh7C8DIgY4ZePqK6rSpgQrCuycTyaU7nczSFdNcrjOzk1mwSbo0yetPScT6ZMsZG4Icis6wmDRRnrgYNY2OxSuzRdsYPXHFWrN8kCqfDAg9+lSWr7HFSzSL1Oms4vMHPatOaMpYo4Una3P0rJsbpAQueTXTWu2W3KZHPrUJXNZtow1lDEYPStG3G6P5hjnnNUb/TZoWMkXzITnb3oguC0BGSGGMimLdaGibdZ1KOOaof2HEs6yqi+apyDVmO8Yvk8kc5qY3fGWpaME5IGG/bGwxzmrK26gcYrPt7lXuskcVrR7WXINEUZzZWdGxjtSiVgOR0qwEG7NNdRtOMfSrsZ3RQmkyCCc14r4ikFz4kkCnI83aPoK9k1T93byOuRtUnPpxXiEZMuuKxOTvJrSl1ZE9j0TRmAhGeorejzj5sc/pWBpQ/dKMfN3rciG7PODismdEbJFiPHIBOasx5VSWIFVkBBzih2ZvlWkXuW0AcZzwatKq+WRxVRXVY1HepQ3UUEtXG+WjSHIFWY7RdvGOlQWZWRmHetKJMEKDimS9DMntQAQM1WMGBt61vTW5JGOlVjalW6fjSasUp3RlvbDaOOO9VJLbnA6VvSwAL3qs0PHyj86LBGRim2ULhqI7cD7uKvmLcSMHrQ0AXaw6Uti9yl5YBPFWYocgUyRTuODg1NE3ADcUJicNCRIsdKkFuCAc81Yji3LxnOOtSrGSuCMUGZnyQBgRgGqMtuUOUYgjpitpo9uSKglTKdKbBPUr2V6Yhsm4PrWsDFMvy45rFlt2Zc7ait55LdwOq56VN7Glr6o0bqLC496Kcbneoz3oo3BNrofJ6OUcEV0/h++BYozfSsRdOllWUoMlOoFQW7SxSgoDuWvSavofPwnyu6PTba4MOJF5Xow9QahRzZ3rQycI3KH1Brm9O1zgpMMZ65roBcwajYiJ3G5B+7cdR7Vi4WO2NVPY14Jg4HPtVq2fbKM9K5exvdkghnIDqcc963YJw0hyR7VnKNjrhNSOnhUMUYHBrYtpXVVAYYrm7C6ORG/XtW1bNuUj1rFqx2LVHQw3oaMB8HA9akTT7S6O4sqt3wcGublWeL5k+YU+C/dCC2R9ad+5g6bWx0B0q3j/iY+pzVKeGCIEDLN2yaji1EMME5Y9qoPM5vnD9ugpOwkn1ZfhiwAQMVehYhcZqlE26rKvjjGaa3JZbWUhsEUyTczZTimj5h6mpwdo6VW5F7FO6tzPBJG3VlK5rwu8ibTdf2SdUlwa9+kYGvIfifpph1H7VGMLLzn3FaU9HYzlqjZ0qXow59a6KBsjdXC+HrsSRRtnqBXY2spIyegHFRJWZtB3RoxEnO4mnkDGRVOOfDEMPpVhpAUAHX2rO5tZkhAK8U4ORnn2psZUx464pTtIx0zTt1C/Qt2YVFJQcmr1ux6nqaoWrAYGQKuRvzjFCIkaMbFyAO3r3qYRhQSSMmqkcvlkED8al8/f2FUZNMR1B6gEVVmUbenAq8ZV2HaBnpUBG7AYDmgFcz4lCjJGQfWo7hc4AGK0JFXaBjmqkvXGB9aho3g7u5nyQnBIA4pFUsRxWhtwhHc1CUUEetKxtzFq1IKYAPFTk9MdTUMLjAGAPpUwZG4PBFM52nciI4Of0qs5CqPU1ZcrwRnjrVWUbyOwoY0hdhKkdBistlCsQa1A4Vcc5rOu/9Z15qWaU07iH5QBnIopjN8oGM+1FBaPEpD/wjl429fMjuEH1XmnxWUTxPLbxtJOj+ZGqjO8HnBq94w0qe9vme2ViI1CnPAA7Yqr4an+wX9l5xOXYxuM8qa9OOup8nf3ebqQz6LFqkHmwhYbg5zGOq4rmbyC90+QxuXHvXqer6ZPY3B1HSEVTktNjnr3xU+nW+meIdNjUMZLojEgI5B7n8615L7CVWyv0PGjdTl9xlfcO+a6fRPEAbZFdEBx0f1+tO8T+Ep9OkzbxSPDz85HpXKOu1MFcN61lKHRnTTqte9FnsOm3qTBWBBNbSX/kcsDt9ewrwux1W8sZFa3nZcduors9F8fyKyxX1oki45ZOv5Vzyo9j06WOja0j1aDUg4BGCK0I7+JiokjQ49q4GDxDodyQw+0QSN/cXjJ9q2LYtIgaF3Knpu4rGUGjsjWhM7P7VbIjMqInHUDmsYfvGZ+5OaoRmQ8OxOK0Lc/KM1Nidti1auQR2FaUI3c1lDAkGM4rUs255+lNEzJgCCDUrMCOKMZHA4phHemZbkcpIxjpWJ4t0xdU0SZAo8xAXU/St91UgcdKgmXCFR0PWlezuUjxPw9IYJpIH4ZTkZrt7SclVIPsRWZ4v8PyWl3/aFghKn5nUDpUWlXiyKpU89x6VrL3ldBFOLsdSrjORViF+xxzWfZSfN83Q1cdQv3TWNjfm6GhGVVSFphcAYY81RN1sQ4HzDtSpOkyB0OT0IqraErVmnC+CMfnWjG4yM+mKxo3YIMirSTEAbsUkEkajOETnkdKl85RGpU9e9ZjzhgM0olyeD8tBPLdGk1wMZzye1M+0MQD3HpVLzsKOQajDEnvzQ2OMS411kkH1qCSQsQV6VVcnLbaPMIXBPapZpFW2LQkwMk8+9ML/ADDGKrF88E9KVZGPA5pXNUjRBAC89OgoZuueDVTzQCCetDSjGc8mkTystGcEEd6jDZHzjiqZlJcdvU1O0hMeO1MmSsEsgCgKOc96oXEmW9DUvmZY8cVTmyXyaTLhoAlC4JyTRUU529MUUA3c8+luJXnugzkj7Qg59MVzWvEp4ncJ8oDDGKKK9CG58nTWp6f4dkaXT4xIdwKnOea4fxJK9l4nhjtGMCFcER/L160UV1R+FGFL42j021VZtJt1lAcNHkhuc8V4f44t4rW7K26BF9BRRVVdh4bdnImV89f0q5pTs1zhjn5T2oornOzqdZpg+RT34r0nQ5GNpFk/w0UVz1T0sIaCMS3Jq/AflFFFc7O1luP7tXtOJKtk9KKKES9jTj+6aYACKKKpmRIija3HaoZANwFFFIFuVLlVMTAgEV5b4ojWx16P7IPK3n5gvQ0UVUNzSXws6G06L9KuuTs696KKQ2VpWODzVGKRk1BAhwGPIoooYkdNCxZRk5qZDzRRUrcsGY7hzSoTsJzzRRSK6Dxywz2FOycDmiimAjE560w/eooqXsOJDEcuc1ZiOCcUUVCNmMl+8DSgnFFFCCWwE8mnyE/rRRVIyluRMSGyKrSEl8nrRRQOJTkJK5PXJoooqWUf/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Confluent erythema, microvesiculation, scaling, and crusting on the face, with similar involvement (to a lesser degree) on the trunk and arms. The facial involvement is more severe due to easier access to scratching; the baby is squeezing the breast skin to relieve the intense pruritus.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Fitzpatrick, TB, Johnson, RA, Wolff, K, et al (Eds). Color Atlas and Synopsis of Clinical Dermatology, 3rd ed, McGraw-Hill, New York, 1997. Copyright &copy; McGraw-Hill.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_55_23408=[""].join("\n");
var outline_f22_55_23408=null;
var title_f22_55_23409="Ampicillin and cloxacillin: International drug information";
var content_f22_55_23409=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Ampicillin and cloxacillin: International drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list synlist drugH1Div drugBrandNames\" id=\"F2215624\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Index Terms",
"    </span>",
"    <ul>",
"     <li>",
"      Ampicillin Trihydrate and Cloxacillin Sodium;",
"     </li>",
"     <li>",
"      Cloxacillin and Ampicillin",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F2215625\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antibiotic, Penicillin",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block iuse drugH1Div\" id=\"F2215626\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reported Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of infections where a mixed infection is present and includes penicillin-resistant staphylococci",
"    </p>",
"   </div>",
"   <div class=\"block idos drugH1Div\" id=\"F2215628\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Range",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     Dosage expressed as combined ampicillin and cloxacillin",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Neonates:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     I.M., I.V.: 75 mg (1 neonatal vial) every 8 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Oral: 90 mg every 4 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Infants and Children &lt;2 years:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     I.M., I.V.: 125-250 mg every 4-6 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Oral: 250 mg every 6 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Children 2-10 years:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     I.M., I.V.: 250-500 mg every 4-6 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Oral: 250-500 mg every 6 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Children &gt;10 years and Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     I.M., I.V.: 500-1000 mg every 4-6 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Oral: 500-1000 mg every 6 hours",
"    </p>",
"   </div>",
"   <div class=\"block prod-avail drugH1Div\" id=\"F11821067\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Product Availability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Product available in various countries; not currently available in the U.S.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F2215629\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Capsule: 500 mg [contains ampicillin 250 mg and cloxacillin 250 mg]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Injection, powder for reconstitution, neonatal: 75 mg [contains ampicillin 50 mg and cloxacillin 25 mg]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Injection, powder for reconstitution: 500 mg [contains ampicillin 250 mg and cloxacillin 250 mg]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Powder for neonatal drops: 90 mg/0.6 mL (8 mL) [contains ampicillin 60 mg and cloxacillin 30 mg; sodium benzoate; packaged with pipette]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Powder for oral suspension: 250 mg/5 mL (100 mL) [contains ampicillin 125 mg and cloxacillin; sodium benzoate; fruit flavor]",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10457 Version 28.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-201.65.114.212-1237D62C13-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_55_23409=[""].join("\n");
var outline_f22_55_23409=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2215624\">",
"      Index Terms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2215625\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2215626\">",
"      Reported Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2215628\">",
"      Dosage Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11821067\">",
"      Product Availability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2215629\">",
"      Dosage Forms",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_INT/10457\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_INT/10457|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f22_55_23410="Snuffles of congenital syphilis";
var content_f22_55_23410=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F65509&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F65509&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Congenital syphilis: Snuffles",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 324px; height: 432px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: the Public Health Image Library, Centers for Disease Control and Prevention. Photo by Dr. Norman Cole.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_55_23410=[""].join("\n");
var outline_f22_55_23410=null;
var title_f22_55_23411="Patient information: Pregnancy symptoms (The Basics)";
var content_f22_55_23411=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/85387\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_picture\" href=\"UTD.htm?36/4/36932\">",
"         Skin changes on the face from pregnancy",
"        </a>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?39/11/40114\">",
"         Patient information: Acid reflux (gastroesophageal reflux disease) in children and adolescents (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?20/59/21426\">",
"         Patient information: Constipation in adults (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?40/15/41202\">",
"         Patient information: Hemorrhoids (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?4/2/4131\">",
"         Patient information: How to tell when labor starts (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?1/39/1650\">",
"         Patient information: Morning sickness (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?36/56/37762\">",
"         Patient information: Taking over-the-counter medicines during pregnancy (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?34/10/34977\">",
"         Patient information: Constipation in adults (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?39/47/40689\">",
"         Patient information: Hemorrhoids (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?36/63/37874\">",
"         Patient information: Nausea and vomiting of pregnancy (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Pregnancy symptoms (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/pregnancy-symptoms-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H31241686\">",
"      <span class=\"h1\">",
"       How much do pregnancy symptoms vary?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Symptoms during pregnancy are different from woman to woman. Also, a woman can have different symptoms from 1 pregnancy to the next. Even so, there are certain symptoms that are common during pregnancy.",
"     </p>",
"     <p>",
"      This article discusses symptoms that can happen during a normal, healthy pregnancy.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H264728955\">",
"      <span class=\"h1\">",
"       What symptoms are common early in pregnancy?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Early in pregnancy, sometimes even before a woman knows she is pregnant, common symptoms can include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Nausea, with or without vomiting &ndash; This is called &ldquo;morning sickness,&rdquo; but it can happen at any time of the day. For most women, morning sickness lasts only the first few months of pregnancy.",
"       </li>",
"       <li>",
"        The breasts getting bigger and feeling painful",
"       </li>",
"       <li>",
"        Needing to urinate more often than usual",
"       </li>",
"       <li>",
"        Feeling more tired than usual",
"       </li>",
"       <li>",
"        Mild cramping in the lower belly",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H264728970\">",
"      <span class=\"h1\">",
"       What symptoms can happen later in pregnancy?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Many different symptoms can happen later in pregnancy. These can include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Heartburn or indigestion &ndash; This can feel like a burning feeling in your chest or throat, or pain in your stomach or chest.",
"       </li>",
"       <li>",
"        Constipation, which means trouble having bowel movements",
"       </li>",
"       <li>",
"        Hemorrhoids, which are swollen veins in the rectum that can be painful or itchy",
"       </li>",
"       <li>",
"        Stuffy nose and nosebleeds",
"       </li>",
"       <li>",
"        Feeling short of breath &ndash; This can get worse slowly as your pregnancy progresses.",
"       </li>",
"       <li>",
"        Low back pain",
"       </li>",
"       <li>",
"        Leg cramps",
"       </li>",
"       <li>",
"        Trouble sleeping",
"       </li>",
"       <li>",
"        Headaches",
"       </li>",
"       <li>",
"        Bleeding from your gums",
"       </li>",
"       <li>",
"        Needing to urinate more often than usual or during the night",
"       </li>",
"       <li>",
"        Feeling tired",
"       </li>",
"       <li>",
"        Your hair getting thicker",
"       </li>",
"       <li>",
"        Mild swelling in your feet or ankles",
"       </li>",
"       <li>",
"        Numbness or tingling in your hand, foot, or leg",
"       </li>",
"       <li>",
"        Varicose veins, which are swollen and twisted veins",
"       </li>",
"       <li>",
"        &ldquo;False&rdquo; contractions &ndash; Contractions are when the uterus tightens. This can cause pain and make the belly feel hard. &ldquo;False&rdquo; contractions, also called &ldquo;Braxton Hicks&rdquo; contractions, do not mean you are in labor. These are different than &ldquo;true&rdquo; contractions, which do mean you are in labor.",
"       </li>",
"       <li>",
"        Skin changes &ndash; Lots of different skin changes can happen during pregnancy. &nbsp;Some of these include:",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"hyphen-block\">",
"       <li>",
"        Skin color changes &ndash; Your palms might turn pink or red. Also, the skin on parts of your body can turn darker. This includes areas on your face or around your nipples (",
"        <a class=\"graphic graphic_picture graphicRef84005 \" href=\"UTD.htm?36/4/36932\">",
"         picture 1",
"        </a>",
"        ).",
"       </li>",
"       <li>",
"        A dark line in the middle of your stomach from your belly button to your pubic area",
"       </li>",
"       <li>",
"        Stretch marks &ndash; These look like red lines and are most common on the belly, breast, and thighs.",
"       </li>",
"       <li>",
"        Spider veins &ndash; These look like small red areas on the skin. They are most common on the neck, face, upper chest, arms, and hands.",
"       </li>",
"       <li>",
"        Skin tags, which are small growths of normal skin",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H264729008\">",
"      <span class=\"h1\">",
"       When should I call my doctor or midwife?",
"      </span>",
"      &nbsp;&mdash;&nbsp;You should call your doctor or midwife if you:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Have bleeding from your vagina",
"       </li>",
"       <li>",
"        Have fluid leaking from your vagina",
"       </li>",
"       <li>",
"        Don&rsquo;t feel your baby move around as much as it used to",
"       </li>",
"       <li>",
"        Have back or belly pain that doesn&rsquo;t get better with things you can try yourself, such as resting or changing your position",
"       </li>",
"       <li>",
"        Feel faint or dizzy",
"       </li>",
"       <li>",
"        Have heartburn that doesn&rsquo;t get better when you take an antacid medicine",
"       </li>",
"       <li>",
"        Have a headache that doesn&rsquo;t get better after you rest for an hour in a dark, quiet room",
"       </li>",
"       <li>",
"        Have pain when you urinate or blood in your urine",
"       </li>",
"       <li>",
"        Have a fever",
"       </li>",
"       <li>",
"        Have contractions that get stronger and more frequent",
"       </li>",
"       <li>",
"        Have pain when you breathe",
"       </li>",
"       <li>",
"        See dark spots or flashes of light, or have blurry vision",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H264729023\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?20/59/21426?source=see_link\">",
"       Patient information: Constipation in adults (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?1/39/1650?source=see_link\">",
"       Patient information: Morning sickness (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?39/11/40114?source=see_link\">",
"       Patient information: Acid reflux (gastroesophageal reflux disease) in children and adolescents (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?36/56/37762?source=see_link\">",
"       Patient information: Taking over-the-counter medicines during pregnancy (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?40/15/41202?source=see_link\">",
"       Patient information: Hemorrhoids (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?4/2/4131?source=see_link\">",
"       Patient information: How to tell when labor starts (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?34/10/34977?source=see_link\">",
"       Patient information: Constipation in adults (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?36/63/37874?source=see_link\">",
"       Patient information: Nausea and vomiting of pregnancy (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?39/47/40689?source=see_link\">",
"       Patient information: Hemorrhoids (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?22/55/23411?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 85387 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-61.55.141.10-46FA143880-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_55_23411=[""].join("\n");
var outline_f22_55_23411=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H31241686\">",
"      How much do pregnancy symptoms vary?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H264728955\">",
"      What symptoms are common early in pregnancy?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H264728970\">",
"      What symptoms can happen later in pregnancy?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H264729008\">",
"      When should I call my doctor or midwife?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H264729023\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/85387\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?36/4/36932\">",
"      Skin changes on the face from pregnancy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?39/11/40114?source=related_link\">",
"      Patient information: Acid reflux (gastroesophageal reflux disease) in children and adolescents (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?34/10/34977?source=related_link\">",
"      Patient information: Constipation in adults (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?20/59/21426?source=related_link\">",
"      Patient information: Constipation in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?39/47/40689?source=related_link\">",
"      Patient information: Hemorrhoids (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?40/15/41202?source=related_link\">",
"      Patient information: Hemorrhoids (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?4/2/4131?source=related_link\">",
"      Patient information: How to tell when labor starts (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?1/39/1650?source=related_link\">",
"      Patient information: Morning sickness (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?36/63/37874?source=related_link\">",
"      Patient information: Nausea and vomiting of pregnancy (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?36/56/37762?source=related_link\">",
"      Patient information: Taking over-the-counter medicines during pregnancy (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f22_55_23412="Black grain histopathology";
var content_f22_55_23412=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F78858&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F78858&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Eumycetoma: Black grain histopathology",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 297px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Histopathology of demonstrating black grain with fungal hyphae and thick-walled chlamidoconidia on the edges (Hematoxylin-Eosin stain x1000).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Beatriz Bustamante, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_55_23412=[""].join("\n");
var outline_f22_55_23412=null;
var title_f22_55_23413="Female perirectal perivesical sp2";
var content_f22_55_23413=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F66156&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F66156&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 486px\">",
"   <div class=\"ttl\">",
"    Palpating for tumor extension in the female perirectal and perivesical spaces during radical hysterectomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 466px; height: 435px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Placing an index finger in the perivesical space and the middle finger in the perirectal space allows the tissue in between (parametrium) to be palpated to assess for tumor extension.",
"    <div class=\"footnotes\">",
"     BL: bladder; VVS: vesicovaginal space; VA: vagina; RVS: rectovaginal space; RE: rectum; RRS: retrorectal space.",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of William J Mann, Jr, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_55_23413=[""].join("\n");
var outline_f22_55_23413=null;
var title_f22_55_23414="Ulcerative breast lesion in blastomycosis";
var content_f22_55_23414=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F83717&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F83717&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Ulcerative breast lesion caused by Blastomyces dermatitidis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 406px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAGWAfgDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwCZHkLIY4ssx6HOR6mtWOEKEc5C+o7+1FiiIxZgwc9Wz1q0EEbDBZQTg47/AIVgnc+hb1tYZMQ+GCgAg8nOelRIEiIj2tnhA7HnPXFWCrSB/LGyPPCY5z6n/Cn/AGdcI2H29AD0PtSGrIktoPlLRSAsecDkfU1Y8vauIxj3HJI/D1qZY1VvmJOMcKOp460+NNjSgFzkbsg9CewH41Wpk5BGkUm2TZISOAxHT29qtzo5EaFlLDJwpI59Pw9ait4zscuBvAKqvPyjvx+VL88eI436/KrBRjP+e9PoZNu+hG9vlVZ5MkthVC8D8qg3vaqzZCuDkBQAv1J/w/OraZSQ7SWkOSXI46dTTpyZowQxO0n58Y/H3qG+qKUuj2KckHmt5jMzuwwVweM9DntzU7xCFy0an5V4nIwM45POSf0pqxSo2w/vZDyQR+p98etSvEHUq7AcY2scsPcf5xQlbUG9tdCeJgqq6kHcuWOOAfanth42Xc2wkZCjHNRW3lRny4yrKQM9xn0+tTLN5iLIrK+3l+c856AetXuYtdhoWOFwkTrkZIGSxz7nt3pjRLM6kPuBzwOM8dM0qvIZiqR4DHkEck+uKlwrMTESwAwTyR+J/pU2YWtqVjapkyNl8cLgZ9qgaIFws3mRsi/MqtjPPHTvV4RhiY42YYyXw2B+dSRRI0ZIVACflwcfjiqt2Hz2WpRgTaXUhWDDHHBP+91xU/lAW4wDuAz8q8n2z6fhT2hwcNh0HB2jr+HTPtSxOxYYIweMthc+2KmwN31RCybZMeXl1GenQHuRVqEIFDAK6nj1z/jUUcjKrgKRt4Geh/xqZCVYMzFcjgMvP5npTS6EybFniXDBmCZ67u4+npVdy0bARLgZ2kEZ4+tWWWMHMTbiR6jnn3qF0LYV2bHReelDiTFkDxEviVevcemPSq4UoPmYhMcHbjB98VaEQxGwZlPoSRup3l5BCBVBGTlaDS/QpRxCOQuFwAMDb0/HPep5CMnEQVtucZy36cU8xMCQJOD8oOBuH+fWpVRAMZkAAzz+tGqG5X1IDHtRigUN06Z/ShFkG4EgjoWboR9OtWzBlQ20Yzx8vX6YpGRXQAEbiO5zz3/yaTiZ8xRZW3lAcnBwAcZHrSLJNjGUCEYPmLwB2ORU7xKsbEAFf48g/wCetMeMohKLnceFz9446YNO1ik0xJQQmWKlF4OeoPTqORVOWISbd8Z3AEZJDAj+dXdjOAzKWUHJ3dj6GoZ5CcEuUyvRhnNJq5UdBq+RHgAgbRjb0HTg+n6VVFqIxufBkxwQMcdsY/CrYAAcKrbCMA+ox1GODSSIkaFF2ehxxnPfim9dx7bGc6MHLeWR/CeRx+FVH/eSqdmxY2yzD8s45xg1qSQiRgj+YikknDEj68c4qAWxmQspX5SVUg446dR/Kp1LTRWllWBSVIz14GTj1OKhkZ3cu20MBhcEkjPfI7+3vVq9WQIsSxpKMAB/u5Hpx3HNVRFLIzupKgcLHgH8c+9K9ylFWuRXAEKttm/fcEDjjPqfT69aRYI94YlGZud0a/e+o9f0pZm2IURcbsDITdz/ALXemWYZJmV0TeH425289vrT3BrQdIqDJ5Xp8rDmqLQh7sPIFRz1YNzz3z9B9KvT+Yhd4Ua4RgN0J+8rAdU9e2V69x6VDBi4hV0dZU25ygIIB7MDyPehpmadrkMojlijEjY3c/eAPHoaxbqVzErsxOck9MhevT/Cti7tAmIVjXD5XJ5C8ZOKr3NsPl2vwSPmZM4OO1S+YFyrUwnl3nyp1dWCllAP+NQmNiiSmMkHKvjoR/8ArrYMH2eUZOxUHrk++DVO/uFQlYDIxGBkksM+47VSV7tmM3dpIgWMFiFWRnjJBDZG09yPUfWmGLAJYZHfJC8//qq2UO1JGDbSANsfHHc5PPHpTXlWLaI2DKcBSB90AdMUMpRM8oq/u2YAMPlBUd+3tWbLEI5W8zlycZJ4OegrTvvKRPOELvjICrjJ/UdappC8kKqYkQbum4Mwz6kVGtzRJGXdTusis7GFhwoXrjHr3Ge1RS/Mu5SSVTJHQepFbM9uiK7AgjGMk8ZPXP8AjWUu1ZCpGVb585yVH+FNtp2ZSSaujN2KFO5goLHHGMEj+VV5dg2hdzg8qQcMO2eeo9q1720dwHjb93t54PUnr9KoJaMj4A8z0bPU/wBKGhOxWmURpyu+UndnG09f51SABdllA34PPT3/ABrUawMcUjIm4dww6d8n/Gqs8I8hXUgrjg9M+mfSiLMZQRhy2+37nzBjy2zOD7jv/Ss+a2RZJRtLAn+Hk57c9q3EQ7XU7uCTjd+YqneSL5oOVySAeMDp0+lWnZXRhOGtjFezZoizZDZxzjr71Qlj2NgMGHqK2p4c8Lkc8H+7+PvWZKjElXwGHrWsWc8oO5UNFKe9FUZn2dY2ywRnMskpJJ3SYLYJzj6DoKtSqqSELiTgc8ZpkpCQgqMynt/jUlovmkByccEDNYI+gtpdiLHuBMYKjt6j8alRd+UKkjrn696mIYttycvwcdAadb/KDkgJngHqcdfwoJ5tB0SPyJAvUZfk5Pv/AIUf6qRg7NnACnGM+w9hUsY8wunTaflJ4x9P8asLGh3KXO0qMH29qr0M3KzsyvGyzzE5ZIxwR/ePYkenGMVOzt5gVWy+MMccD2+tNDDG2MMh6lsYAA7VDhjswDjJPPY+v/16L3Jsmx7Sn5sF2Q4+6Bj6Y9akhH7lS24soywGRge5qUIABvI3YHuceopwYu5UYKdwB+hzSe5LehTS3Z5i5cyKPunOAvPb8KuRQxhNiBS56N/fP8z9adJGhRckAHqCeB/n0oh/eKSC5BG35hjHt7AVSQpTvqVpVIOwqGwQpGzg8dSf8KngUqgULtIHygcH64H9asKihRtBaQ/7PH/16URhmLK+B0Drz/8AW/KmS5dGRIMIwCbnHBHJLfWmbMgGONiy8DB49/p+AzVmOPBxlQUPXPQn196mJUkCQ4QHC4+UY9fU0t9yeexEkbKPmCKoGcFcYquyosu5Wcbh17Njt71oAoN4VQNy9C3H1qrJN5srEpgDof8AA9qGTG7bE2EHzFfrzyv5VEsil5E3QidApaPIZsHIDEdcHnHbipgoILhQwPU54FMSOFXa4WFFnKCN5NgVymSQrHuMk4HvRshsikUyPuAdiRj5+nr17VKVYxqSTyOwx+FTsMqH272DA46c/wAqiZFkcfKwIB+XPSgfMNQE/MDtbk/N/I0Sh9pKhSQOQGPJ+tWIjwCwByOMDOKhmkjGUJkUngkAgn9MUaCu7lSTzWmAKmMcHdgEj6d6nMTlMLy3PJ5xT5Io2JYB8HkcnineWsZyz7k6BG6f40Dcik6hXJYsWIG4gDJpuH3HczYJChs8/X86tqPMk+VACPlOCMiovKhjlLS4znGTz9KTsWpdxzHbHlkIKjC7W4/D3zUcbFsDrxk9P0qeMbi/lEY7qwJpkiFS2EAOeNvTPtRbqJEYYEsBhz2G3GPqajIAQl1IIGCAcke49aVUCM6+UqF/myP4uOTT0XDr/D64PIphtsV2ti3CkCIKNuwkZ9fxpY7YKu1ywUZJAJwan3tywBYZII6HPr15708unKknB7HgD2zQkh80loUU83pGypnqQAcke4/nVGbzC6lFLAE7gRjavsf1q/JJayMShDAnIZCcd88iqzkbSQ7R7Oc4yWHUGpehrHfYTBaMqCoI4APP06c5pqyB4j5CFXGCSRkEikFxHJCJI2G8c7l5wf5jpUi/MMFgoOTu7t9aWj1Q7Mjl2uWVCnPscc/Wqkp2EKUYDsR0xWlMV2kImTj7wbt7dx9KqNbcBt26Tbt3D7p55/lUtNAmijKYnUIVYjoQvQj39KjBYjLEEjhWPPTpkf1qzIArMYyNpAYnb/Pt2qt5yrt8oM+0ZCHI4NBduxEhmRDlApJ6qSSO/TFRzQxXs3mSqTNjIdCUZfow5/DpWgjRyO2MqRlcOCMn603y/KkEh3YXJJJyDn1pozlbsUWjClAx3Oq7SJWO7A757mq8jyh2UqjRseGHYe4/wq9eQ/aI5CSHbnOT8rCs2VRC5KsDnHy/19qbROjRDcRGQ5QYJHykEbifWspI5IrlsR7VwQSTgE+ufWtctKyS+XGB85bJIGc/1qg52hnYYJJBQHj2XBPf1oir6mUlbQkdlCDzV2yEdhkEfh1+tZ9yUkYCFiI+qt0571I0pi3ANgMNpJzhfb+fNRTzmU5CDyQuQhP3h9BScro1hF7lG4hJn3FnQn+6chvX29KurbpFFtkADN0A46/hxxT4rd5NplKuNuBxjB9/89qj2v5TiQDap2ghsnb/AI+tFluU3zaIoXkaOrEhskDCkgA8evb+uKoukn2ZPIVDLkZV8n5c8nPbjkfhWlNC7NIioVIYAsnyY6dyKo3REZIO1cEjKqefxqVZvUdr6IoSRt5YZZD82Rh/m5Ht/hVVftECyZ3OzH70fUmr0eZxE8oB2npjA+n1pJYQhwwZg3IVj83HPWhasHa1ilPcmZmWVmOOSg6Z/wAayL9fm/clxxxuPHuPar+oAlwOMYy57CqM8u3YrEsm09T1/GqeouVFOZHyMhlYjIc9cfT/ABrD1C0cSKWJAJ/H610EJErNgMQuPvnkDvj8v5VSmcMQjxhlA4LdPapT1szOUbamZLE0iMgfcMDGTgnHb61nXK/f3ABsZLd61ZYUz56EMuRgA8r6VVu/kZ8xK2cDJrRM5px6IxJBknbyo9qKlmRQrHJDHt2NFbHI1Y+zQxYgDIx8pBHNXrY7HAGSMYIxxTiFfhCA3Y46U5ofLB5Ulh0J/maw2PcbT0DY5XIwwZsDn8M1ajiYp0Ukcdeg/rUUCZjDFGUbQMdz7VaiAxyc4zwOg/Cn0MpPoMjUABIRgAck9B9aWVVC7WZircEAdPr6VLtTdjIIbqM8GowpZdpUnbypIwM09SVqxiMCzcjrjb2zinGNc8D94x+Z8YJx6Y/KlUiFTJMQT/d7AmknlBjURjdsIO3GBj+lJ2Hq3dChlWSM7wXBx93hePX1qUL8+Q+5x3Hf60QLvOVVVbsVB49qn8sIxKoC+3aRjA9aaRLa2IUOcbV8x1c7lB+XPuattDtG1uWc4IVRj6ZqOI7XUgqpP3lC9alZnZQNrBT8xAwMj61S7Gcn0Q1gqkKT8mNvXHbofSlUlYvlIBHVj2H0qvGGxu3AnJbA4wP896mw28bzncOM96GKw3eCuAq4J4PTNKxkMR2KzHPIxgE++e1DMqqXkDMWwABwcntz9KcjZZk2Zx97GcDI6E+1OwfIAAcLjecYIA/SkVSyqCvfkAdMU6NSqsq7EH3sDOMdBTsBY4wxKDkpxwKQNlhY18gqFy4OcnpUbRGQKBsDK2Rjn8aCg2B1PDNhs56euKkljMsJRgAp4IBwNv0FFr6GVykYwrt5odgcsuOdp7kU1HIOcOB02ggD65qeSFw6uCsnVeSe/fA4pGhG1omZixwepIJ/rRa2hpdMI8nJDLgHPrx6ZppVXJKzpICMjGSOP8Km3LbrndED3XnP+faqzODKPK2p3AU4BP8ASnvoJJt3Q9VGwlSMD7ygdvp6UrKifN5m5h93vgenvTIg00mSuQmRhDkDn9atb1Y4BJ79eR7Y796LWB3RmHAMituA/iXABJPqKt2xBJB+XgDlTj8KbIpYiNWOF+YHp+FMB8tgGTO/5g27p7CkzRu60LDwthgrKFABAPf8abJC3B6Ac/KeM+uKcZOBl90RHXqoPrnvTiyGNsb9gPPzdR9KOplsVZEALI3ccjr+OaiEQRUOWRTwG7E+/wD9erJ2jGcheoPXI7ZoZ/MAbBwPXoaTtctSZVmVMLuXJ4Cc4rO1Gx+2bhLLLGANpKHaT7E+nXitQwqiPtbYp5O3n9DVVWwu0FtuSGxyD74PIot3NYSa1iyK3thaQRwR4jhUHCx4VQOmB71EYmw7FiVyeQ547c1YMqHlsEoBnH8PpU8aCTO0knnqen+FFkPmaV2Zs8CwRiWFUjYAbiB94e/+FRRSQl1KyZVAPlX3PvV6QKRtIImUgbD1B+npUbW6Ruy4KsxJJIxn/wCtWdrbFxlpqQkqwCN8u7jay4J56g/nTZFCtg8hxkccY9hUs5MacxhxwCRxkev4elMkk3OCACrdB0GRQ72uCv0KbwhMrGecF93JycelRbVeVVDZcAY54x9avSxHy3MqfOQcD2qLAMY8wBjjjbStrqWnpcYJEUMFQtn5SvpjvUQ+fOGIOcevGOKr3asHiKytsB4yMn6Z7U+KRlJEinB+VSnb6+tO6ZDjpdD5Y/kUNwR0HQfhWVewFxjcQOjDGdxrUuWTALeozgY4+tVbk7QpQhVOcH17n8ad0QrrUpW9uyx4kwTg5Oawb/Y1+DG6GVeACOmfbvXQSByg+XaP4htzkDOKx7uK2juPNARTgc4zzn9OtVyvZGblZ3ZWeJ12rOq+WSC5VvvEfXp/WmyQoGkcsBG2OgxkCpjfBk/fLtQN8wI+bPt7VCty0nmKpYcklR1APoazcVFm0OaSuT28cjrjBHTd7j2qCY75VWJDkjGc/mTUluCiBmdjg5UOeBnucVD1XceQMk7R94+tD1DZ3Ksk8ka+ZMxZlYgcfdGeFz3xxzVO4jWQsyl2BbI44yOp+lWpC7BmKHOckgZVh069c1C0a+TsKgHoADwD/hU6tlRdioCvztHnZ0OeMH/Ac1A5Z5NjHlefl5z7A1YltHjk+Qq0eSPpxnOPrVW7ilUq8abyRt49R/SjWxTs3ZFK4gdmXAUE/NgDgHHIxWPqVssqoUDEschXJAbHaumYSTRs1xDlgAGGOg9qovFGpZcjGMqcZwM+9VYjmsYkcJQbZHUk8bRzu/8Ar1nXlskkIRC3B7+ufWta9YKqYYKhO1u3IrPu0QW6kyBXQEjPUc+tFraITbZlyiVV2Dlg3LgcfX8ap3cSLvb5gcdMZyf8K05fMMW8KTEM5APKjPXH51Rls1nVR5qKzDIZjVJ3OeejMa4j29ACD6HIoqaQMhKsCScqM9x/SitUzknHU+02jLXAU4w549/arTKW2IzADjIz1/zxVdvlcAH5uq7v/rU5WYyRs3TPJxwPesvI9ZpvUvhSfuYJHOTwAKZJuLEjJQjrnoPahnHltkbtoweelCSsDgk4PRR1PHTAqjJJ7j1CsmYm5Pygkc8VGzh0zu2kDqvX60Ss2RtUD/gJ4+v+NTlcpIsa/MQBz+uaG7he2rI4/NlX5AEOOnUH3qsyNJMBKGYR4JVAen4VNcGRiyLEMIcZ3cgdvwNWFj2xuFz5h/Dcfwqdy78uoKAi4VsDGR83T8al37XUl8Z4A7tUUkSzwtE5yH+9tOMdjipo4yCFIwOoP0/rVLyMnbqT4WQI2flwe2CKYxDYwrM44BNMzmRg7cHsDwPrU4UjIixzzgZ5FUtTNqw2NR5cm0+Zu6+4pkiiPIXJB42x9zinLJtGMrlcj0/KnEARgqASejdOfWmLZ6jWZGQqDggAAKOn1P8ASnAiMhdzKAepwSe/ApTFxudyFHU993tjpSQrv+dsoByAeBn1NCDoSbyfk3L5Z+YAev0pjEEqVZVAIGS3b0P/ANapNoYttbJGc568+mOOaCssRV97SAcfKBn6j0oZKHcFSEZVwMcZzj8aZbkk5Cq2cdOOPf8AwqQ7WAyO4GQQfzzTc7ThhlwSSB2/+vQhXLBYbdzBfmIxkjP0qNVRzhTuyQdmcClWFnV8sDgHBIANKFeHoGxjhlGOPemTp8yOZ0iUCQmNfQL39eO9QSREhnZT5hO7djP4Va2nBEqFs8AZyfakXcIi5G3bkgnIJHSmUnYg2iNlLbQQSMY4PpShVeJXyAQcHk8+wxVgx5TcUwrAljwT1psAZYSyhVXHJHNJhzdSC4jHls4QEHqqjGMfzqIKAhDDfzgFuQKt3AY4dMEHlt+MfQVCJf3hLEKG4J61LHF6CdXIQYIx26cdfpTiAg2gncO3rT2X5W2qABwBxUafIAm8EdyBxSAa6bYdrAI3UnpxVKaMOwG4H0I5x7cVZnUhgPmOeCq/rj8Kh3KhKRHacfMCOlEkpFx7irhSwLKxHA/LoarSgkAEEqTg47fgOamwcIzbm+bAPQc1JHGyou1kx2GTn6+9BV+XUzLlCykPtJUgEluvPb/69LA0MbbY2ZTtI+bJz/hVxlUHcRk55CgYFVNQJWNj/CQP3i9hnvQaJ390lldflkKMHHTBGT/+uoZGRGz27H/6/aqr7mVEQcjkbuo/GpQilMlsYGCvoKh3voXypbsZLtaQIq8HgqD909sH/IpsgKD7ys/B5XB4/SmxII5Y0bbgjqOp/wDrVPLExGMMdwOG4PP9KW43ZOxSaYyZIDMxxzjB+tLFhz8nA6Enrn3oMP7zJXDgnMbdF9CPakCs74XgKvVcHOfWheY2uwyRF8py5Uurc+3v+VZ00y2z842sMgDkr659q1zbyNGHOC/qe4qrLbqGIcnI4yFBNNp7Cg11K0blzhQuAcgHt+NMEccbZQgM4z1zk9f8mnBRCHXBwCduAPT1pr5+UsE553DrjHb0pbA1fYpFiqFHIUBuGAbp/jWFdsyMQqIoBPUcH356/SuhLeWp+8ztkMW7/Ss+6Ee3a6juoZlOPUfjVRkzKUU2zCjhLIFO5VcA7jxyPfsOK0FimNvvdUG0YD4IBHcUyaaCMIMfMo3EE4/Q9qe14ZnJXDZ5GPu9f5ZptXdwUmlyopX0bvIGYYDdc9OOmP5VGf3f7uUK5PIKDJXjpU99cobeR2YIVO0ZGMf7Pv8A0qhbz25laOWRUXJITOcH19+vH40uU0UrotTRF0/1e/kdT0qGSRg2B9zHKkcL9Papo5EVpPJcBI9uNp+VT6H1+lUrzCwtJmQfNuJI6+4Hp7VNib9GSS3RkRMhPNBJI6AcdcemPSsrUY/MSRYk2sfmBGeCD0+ntUiXBS5bYvLAEADOPWpQ4kt3jztYsefbsKGrivyO5iwzyO7NmRAPlZB/PNVrm5AkcXPzAr6Yz9a1pY1QyOpSN/7rdDx39qyZUD70IyoySueAenX/ACKlJ21LupO5mXf+kWxCrlnAOM5496xWjKzsrHC7RhS3JX611BhUtsWRlZ/u4wOP/wBdY+pWwO7y3JyMbSMFvp+VVa1rCuuhUEsbsFLbn5bpnb7e9UbiFhuaInc/8OM9up/xq9JblQhzjGCO3Pb6/hUeoxRKdyO44GQBgg59Ka1VzCbSZhywlAMOkzON3Q0VNcqRlWAwH/XNFWmnuYNtaH2GtvHucCV1A6ZfnNT7JmKAvgY3njnA9RSRQ7okkZQdx4XPSrQh3SAyD5eu30P1rOLdtT03OzI1jZEBJURE9v51NFIrMqHBGSQcYxU5IKHBBBGSMe1NS3BO5l3AHcB6D1qtzLmTWpNtUMSxz6AfzxTmaPO47FDHqR1NRyFVQNyEXjeD6+lKoZp2Ax5eehxkDHBoItciKNIm5RuZj1bvzwKsx5KlsnjJKjI59qTAYkliMHJwtPTodsZPUDBz070wcgRWKspwD70quzj5xgg4BB/lUjRM4UlQV9fTj1pSmDIM7d2BjHSmiLrqORFJGQnJ5JFOwxmcmVzjGAO1MMRUGJS2ezev/wBeonJJfA2bR94ryTTehNiTyXxg7WHYHuP8KcitHIoZQy8LjrtH4dKfAwI8wFssOm3vTUkbzHUA4GASo6/WgRMULEYAYMOS56e3vQUwMkncOB749qlj+7ufGVPSgbGdecKeCScZPoCe9Mzu0RQgjICnZ1Jyf6dKkYqQWwV7HK4yPWnq+HJUZI4+UYx/jSyJujCuMrwPmFFhdSvDJ5iSSKVVAf3e5ev4etSIqgDcny8ngYJPvTljAP7smMrltuMKPwokPysVVtzcjnimO/YIUZJSW2+XnkD/AD0qRm3KQFbjuxx+NRI4ZgVdSemCM5HsaYI33E7gpPb09+aaE1rqS58xlIJIUZIUZz7UwAKGyuR/00PQVKqyKNxm3qAOOhx9aR0RSGAwMZJBzuFIV9SIyr52wE7ducHt/jSxKDJ3DfxAHqO1DMEiUx5PORuHU+g9KkULKwMh5c9CM4I96TQ3tcbJAJCA6DcegxjPr09qi2gHBiAx8pHVcVZYgMVZvvDjPQikCpyoOM/N8vY9OKZKZAmVUlt2ecEn/IqKRNrYjTjoAAcfmKs7WEXCklcnBJyw/lVZfmz5QXaOdxJ4xSsXFg5LDaNuFOCOQfxqvcKzKUJKkeh5/wA9Ks3DrNGMyKhHAKjOfrTNmPlz93lWGMH/ACO1S0VF2KwDKqpIDuz065+tDRsNzI7RgHrjPI7HPT8KkkTljjB6KelJID/yydlIGMNyPxFMu9tSswkdH3rlB0KZ/XvVe4YG3IkVlyoDBlOSO/TtV8yFMmRduT1zn8aiYBssUBzkHd296mxadtbGQkMsUgMYzE+VDBuPUZqYSxICG3kseycHHORU8pAlwNm1v4sdPUfjUdyql1U7l5I5H9aLWNXLm3GSjzduY1GDkMPX3pCJImZSW3NztxkdO1SLtiYOgJA5b3pXuBIsbIwXewOHGD09KT7iT6dCscOcuCXX8PyFNWEq4Zxs2/dG388/41NIRvDAqFB+b0qGS+G8oFxk/XIpJLqV7z2Kd5qUFvMsM7mJ2xt+XhsnAwaZc5c5H3/4QeD+dPuohlXmT51yRjk9e3pVC58xmWRZI2AbIDfxdsexpu/U0UY6WGTLv8v58OxHyg5z/jTZDCRskOVB6AdvQ1KoWZQSCo6kKc8+5pHUqwz2O0leOvtRpcllPy4vKTA2Dnb1PHaqskn7na4xIOCcfKD2PqM1cKlHZCRtxwxznI9apyr5q8Nnd02jIA9OKEr6ky1KkyFJAGJeYgEkj74/p7Cq1xbSFt/klWXJCnoOOc10FtZqLcZIAJyWHXp/hSSwxoW83G3jlucjtmrv0ZhK17o4+6SWSMySkIWGMYBCD3/WqVnax+b86b8qCjcYAHHB7e9dVqMCKnKfKSe3PArMs445fNk2jywSSM4IOOKE1fULy5bormWCGP5IyjqwDHPY+1Vr2RlMoHykAnAI6en0q9dojzBQmQB+8Gfw4qjeW7+S6iJd5OCc9M0m1cSjLQyXmZRmKNieGQk8/SnJqPlOYwgMnXAHrUhhZZDgOQOMYycVnvZSea8yMwznBBGRz6+tFuo3duzFuLsyoE5BVSTxzVSCQKwBGFAIGB0+tX5YIvs5Kjy42AYdznHf3qjPAqIwQH7nUnv7VDWtxKelrCzC3bEgc7RyQpwc9/51kXDxvuEDCRozxzzk9qkS2mDGLLSLngY4Xjgj0qh9mlg3udyNuLZA4/GmldXRDny7jYU3x+XNuITjDYHX0rMfcVKBm3KehAOTmtBmdQ7fKDj5jyOM9KgnCujMgXJGAQKr2emhk629yjIIkdW3Dnv2bntRUV+mT8oj3A/hg8celFNxM+ZPU+yLRT5ZwNh6E9cD+taEfCdSXIJGRVG2cl1yjbs5Pbp1rRTDLkkbk446VnFHqVWPVAdgCjIB/GnxYVNgBYDHAPOfeo4yCcHOVHJI6+woZmReEYO3pzmmZWb0BM7pCPlYNgrToxuyy8Y4wO34021kV1MwBQEY2kdxUpTMY4z34/woSHLTQUffCKeAMnn9KlXCEKAPU9CPxqFGbOT8uRjpjrVgRqy4Ax0OBTIlpuPRgWkBY8nGAam2AHjA+neoUjwOSu4g7qmXhmOQeh2/5600ZSa6EUwIVuSMk49s0JGrJnaPm4wP89aSQksAVVmHAHb8aawICjOCc803oPoSN0ALlDnkdh7dKkRMrv2bQRyAePrUOSTghSo9en0qZA7Dnccde4pWJYuzAwvHqFHFKAuwcggYyCMAe9SKdowjKAO55welDLiQb+RjnHGaexN9bD1UYXDcqPTPb9PajZ5gAIUnPIbt7Zpqh9iqqEDsSelSeagyNvQcDrVE6js9geQeD/PimlAHySvIzj0470eYoAB3Bie68mpDjcSoOB3A/TmgWxBLGFAGTnPynHU+wpudm/cnII5XnFTgbAW2jd3wM1GQWZgApJGMf5/rQNMXBMa5QjPHI6D+dKilhhR8qqMHNOAKJxkOfRc9O/NIm50ZgnJGcA/55oE2RlELnceB2HGT7U9yQjEnHHB707Jzsfaq4xkjBHtihVJCgA7R8wJHegLjFJySmCSMAcYz3FI/y4DBeCMAnB/Cl2B3bejPjuTjJqJFAlZ+PTK0DQrnJX5S46kbsZ9//rUgTLlm+UDpk8U452/IE45Oc09jukLZwR90gdfwoFcgc7tm4nIJ7YGenWoWjOVMhPyk/MBgr/jU7Luf7pLAk7sjrUAJUkMvI+9k5zSLW2hDJFJltwGCc/McECgKoi4AIwefT/GpmYAKq7ACOWb/ADzVS4fEqkZd2/gJ4570i1eSG3KjaQr/ACtwMjPFQp5+HBXco5yTz9KWVZGB+eOML3wTj05NU2ik5Mm+T0BIUH8qTbN4rSws9yvRcsMlWYYI/H0qrPeIqoEbzVPBIGSAfX/Gp3t2aMRlAsRAPyDHA/zmmoi+UzIEYsf7vDelK5suVLuMikhJYhxnjJU9T3FVLq7YOm3a6k7dx6L71enhL4kdiHUAMMAfpVF43E4K7MgbgMYAHoTQxwcb3IvMleJsEyFvvEjOPyp+8RqGj3u69cDB/A0CZgpwqHGef4l9eO/1qT5HjLByoUEYB9e/0HpU7lNlRrppFdirZXlmxgD1qo2XDHbmTqVIwMmrVqZIrNYri6S7uNnzXCwiJWOeDsBIB7Y71Ckimd8Hr/BjlfXGKIjWqdkJFE6xswGCDzgZYA9qZNCHtZY5WljEiEboW2sme6nsatNwAFJDjBOVxuNRefJInZe+W5Oc8/rRbqZzK8qxBP4ck+vI/wD10ilAzIRj0GME/wD16QRkqrEBzzg+nNNDrFKAVZlOc55I9/pRzEtdCQo4TLgEsfveg/umq8yDyWVumed3Yf54qzJIW2tuPlDpgDn8aZGge3UouwL8irnPA9+/FCavoZPRXZkqjFlyS2ScBuwHrStp7Rys8RAVhggkHpV5oz8yrj5W4J5I9vf61Smm8mLBTLKTk44x3o9S9ZPQqz2xilZlYKp7Yx61XkgVtxjGDt2EZzge9X3Kzn53YAjARhgY7fyqteXETEiNWL4wcdD/AFNJvsNRb0ZheSVlmaUDjjJP3sdqRLYFGBC7l55OMH6U6SPyXErI6KepwSufUj8KuCFSo35L4yCe350oN2NKkdDFvY1kMgJ3cdcdPTFZh815JfNaEQnHlhM7wR1znj8q6e5XcyZbcuMDHVvpWXJD5bqqZK5wSeRQZWTM9osEoPmdiGypOT68+1UpYMMGV8K3fHX3xW1LbuQxUgYxgA4/Wsy+hkjkMbsApB2nNF2tCHG5zMgV5XLqN3Ck4J2/T19arwwyL/DjngjnitmYLnLkqFGcAcg1VlDMhVdxX8MAjsf51pGbaMKlJGHeWxRyrjg8sRyPpRWpJG8hxIUPqM+1FNS7GPs0fVflmM+YJCojJPA/T6VNAxxuEhxkKeOvpzUjZEXBB6gntTFCNLtUMAwzgdCag9PmutSd2MJBHzr3Y9vf6VHLLu/iAOPvDqM+1IyKHYFQVAwQTn/JpUiABdV6j5QThSO2e+RSd2CStclsyyMgA3no3pVtDuzwdo+9j+VVbYsqPlflXPHYj29auqwa33fMqkA9MH8feqWxjPcbIhIOAzDb6d/r6U7zCGUAHcB0qKSfEpAZmIHJPI96ktpd6pldpXhvQ+9JTV7Ca01JVfgqwDD1z19zT4+AQQuOtRsoZ2GFYE5BPIqQ4RlG4FtowSeDVK5nboJIrM2VGR2JHA96YUkeQLnCx/efGN3HGD6etSgOAzgA5+6GPT8KRArOA3THHuatBsCRM23JG8nPzc89jUyBmQ5IJHJ29jUZEasSCS59cnPqKeJEx5eCuRkY4xmgl3YuCJh5ZPTkk4P+eamX5geVIzjbjnPemINipyoYdeeTT1cqo+Q9cZzxTIYoGcntjIGen5U1AysuDnI+6xwM1JId0XPyr7HtTVGEXgE54Bx29aBeY4q5bdnntkdfp+VMG5ixbOB05Iz+NOfeSp7jqA3IqQD5gdxI9s9aBXsMTsVVSwPr+hNKCwI3xuq4J67v5U9FwSxHyAccdaRlCgfeO4jO3FAriZwAhTPIOc8UwBQAMhcZ6nGfxqTKuVBGc8DjJxSSkBSVZRxgjd1oAagKjlsADo/U0oJyCVAYegO3FDPgg7GxjjPGPpQ0vLgFunp0/CmAvmPuPXYB+GfwqORV6Dco7YIAB96a5IU7EVZGHUtmkSTDlAQGHXaev0NA0uqFkR8klgQV7t8x+nvUZDBzhMnkZzjbx3PepMna+5AG/hycZqsSHGEjLMv3eOD9PagqI245/dIOCAT7H1qMsq7Q7OG4HB5NSK6rGhXLSfxN1/M05mDsxUEkgZ5wrGkXdrQYEGcOpVOuOw54/H3qEw7MiLaFB+bd0/A1cPK4bYRjPzHp/WolwQFzlTwDjn8qTGm+hXWMlW3Afd+6QMn6+tRyRsc/KAvQ+pNWo87gB1AyOO1NcrFkHJVhluc/iPpStcfMUSP3pEpPHQDoR/jTXhRoSr57g4PXmrFxMvylDlR94gdqoSStNMQuVIJUZHXjqaDSKbKk6lZGbzGZTncpPT2FVpsb0GTymVBHPuSe+On0qebJKtlvvbt3QMM/kB7U2WM7FeIONmSGPGDUKyOleZmO8iuGYnlgoG7II9vSrqwv8wkySowAw4x2py2//LSZ9gxuB6k9+lNk3oMsSM8/NyBVaMbbKdyjIGBwDgcEbu/WoreDy4VXO456465/rUzRO5ywY985zxT43O7y+E2/dyeM+1JIfO7WK7RfOWk/efxbQcEc9KkhXarAbcg9cfzq4IVcHDZ/r61AUZiSCeMg889e3tSuZ81ypcRt8xyUcnb14qOGMkk9GzgHpVuVVYNuCllJwPWoZAUyxbAbt6+9SlqJvoMCAHlF5G3A4Bx1yKUBwo2oqtnHBB9qVnkkG5+M/wAX+PpT5wXjPDAnHTjmi/YhruRMFZABxxznriqMoR8DIZjkMxXI/H+VO3hgR8zHJHXGOaI1KRnayEdMdh+XWkveGo8upBJH5ZLMoYY5bPUehqlJGjNncWdVx8vbnPPtzW2NxVVCx5XhsVk3xRUYlQjD/Zz3ptDi23YxZ5A4QKxDk/Meg+gzxiktZNkOGePcCRsPOOf881FcxAy7mGQG+6TjHuAfzqRBE0MWBtzgJlMdCai9jpcVayEliCSr0Y9+2Pp7VTvJUjcRnJQ8gY5PP+FWJnZJgCjHIyJCRwQO1URumKF5VJHOWH3eP1pu3Qy5erKV3KAhVWPy9if0qnIsjlMIWyv8XH/6qu6ghUFlX936H+lZ7MN42hiOoI4yc9/U1LvfUVly6FW5XE+5RuZhg4PUZqiRKVZYm3LknBGcknk1uTojpuaMDBIOPX1FYxiYBlAPXOAR07fSqTa0MWrlC43PIYyFUE9PQ0VFepJuUBiBywLDvRVadTNQfQ+uEU+UCybQWweM4P8AWpWTCg5wSeSBz6GoI51Eiop8zaOPY/SpS42AtlegZup/Si6N2ncdHnziCCCBgnHB96HXaFAb5d2M9TmnMi70kTjAK89CtTIO7AjPbPNNoXNbUhikxsByy8AkdBVidisbeX196hWIvnccDOVA71IUJLL8zDsf6UWaQna9zMS5cZAO7+LC/wCea04JmdcqobA7Cq5ttm5MhRk7s9R+NWLeIghsqMEjgfzrGEZJ6l1JRa0C6lcrlT909jjmiymlaYqygsRxtPH/AOupkjORuJJBIbpzmpExHkxp2xzyT9B2rdK7Mm1axIQdm1l7HAPf6GnK6LtG5sLgFumAKjMzfd2bQRg55AP1p0WBkAAbscDnmtLXMmtCX5gCxfr3Hb/GkMBIJbCgH5RmmwhzuO0gg455zxQkkmGzgEdv6UhWa2J4zn5SV3jqNvWlYFgecvjuOOvQUxjkbXJOCCCBgg/0p3Kk7iBx0JwDVEtDk+9wMbRjk9geuKVC28scfd9M7qCRjcOoyTgUiyZ2tuIXsAvX8KCABkYnlQDwc9PY095GiRS24EDkMRux60rgDIVSSRkDtSKgYsqqDGQcqo6kfjQDY/DOoYHcx7E4H40fMhwipgngAZz69KRBl8LuXI6dRj8alcOqjbsycd+CT646UWIZAwcOcDL5wVPBx/8ArpN2HIypLdNx4YjtmlYACQq3AGf16ZP86gO7acfKrcnceCOTkn6nsOaZS1Hfech2wcYZd2ef60yOYNESCzEdsEk4z1x2+tNfJRDvRmC4wFxt9fbFCo0qZKk7hnCjAz644Hagq2mo4HLg74wo+YfL6j3+tAjBBTzQX64Jweveo3uQmPNJwSOD91j0/CmzypkFjGxHI7MB/hQOzHlU3byhLr3ZtwB9QTUUrbCFyoUj7irjt60snknhuc9n4JGOo9TVWaUK4XzsICDGhUnJ7GhIuKuXXlRWKrkLs7Agf4VGW2sBuymBwBjHNVI5GnlQjYVGWV0PO/kHjp0/nVlFKrlzvjJ6AYbHrmhjtbcGVpWKu4wM5+XBpoO5lw2CDgd8mlkJLl2jCEDKE5HH+NNecBS67ecnBP8AT+tTZDsxHkAK8Y7Kccgiql3O6gqAX3gnjg/lUl1MPKJXD+oBGRkdTWbIHNywZgEC5LMMkEdh70pJ9DSlFbssFztV414HGfeoh5hDSYUMCTt74oiEp8t22mQYVgP4gemKbPGxdhtdmB3BOuOaVzVb6laW1hneJrxFmSKRZ41cAqjD7rKOxGTg+9SeYfmMinZ1z6eho8xVkdEVkI+YDpk+3+FSqcyMTwR1OeB6/jSRT8yvJnDHcWTGwjH5Y9qz4ZPMbPzeWhHLd+mKtOC08saSERg55/w9KlVYwT837sKOmcDPT60PTRFXsgAUqN3yxngZx1qs8WZQpIBz065qzuZYX+VlUcE4wMfSonTL7WAZSM5A6VLkZocE8wbVchM9fT6enNRNtLZYbmxg446dG/8ArU6Qgp6AE5Oevt70zb94BcbRyc/57UCsRNEXAZmyR/D/AFqnJORKy4y5JHA4GO1XJHL4K/d9Cex61TnIzhZCuByQKiTsUvMiWXcgLKVB4CnkfjVpGLEjbgYwAeOajK8q7AgHrz/SnOX3jYzZ9T29KomWo11BYcbWLcj+tQMmB8owoz0qefzG5JLN0yDjnvxULMvyq7YU9/8AChtE2vsUpyIlYRAg/ewO9c9c3Uqhz5YZ88b2/PFdDewj5TDJxuwA2OlZyWwnd2Kj5G3LlOM+3rUSudFJxSuzMX72cbsHILnjB7GppnV1CgkvjJI7VK67ZnZjl1bDbQdvPTiqk8IAHlcIfmyufl/pReysXuxtxZyKqBm35G0g9SOtUm2o+UUk7gGBOBn6VfmkZI03NlRwvGc5PcfpUMhWWIzLhgh+bdxg+1Fr6oi7tqUriQyq0e0FcA/KAD+FZsyCPJj+91Ax0B9vpWiqfvRvnkcMGfLEFsnn/DiqlzH+6CPhieMjtRurmV+V2M+a6JTyxGB/ewM4HQHNUJIyZmkdcIB94nnH+FWjhZiZCQyEocDqfeqt3MizOscmDjdjb39uxotbUVuiKMiNsKycOM7jjp+FFMvmPntvHynkEjBHHPPpRSUiXBs+oXjdBjPOeMVdiIkZSRhsDg8nHpSSuzsAvyg9zT4mAWPByQcbm6/nV6XNJNtEpVlwRncOeamiduWIyfag4VQwOc9/U0JJuA6hgeR6e1VYxbuhXUCRSAMDPUcf/XqUoQQASD0GOT/+ql3ooLAMeO9RJneAMD0b/PWqsTdscqBQNy789OMn6mmq4dtqKS5/iA5/OllQvhQ+eeR0JHpQqbXC+nJ5oK6DvnIwdoHTLenOeacg/dggFUwOc849vam784DA475HH/6qfCJCcq6EA46dvShbktaEghVl2sOTk8NnANSq24lQg6dv51CkvloEA3Y+8Mdv/wBdSxDacuTkcE/1qrkO63Hsm9SMuB9Mfjmm5YqBGrKCefl4p8qKSfmYlfTk0oG4Ky5xwcsf1p2JTG26kF+VOPWpsAfe+703Fe5pmxty5O3jA4/zmlcMDgPkk54A5HrTJeojAEEEEAdcjrQdhwC2AxBBHBxToY88NuBHYHO6nKMtwRhOh/8A10Cv0BBkZ+fcfQ5z+XSpVLZyOQejFeM/nUL5yEXoDnCnpTgyiRiSd2Bn592R/SglrqOeQt8q7tpx8oO3H1pmOGV5QGB4AHP9Klk2sDgAjPQ/L9Ki3NIHDvIQCciNccdetAl5DJgERRPIhJP3toyPYehqE+WAWMZU4CliMnOPX1+gqVpX3hUiB45RFG4Z7Enj0qB3cKpjiWFVw+ZHJbGfb+lUkWhDJIY1xOqYIyzEcAdsdqhMrExjdlT94MOQO3ShsQ5lupQmFMjdCSO2AOeBnrTQVYRsVkKu33VjyCMcH36Z54p2NEtLodNEw4jkYOclQgAGOuRzkjr6VTWZ/scpmt1aLorBcbh/dPv9a0PsqnkQD5lI3hlA4+bgdR/+uoJyr2kgjSRohkEKgyxGOv0P8qaSKjLWzKCywrBAVRoFB+6UDlTng8jp64qXUW8qVU8syFGABR+UJ7j29u1OjuiieW8c2SvJHt/+rNPguIHjkSd2iLKRndkkDOCWxx1pXRo7p3sReb5abwjfdIQcq5p8V0MADcHA3naOFP8Aebt36UxETylt5NwMoZWLjgkHpkdOnameap8uMMixPJgoSSV9gPoP85p2uFrrzJpXRzhGLDggndjP07VXQvJGFMny5wPm6knrmnR7pZmLyoEUDAjxnPcnPf29qcrRM7ozDdsABHJP4dql2GlbQbJ8pKAfugcggg4xTDsSQ7wTn5+mSB2//VT2kSSRFxJgc4GAPpn9aNkjbijNkkADpz6ZqJMa0ISrSExhyCrff6YGOgq1DCCSFPvyfvf40xI3Rs5wjHdjkn3FKXEbBfvA84U5OB61C3BvsQX8O/d5bBXXkEHpx0rCE1zNE08coZFJAUjjjrzWpf3JkQJjbjqwOCR6AVFpMYOmgEMC2cAjBwfb8qfobwvCF3uRaahSNtw2MzZDHn6fWpi+HwWVdx4bHf0xTzsaNfvKM8nB4NV5IHPDKMHnIP8An61MmK93cWRCVZei/wAWB9729qfGCcKVVeQCAO+PWpYkdWO7JK/wE/qanEyqQvlkj1Ucg1KXUzk3sZm0lyrrjnjPAb8fWo7iREiYuykZPJPI9qvXE8axMX65wBjv7VQA82RXnXGFIQE9Pf60KyKSb1aK0dwvmBU2vgZAHp9KS6uomURC3ZpXPG7jk9s1YljRHAXCnOD9KhuY1fGMow75waUm2UrNkW0xjALbcZIXotIjoGKgHbnkZwPqTVTc6SOFbd7EbvyNPkZvL2kcHjg8/lUvTYHEm8zYxMuCO3oP8KYyjd8vI9Pr0zUBl2MUbhgOhORz0NQSXEkO4jlBk7c459MUnIXKR3qOF24GPvFscj2x/hVEyTYTY+wkEjn+X1qSe+8zas6ZOBgqDk4/lVeWQMvynay/cc5xSUrq6NYxa3RPNDOqxrGh3dCxH8PfFYt7tilKJhQMKFzkfXP41oNdSD927nkjDdRjHQfzp0u4pjKEHHIGeP8AOKGubRCV4vUzYpGDIJABjnpjd9TTZJlG47NhbCgg+n+etTTRtLF9/JAx8x5z3zjtVSe0kWILKOHX5ecZPrn8qeqVglZso3VyolXCbdxIPOMH1qFbdplwTyxJB3YOOe9MkbyyRIT5hHzDsPT/APXUM86xuI0wzM2eDjB/pQt9SZRdtChebkiKpGxZcsHJGc+/eqCRSbWLhtvc5z361svEhAxkIeSD1zWZdOqMNxQE8c9+/wCVNoi7eiI2tw0TNuYuDnnk0VDdCRDvEe1f7oPTPaigzsz6qcjnIG7AJGev0qSCFfOBcAZ6c5yajgiUKS+dpPOece1XGHyA/dIHXP6D2q0u4N20QgRdpXBCYwQDgGjGzCScsRgDHWkAIYHJBIwPf6USxnqe5G7mqEiZiyKAzA5BH41DtZgvmMzBMEZGPw9+1OAJ6k5ABzng/wCNK452nJUYIA6c0AnYkjGScsAc4Gefwoxhw568kYGcf/WpFyuSoLZHrjNKzMybfTgkDBFPrYnrckl2srF/urnIz09KbvYMNm1gRg8/qKaCFGN5UgdetIq+V8wJ+YA/N2/wpgktiURAEsGHzfwnuf6VOm7fglTgj3HTrUfmblX5VI9QeB7Uwk+aGPJGQQO/4U2TZvck8x8Z6H8/0qwpCAZxjA5PQ1DFhwvQ/wB04yP85p6hgp3dB6U4kPUlBDsNsmcZIwKaAGUMp456n+VRBiS4BVgwHPf/AOvVlfmVWDBVHBJHP/1qZLVg8zADH5c+2MmnhgXT5hvxwP8APFNU7m54J5JJ7fSkRz5Z3FkAbndwM+n0oJaJSxYBQOHHAyMfkKaTHGHLbfbFMlIXPlkE544xx7U0kCMNGm7OG2qfl+tCJS0H+Ymc7S2c4JU4/M9OKTzcrhxhuBgNtGD257daQlljIkDhducIvI7+v0qFlLoJGZHbOCFyxwR1PfNMfKhySyCFlHkhOSOr89hgdKZLAnnW8bTFwUIYBOdoGRz168EVHFdO3722dZ/LIDYBUgnjn/Gp5XWZEaOBzJGXU+V8zBjjGD3zk9aoesWIktul7cQSMIWkiUGPjHKkfe9Qc1i3Oqi3TyYHkMMQVWkTBAwpJ5xjnB+mRSeJrqKG2aOSfykMhR5kGWQ5GGUeg6VxsV8qWb4YEYTbnrKQWLZx68f4UNq524bC+0jzs7g6rDLZq7MgBjVjhSRk4+UZ/n7VDLrUImuYLCBFjnyxU4A3nGT9MCvO7rXUjuESaZmuWGBAvzFVAzzjoPrUlhrlj8qs6xyvkRxsAMk9ep9O3Y1DqwTs2dX9nxirvU76wuEuFHmKzu/I5+ZzjqB2QDpnv1NV9WvBJKy4Vg7EqXPGPTP90Eduvaubh15ogYTCYYTguM5L+gY9T646VpxaZNfql2zOUhIeRw+TIAfuNntyOFx7VakpLQzlQVOXNPRG1YEPax/M25RvBPyMgHoB3Ynn0FUZkeO9VpGfbI7KSp3BHGMjPuO1W4Ii6IygMVId2bDsRkDAXtyQMZ56npU5juTvWWVnKOQCrg8/XHbjJ/CntoYRnyyYkJVZSytG8PK78Z2j+E9OOtTxk7TIkkbyqflOMEnH5VmxTXMdvNFcTR4dfvg5XGej4q4Fk+xqTKjKc5iVd4cexHqR36VASj1CTMeEf5XKbiMZ4zjk/wBajdioYKVYk555Pv09uKI2IGV8tY5CRtfqBjPPtTJPNj3PIAd3IUYHXv7DFSxpdBZrg2qO7KVJGFKjr35qulxBwE2gs2V3Lt/WlmY7thfZEihuAGB+p7VRlnjMBWENIXJK5OBkf0JqWawgrag88ct5hjvccoevfpj196vxXEPlhnfAwST6Gsu3Rps3M4ABIGM9MHkL7+9XWiWPzG3Ntz8y9ql3KqRWwkUoJ2ZIfG7GMH34p0bukZdE55HufWoHjZV3Hcxzw2O/tQk7b/IH3cHJ7/8A1qnmRDjfYlLNECxyFPXHOaalyV4O4Dk7t3H408xkMCowGXgA4rPVfOOfuxhs/Mevpkdqd2KKT3HwyPKBKR+7TIj7ZB/iNRXYdZAzjdGoxx1B9atxMPI5+YdMHqfeopAxjAk4XgNtGallqXvBGVdFEhB28HHvUN5GY+Bl0K5IByRj0oXGQ0fzjPBHrTc+WQWjH3ec9vY1LloK1mUjEVjyAN2c4PP+eKhuLprcjcG3HlWAGPpViZXi4U8AZ64/Csy8kjeQqqsXYdGH3v8AGs5X6FxXMxk8xkPmx4U5wV7/AI+30qpPgKoZ8HHHfJ7Usk0ZEqs3lMBliDgD6VlXOoc4RpW2gktwcCpfmbxp3ehfs7Uh/NZwzcg9wR9P8OmamnG5gjYIKnYT2Ix+tZkF+7RnzMowYfd5PTg4/Kla8cyNnJVVwd68KfY1cbJWQTpzvqKrgzOijdyCc4Az7VK3ktBh3O/PAPXP9KiV8sflKEAgliM/SlZl2kO2SWyOeMe1PYzmuxUuCY5HCEkg446Z9M0mbhkkLD90Bxn19elMnCpuJLbeCVbpTLe5m2DaxAJIyW6fhVJp6MiS0uVLsEJhWRiwySR+NZLMFddoyHG1jj9cdjWtc5y3zKoPGBz9PpVFVEa5clg/zZIyfX8PrSRL0RDdygbEBZVB+Y45wfesq5t8qvzliCfmPzAn1xWlqEisUZYyvQ5xwfrWYGuFXase4KcgE9vX603uTFWV0UNQa4i/dRZZXUZ9DRUU0haVlYMSePm7ZNFCsxbH19Gp3cLjAyPenIC24jnpimxHKgMDj0I4p4Eca43EjIAHJzngVoYt6iEAtuJPHTBoSRyRuXaD05zU4UdS2Mc5HY1Fv3fdAyOtAXvoR3BfaS2MEcYH8/Wlt93Ic529W9aeiEvxwx/WpYgNpUcdvQYoitbsblZWBAWU5yWX/PApyEMpIJZ/93pSE4IY8DHI7VIBhPkbIPY8VaVyG9SMq3zFlxjoD3pRGJFUnJI4JweakYMNvTPr605jkryuOme2ae4uYj8vYg3bmAHK496dkNuCgEg7s5GSf6VJE21ccnqDznNNEWzlQpOclumaVuqFcVhhVIUDJyR1GD1xTXQNtABwOM5pWK7D82Bx2OD7CkAlJChdqrg4IzkU0BKoGMFV4HOBjHtTwxdmCfd/i4zn2pigo+1TvB+bOeT7YqJ4zvUqWIwRtPcnp+XPAqiSaOQBsqB0PIPJJPrTw4ZmYEDbgZ6E+wz71WWURsigDaV4wT+VSEPsJ28kZ+Y+ntQFiWZ9yndknGflHqf89Kjd2Ukqu0gnhTkn8elMIZowBypOVONq/U/rUUxRRjJxuwCOnPf8f60k+rEl0JlO6JT5ayRr8xByc+oJ/rVaS5eElYk8vPICyBT+VLvQeYzRxYVtih/lD/T6VVNzbkyys0YaFWY7F4Xj7w9DxgjkHNWUo+RNfSxq24hln+/5n8S47HHJHH9RUMj3towur+cRQ4PygZfywAfYDGe/NUby5MBgniIXevyb0BAUc+vJ9Pr+Fcx4h8QXOoytD5hkMuFwwxvA5H0x6iq8zop0JSslt1uVtXuZtUuWeQMwcED+71yMn8K4vVfFFraSMtiUY+Z5RuXOI0cdQB1bjv096xvHniaS+K6BoiLLZ2z755VODPJnksc/cGQo6frXAJEZHG4dfbgVw1q+6R7uHotpK39efmbeq689zL5pkcAHKsrbGUd1wODn1OelULG7n1O6uHv7mPYENw808gR2I/hU45Y54XvUkuiTw28UzgASAsinglQMlvpV7QNPS6vIVmtVnt43XzEDeWGHfLjn1PHNcvtEtzslQqS9+LtYt6Rql9YSR30TXBhYEB5wSrKDjhgOoJwfr717h4X1231C0+z2TruiyZIiQeMZ4/z615Hqnh+2WRlsmvI7VGYwq8mdhIHAB47DnqeKitLfUNOljMUAubaTLM8a4mxy2Sw5z15PA+mamjio05e47mVegsTBd/63PfrPUmbaIGjYOQAwXBQD6cEdc9610t0gAaQSIwyUkZfXqQDgYOOuM815x4XvUvbWKdZpW3BTJuXLA8YwPQjuK9Ae/UwCL7SuB8hldSvUcbh149vpXrwqKpHmR89iaDpy5V8yK6W3eDy55oYJUQSNIMMACeQv9az0uPJYpEY7iINlVVT8zeoHpyOfWtJbWOaNHkcQxSAeYAPMBz092JI71WvLQWDyNLmV3Afa6BXX0GF9uo/nim49hU5R+F/1/XqMa8YSNIISgkGSN3yqf8R7VE07SRBLeORQwKlmOV24zx65PNRXF0x8kmPPz4OxuF46c8kdOT0qveSNMFWNljRmO6RCSAMccfXj+VQzojTW7Qt2ZhGkCmGQn5iVJXGfapkTyY1VwDn5QiHBHvz+dR/ZW2rcSB2BG1vmyWx6Z6CrSRiJ3zvCMoyByR/gM96kJSWxCsmXKBduJNxYHIJxwBj+lWxIfMVdpOeSTg4A/wDr1BKjuy5AHBKqoHB45p+VEipKdwfjA6568VLZlLXcszWzTJlDjac8HGB/9eqU3ysBINxXoAv61bMpzIFZiwTcQV6c85/SqglZg3C+b6nqf8PSlK3UiNxsjExKoYhiwzz/AFqMLwVjGFOVPcfXNMuS7lANoDMMDuO/X1qVQ24sRuA6KTSLS0HwkpGxcE54O4Z49aV13BUYbHPp0OPWmi54MTKQORxyfx+lRvOqFjkOxAznt6cVN09CLPccqCNSGA3AEnHIwfaqcu4sSD1B+8Bz+NStK0rmNQX5ySxxUdw4OOM44wD+mKVi1oUrg4Uh0fauCcc5/wD11TuiJImPlsD1Ptz1qe+d1y5K4x8yg9PrWJe3hjixE6lnOSAPXjH0+tZyeupvCDlZIybqc/aVXbgA7lBIPH9Kom7M0zBWEUYByMZ/Kn38StdL5e0HHJVtw68An1rJmYCaZIVIb7xbuPf247VjezsekoJliO+EkyxFWWbncwbAZe31qV5o2TCvIAQOD+uP/r1klWeUdA2MDJ+6aRJ5hKY1cMdp8wn+I+macZMqcV0OliukkiCOuQAR+ffP4VWZoYisKsPIHG3HT8O3rWHFODPGvmOuT0GchcnP4Vpm4SaUGJgzqMkA8j1rRO5ySpqLLrvHIQJ5DuwVUN257mkeHaF3EFMcc+nes6W5fmIozp1BAqO4uSbdEU5GcA4PI96uOhzzi+hYlP7xd4UxngLzgn/9dUroku6x4ATBDAZ59KsRtPLgSAA4zknkn0HtTpQIwr7TuIyB6+/8qt26GD0Mu52gLvOS2STnH6f4VQ8ySORtnp27Eds1pyRNIMElWbg9sf4daozW5hQo+Y3HJOBn8/Wla4r9DKv50EZkdgZFbJI5y3Tn86KoXgzDkDhWwoHAJzwfU0VL0HyJn2SSUT5s+2KUSKIyWbHbPengZOd3PoPSopEUM3PynnHYmtvQw0JUkZ8AngjpjnFIACV4B7gE9D6VHGCGYqd2BwMgY9s0u7ax8zaD9en+NJsdiXJTMhOXOOQenFWFLKgHXjk/1qBWWTYxIPYY705A+5iCQCc5z+lNdjOWpNGAThgAc8mnqVPBPzDPGOKjAw+CMnvxkU8YJJXkg/U4+tVqRYVmAcAqxweuf5ikVmk2+WCQepPp/jUnGO3A6d6ZOqRqDkMwHHPNVa4XsC4Xc7kl+AfYUlwRyC3yYPOf0pArDA5aTqSDxjvSrEXAaTDMnGOuP8intoO6WrGiQ+VlMtgAZFTJLIobeqAA8fNwaAVVFzj5uCT6ehp0ICjYUJ9Aeg/Gi5LatsPjBBCnB3fe9TTMEMVXDPnOScD/AOvSsuQccsT/AHunuKiZj5yrsYq2Q3OMHHGDRcSVxclgcDlcKef8/nRKxYgNtBxgck596VV5ynTBBzxn2qJySH3FVHXnkg/T+tCuCd2hm7cJGZcHGSG7YqrcO2+WPL/PkheufZRippt5j+Q4PDDeCCx6EexxVGfDuRJIF29FbczL3BGOOpx3oexrFAuQ3nSxLPMPm3SAc5zggHkjAwR+tRi/ZpgI5D99nwiCQScYJ4znjt05pZJJFaEOkf7td4jy2/1yB1OMVUuHuTHK7KI3XB3TSbUXBzxgfLx60JtGqXWX9f16GV4vkN1DshiAdTk7MsqjPAI6Z4/CvMPF2u3UCC2iHlSyAgOAd6L0Y+x6/SvTb6f7bcwyOSI3by2dioTGeqqo5XPIPevG/FU0Wp+MrlYZma2hyiSMOfy9f8msMXNxhdM9jLYqT5JLbUx5dSv7fSm8PQeVa2rzb7lgNr3LD7vmP/cAwQvTPPJpPDmlNql/JbrPbpMkLyReaCEkZedmexIzg+uB3rR1jT54VQzFbqYYdnGSX3AYU9/l6e1dB4bs5rMx/a4U37OM4BUdq811L7ntKEKdNzg7N/mLaWS/2en9pvJO0cYjEZPRR0X2PXpVqzgsZrMw2bTWEUnyi4VVZ416khjwGzx06Gugjto5rPeBgPwOOlZF0sjQ3Js1xHaECbao4ycZ/wBkDuT6ipUWrSR59St7ROLB7U/NHPOZicAyhQQx9ccY79OKkvLCGwjjfT9R+0+cXBi27J4Rgj5l6YZe+eckVLp8MhQSOE8t1ZkG8MQAdp3Y6c9u45qVSgVrxwVBP3xywXpnFYP3U20RTlJvfRempV+FerTw6td6OYiqrF5kDy/M2M5CH3Azj6V65boHsJEWMKR1MqbimcHdjqB1PevLtGt7K08eQXM0lu8klvuimLD5cjhR2BIyMfXvXp63iX146QogjMe2PeSvz8Hg9RXt4GalT5eqPMzJXq80VurlTULa13SLZPBGxOBNbHAUcZLZ78jgd6z7qZRMnkzXL3AbaGYcsRnjcO2M8HvVxvNa4aWeRIsMURgBvkZRzl+4z0Hes2cyvdtLeIYJwMqrD/XDPBPAB+o+ldZhRWtnrYkeYXK+bcxBrh8K4UYYjsMj6fjU9uqNh3JL9Qo68eo9O2KpRFpZ5VYLLLtyQRg9en4CtO33rJx/EuQCRlPo3b/CsW2az91WCR/JEivneDn5Rx+IqRcmI5B2qMqOAST7+lOZSwEZ28cbRkgj1zUBdYlaL5jIuUG3+lBhutBmwFlcMGkPUjgECpJ1Y7pFwCMk4X7vFJE218DnOMgDjA/rUkjSN8rECJsYYdzjt6VA3e6Ks8xeMguMfLnsP/r0yJ3kCsEjwM8Kenp+NPuIztjLF3XIwoGSfqaSPcgbaqbSw5Jx+VTvuVo1oRvEJHieYAkZwAeR6E+lP+bIVCVB5bJ5FJKTIW+WMMeVA7iot+9yOgPYnv2osLUVomZsqsZP3SQeg9c+vNRSW/l5/eE5PXA4HtVndEUYF9p4HzY7GomlVmAQ5xk8Y6fX8aXKgTkwhQIvynk5yT61nX4zASzlgT06Z5q+5ySVHAGdrGse+kZ2ZWwi4JG89c9/fFKWg6abZXkI8lvKbBX5Thuev86wdWyrMkkaIVy7lhnr0NbS7trKuQ6AFu+6sLUpW3STHChNu4HO7H0qDuor3tDIidQTG5C8HLA9apsE8wLCQd65xu5465qfz13ZcbN3Jwc9eg+lNRIdjSk84y4+v8+lZQjzM7NtTIu5FeTySVIbgMvVPx71mjUZIJWSVd0g+Td2YY71curoJNIVVCU9V+X2+lU3hjvw0wjKytuY4PX61ErXNErb7GlbvDcqk0YO4gFiByp781oR2xSVSCZCeGPQqPwqhZMn2UeQ7fKB16E91x2+tdBFxIGmUKrDjHJz/nrVo4675diISFlX5QXHBQntioL8ZjGwNkAsQBwxp7yOBhVBJOeTjbUkaNPGDIcH1HfP8jWl3ayOFu2rM62TfHnJ3kHbg5FSylnRQSwAAAz+lWZYAihQFHHOB396iMYTBQ8Ywvr68UK9zJy6mfI8yMVYAhsKciqmoXClY45CrDlsn/GtOVGeMlcbzkkeo7VhXMDMx8xmG7Py4/Xmqu1og0b1KKBXDRuVwCdgxx+HtRVi3kMIlTyiwUBQAOo9j60UWTIcrH1iWJk5yfQcc1LF7jAzyai8pSCxbBIG71NRyXDRhkBxsOBwOa1XmRa/wjlkEEjD5QCc9elUb2RmzIWDE4IHoKLl38pi33sZAGMfTPamWkCT25mu0+XJyRwMdvrU7+6johHlXMy3Z3IZmViVHXH938auwTbwxLcDp7e9czdZt2mcS+ZgZ25wQB/kdatWN2eNjI24jPGCD6inGVtGOpQuuZHRx5OS5JyOB0NSKAQctgHkEHiq8U3yfMw29QetPwHlIRsuQOeg/wDr1cThaLiONpYhS3XcRwKZIpKjG0nORUccmV67hjOe1HOe49/emyUtR8G5WB4Pr6jntUhIHVec9uoqONQW+QAqwyAe5+tOkJKZb73JznIBP0ouLRsftDtwBzxuHOeO3pTY1x/CGzxknmmwtx8jBR0yTx/9ennDq3GN3HPXHTp61SsS77MmEm1CSCuOo7j8KrxXMcs0yq3MTCNuDmMkbsc8dCDmnMvlxsODzgDPr701vnkCtkDJCYJxj0oBJMkK/eY5J785/wA/hUBlVQF6MpJBxgZo3YAy+1cFsZ/z+lNk2gD5yXzyo/i454/wot1GrdSvNvVWGMqo42nkD6/pgVWkuG8s7WCZH3HyOO4JI5PtzU8jFt6llLA7iBy6+4x0qu6ttXa/l4YsMEMGB64zx/8AXoNopdSpcTLFMotnnGfmCLx26lj3z7mszUrn904uIrdXBDo65ERYHglTkswJOQRgDvWg77lHkNiUcq7y4Vj7e/scdT1rHuL2eYmNoiGjBZUVFk8vPYc/IDjJwCePpVR3OmEdmUdRuS4uJvMk3orOxZSDGxA6+nX+VeW+HLQNNfXkjAtMzRRMecuGBZvoBj867fxheywaNIiK5uLkj95k4CdzjvkjFcHb21yddfRrO52b7kxo7fIgb+InqQDjp7CvPx0+aXKj28DH93K+l/yW5ueOrpbS9gt7OCSLywu4uwcklQd3HTr09MZ5rHi11zBvnm3SMcEL948dOa2/DHhS68TWV95UyvNCwRYFZRIznDbmLcBAOD3JIxVLSfCyCbdc3EiuPldVABJz2/GuLllo31PToVMPCDpSd5R3H+HddnkuZIkU/Z9u4Agk/wCArUu7C5nt7iC1mjWG5kEkm5eVPsR69/Wuig8ILb2gmna1glZM+T5wMh7che+RWppllocIiiuDffu2+cgDfKPUHPy49OatU5PRux52IxdCTcqSvbsrmfo/2LTrZ4544UiY7iY1OWI/hBycL/jXHXur3Gq37Jb2TpaEsjMuF3gA4Az6mu41e5sYLGRIbLyCZfNaV5iwCjK4YHvjrWRHFFPezKscc32j5UKfKGJIw31x3rKpqlFsrCOMFKpKG/f8dv8AM523nWzitnu4dzJJHvBxiPJwXAHfpXrkFpEXgjYl0kwwLKccjrnPXPQ9K811SKK0lmSR42SFyvJxuIJ469M9K9P0x82UCqF2ywAOG6Y6kex/Su7LN5JnDmc01GURJCkaTq8koiT9y+cIQD1Byp3AdM5yP1rmb+WVoRmRbi3AAiJJzCenc8/rUr6in2yaOW7e0X5kWVAeSBkKx/hOR74zxkVUhLvKVaRpY4wCxI/1ZJ5A+n/169CbRzUabhqzZ0kEoJlVWuISZHkZsAewPfNXIZN0p2EtkEnIwNx6k474qMW620jKqnIQZBJwRnoT3z2JpXGcuCVC/MAo+XH49cVnsiJNSbZdxtViZFC+u7C/TNZ1vK/73jA3FgRwR2xT9huEEbLtQMrCI9Bg9x78cfjU00JEq4PzdVAxgD1P+FDehn8Oj3JI4wwO0gHOfl+7+HrTgNjBd+AT6ZAOO2aIw0O7DKxAGQR933FOlnXYpTazdu3Oead0jPVsiePIG7OMbiC3A6/4dKrynCAcHA9OOaerB3AIVtg57ZpqRu8RyFUYO7PJPvU3LWmrAhVDE5LNg4GO3v2qncMFDbmB44KfKBUkrnIzux2AXOQf89aPIHIYl35PJob10GtNyNBHIyACPJGS2Qc1Gy7m+QYGeh60jRtEqxbdwxkHvTnDs2S6jsxA6en1qXfqMjuJX+4NwY/3u/NROkU4IZhuUjLEZCkd6ivWO4/viHxzkgDHXHtVZ5d8WUBLYPBz83oCahu2g1FmFqWoiO8lWJzMFGEGMoTnk49enOao3RN2F84tmT5c849xjsO2a1pNGtZV8wNIWAzIgOFHqDVe8tYza7Y0kAGAGPp/WueEZ3bkd0JQTSicrqEZs0WCRXKvkrg5Xd6VlSTLsZlJbOWOe3qDW/qtq0oMcrMgjGcbcY+v5ZrDtEG913eWQSdxHAOf1okup2xakrvcpy4mXAOFOMkDhvr71Zsptk4jFvvK53ArlSewqeaGS3QiKEOgfqozgdyPxqS0kaIxOHQo6l1GO/fnv/So1ZEpO3kJA5GpDfFsPDbOgOB6+2a1lkEsbBWzjCknnms+5iWQ4b5CMZweRn/61XbESJG2QJI8kAnqa0imcdV31EmjaFt8nPfA/n704RsCExu49+M8YqedYmKlArE4GPSpVtvlK7gMnIB6GtNThlLuV7ZCHO7/AFZXgdcD/IqrelVkwpIUjg+oq1PC8JHP8W3AOKhAR2ZHAX+8Keuxmml7xnyLtiy7726VmXLHdlwpPIAPvWrqCjykdHAJYhh0yMdf0rHkLFcrwMBgMc9e9D0KWupA0DSrnJDHk+3FFNubj5vk+4erZ4/KimmmibNn1m5IkIHJ+tUhbtg5Pv8AKKtyqQ/y4PXgd6SMnHTr1FX11ITaWhSltSRIAxDYPHUH8Kz7G4a0KwvucOwUqzcH0IPY+1bTneApyJDkZxxisbVoHLuykxgdRt6njBNRLTVHVSlzXhInFpFeysIT88bbSGGPwJqKSExyHy2G8EZyeAOmPeqMdzPE7bVEjOBv2DBB9TVu3lmnkDztll5CgcHtk/Sq51LU1cZR3ehp2Mh2IhI244HofpV1G+YjaAuetUfs/wBxhu3L0K4NW4d6thyQO4Pf/wDV/WrUkzimkXUwQzFgFPIwaZHL1BC9ep/zzTEJC5dR14x6VOEUSZI+Y8HbVPbQw9SQMn3xncevPBHrSLJluVwMdOOf/rVGAojOBtVjn3FSrsSNS/4dsH0oWpDQ3ahY52jOAOuKahZ3CE4QjguOn40jo5YurIuQTjHHX19aaVbeuxmIX5sjkjP+etUtBr1HyFgxUMQFAILDOT60J8jBiGIYenQ+hpo3klDIPmOWOOPocc052dEEZGOhDY5X6f40w8hZG+6RjKLkE9h6fSqs0jCNA5wDwpz8xB7D0Jqac7DHjovOFPWoLnaJMkDyScEA5H40mVCxAkhVCGUgZyCSPzP+FQzzIQu5QdzYVnGM844U8fUGo72QqHZ3jZUG1SFJIHfB/wAfwpskbu0SRR9P3igyLufvzz+nWm3Y3UU1cq3ssSyiMhTP/eUZJ9iDnA/kPWsG7ZYTPbW+S7YBjX940uSCVjwOB64HGMc1rXU0M1wySN+/6k55IxjuKwdQuXklKW6CNWBBRQP3eMAgycNj1Ixnpk0LudNOL2MzxDARJZmBi8jkoyvgAyAcp3G3HQ1548EcY0d7aCTDWnn3EgmDMXcsAxx93kcKeSMZ5NeiE4iaFptiLDuikcjKuBkbh1BI49OleORz3NhqExiMbSuHjwU8wEsCucdMjdweoPIrjxUVznrYNyUX5fje/U6PSNaFvqV1BDPvjlkdWl8vAm9CFH3c9PSu7sbNn2KFMjlgAq8kA8AH3JI/MV5LoonjnVRGhm+7ucH5OfX14r3Hw/qS6Zc26ae6oIG2+fNGu5nbGWZjlQVweew7VxqEefXY6MXOUYKUFqws4kVnhkkaGWNdoG3uO3t6Z9ankKsqrBL5jHPA53N61zOsRXWmahLFYyz6oZpSsZVtyyyk9I2AAYcgY9ewrZtdPvUv7WyBje5njEgTdt3ZyNgB5DcHgjNaaq8bHNKMUlU5t1f/AD+4dbalcW9+RbyKjgEZKqzLnocEYzx6VRijENyJLjBVTuKkkbyT04/Or8YSV5kkhZJVJDKykOn4dafeXDW9v9njZXDr5gKjO4EccEfUfgaxqxsuaWyG5paRW5hXOmR3mqJbXKOZDephOCrBSO/sO3eu8+1QW9rO1wxjCs7I69FxwOenvntWDp9jJHq5nuQFkRU8tfL2shfvgcdB2q1rLldPlZ2dIkHCOcLKfUL6f5Nd2XQcIyn3OLFS9rKMbmHoqE3V1LMF8mR9rybyCi7sj5sZIJ9Ofw5rp7D93CIAQbdGPlyEAByecMO5P/68VgWMMX2ay81ZGgOcLvyEY4w305Pt+Va1qgZVVNgnTKlGIAGOD04wfQV1X8iaquy75oPlhZXCI2MZ4B9Pf6dKswlIFdnPmN1CIB8hP8XHT6VCynfJ5bSEsoBIHG0dcY7D1HNSLGTu8oeXGR8uDyPr/hU63OdpWJoNiyPG3zM/IAOSath4zGSRlsfIAPpzUEK9UQBRnkMckkev1qaUcblGATk5XgH29aTehjLcZcSB0Ug/eYKSB976ehphKZOFztG3LHqfX8DQ7CQbwmWboAen+FKjNGUChG7qCOSe9GobIgYKJB5g2D+LI5J/pSPI5UhW8piNv0z3/Sidy9y6xyjd24z26/WqzPKZGCqAo+UDJ+hOe4pMq19x8qkg+WsgBVdhyD3/AP181FvKyZOQQMZBH5VM020tuVmYAD5TnP8A9biqpaMoMJsTOD7UkUrsgeWcsFR8JjJycgH1qq0+Jh5reYG+YIoI49h2FaMsSohJfC8khv1+lUPlLb2GGPqecelJqzLi07izQO6mVEVD/DgfkMetZ5W4SVXZSgZcnd3I+nTJrUjB80EbgBwOc/iKjuo13OrkgdW+YHn+tLRoSn0Mva00fliIzFRvwWACnv39zUDRxo4by5dxXgHP59eK0y5UYiAJ647/AFP0qnJJdSynLRrIo+Ybc49zSdjRNvToZ90ibCJlAMpzlSSQe2awZ9NWa482Ikqo2sW46c8V0kiyMhZiu8tkHbnp2qG3tgYGUkKx/i7Z/pWcopmsavKrpnLXVm4utuWKKuW2HqPf+VEVhCqqIUIbBxs4Cj0+lbl5CI2Zcbxkcqf89KpCJRIvAKn+Ac8g1KsW6ja0K8dr5Ua73IVehAyc9c1GWkWUSqDjI+fGOPX8a07mPeoBUoGGCAOVHqarSomBtYtzhlPerSaMPaE4hZbdmKgHIyd3B9BSSqyhdo3fMOMY59Pej+0TB+4cqV7HGVNXEfzY2wCxKkj1Bq7LZHLO63Mu9yG/dtuUe3fGKyrxzBGc5DNxwcZ+tbF45yWGd2Pmz37VmeUs6lGIUbic560NXFHRGPJIzFQeCRtLD1pgjEiM4yT9elWp4SjmNQCex5HI71VuJnj+VdhOOmcdelT6lt6aFKa2jmUh1DLwMH1FFWG4jfbJkgY98evFFO2hlc+rSuPvZ2nrSwr5Y3cbW7GmREbNvv0HarC8joAtbKxk7rQaePu9Sc5zn86q3Vqs0bFtwHOWB6fT3q55W4MWznpUhBKDPQcjHpQ1dCU+V6GKlgqMioG3bcHI/Kp7WDDZ2kM3JNWZUBkJHfrxQgbPIB3dfb6Vmo2Zs6jaHRxBV4BAbo2P0qYRnAY5B6j8qeCFfBA45B9aczDknO3uM1srHO5MSM/OVIX2qSQYBJx6DjvUKEI4OeOCc8ge1SqQe+Rz1PT8O1HQlp3IwpbkDB65zx9aegbygQMgkkYHP4UR4E6nJYDICgcD3qQ4XJDD7w+6c4H+NC0BshAbqQc4yAo4NCFVOCSQOVGMZ+tTqqA7lGFHVsfy9aZkkkEk54wozj/OKbEpXIoyxZhJjkdenHvim3G5mUREcNgjGAR61YdVBKkYyOACDnNQSfNuOCcDkHn34ovoC3uhkiExsi4O7oc9P61TuJGO1VUmRO2AM++PT/PFWJmYEkk/MAcgYI/wqtMrvIpTOxADuwOP6U9jeC11KzRS7gWdhvwxJ4MZ9KhI8uLa4jjUAksr5OD6tnj61YUOQSyBQp3HCZLc9zUZaCc7lMe47juQDJ987ufp60LyNVdaHMX9ysl3IsjMzJgxrkgx98g87hVS4ia8nRZiTNOxGWl3EkH+JSBt2jnHfrWncoGuHj8vzIxxu+6wHXOO4/CqPkyCSRkZgjNtJnYgKuegYjkcZP0pRud97LTsZlrYm+1WaOCNpYVdWEcp5kA6At7/AE4rzLWNPnttaWb7Mf3j/JEUIwT0AxyTk/yr2OKAQy/6ZIimSIlQ/UDP3jjoT1A6nFR6voNnqypGzsLpg0qAjsmMc9s/nx0rDE0nJc0Tow+LVCpaWqZ5f4Cu4Y/EqSXrQLGmd4mUlHyeVI7Z5P1rsdRMQkhj3xpEs4Cv5pPyZxkgDhunPeuY13wje6Xds5srgwRygm4jUsZeflJHPU9cVo+F2LTSkyiYJ++iYDc0ZJwRjt1xXnXafKzuqNT/AH0ZXVjo9SsJblUeHUcujZ8pw6x7OTkOo+/uwQOM/TNWtNSKayml1G1uP7VglaT7aHw7BRgpnOBjHBHQ561BDAI7zdEl1Hp6488LIzFAMAuVOOuTwK6i81QXdvJZ2SW8NnEBLEscZAEeR8wPOMkn8R610waSvI8+rVnZRWq+63fb8vxI7+O+iv7m/wBQJfUZo4VWVQUCIYx857MW6Z9VNc/NE4lga1gjmmhLhoJW2oyjnrnnt39q3HkaMCeG4kmneHa7s2/apOAo569D+PaufjjlvNSS1tVZmTdDLI7YHzZBXHc4AziufEr2lrfcTQTUG+3y/wCGNXwzFiPzpZme2uCSzEFWUHpjvjHANQeLzcSXdvZiWVmUhgZGBI6gbuxx0yT7VvaoIo0V5gHKoA0gGMbQMbcegH5Vw1tczS6jLIWijQPtPmKAvqQT3UjsK9anH2VJQMaV6s3VXQ17idgyi2LRf8s5Udg5fjHH970x0Awa0LGLjY7kxxnajOcnb6HGSSPQcGsuILFITI5nZZOCuBubAxjGTjBH4e9b0DvDbBkjRZHOcRfMRx2Pr1zUyavcqaUVZEyq/wDGCoc7gWbCgnocDp0NSlVjfKuC4bhtpKnnnA9R602zRG+Zk3qoySxzuHfrwP1onBbgK7ZGeOAO+P8A9VO9jnersTgRbnAUupHJJwD+I+vepFfztqkgqOpXIUj0zUMKMH3h9yg5K9AP6fzqRmjy24nfn5V/xqbmbWo5OvzMevOF4+v0p84XYpVv3rtj0yO/4VUeUK6lnxztIUnj2Ht70IQ0r7yFAPQ9Mew7gU7icftFMzKk2ShKgcgDk/8A1qmVg5ZmYNnjjIB+lE6qd7HcN5+XHOT9P6Uy4KI+eck9AM49fpU3ZroJM67iikiQ9MjGT/LiqTB5CBkbc/MN2c1ZkMcgXd84wARnkj60syRPEocAdlIPIP8AQUmJOxGVinztJEYJOQeT2qrd2Us0BRJPLLd+pIBz+dXEXy0PGRjqRwPpVaeQmJgrEjd2x/nPFJ+Y4yd/dKcds0EIBkaR88ZwCatqij/WdM9fU0octEcAkMOx7f57VE6x5wW/dr0A6j8KLWWhMpNvUinXeN3APTLd+eBxVeFmjAOFPBOc5Jq0pGzEpKSDseap3YTBZXGP8O+alsE+hVkyRnbhSDnPaoQ7LEybWdxwAMBT/jUjYeVWbDfMAV6jB9qlvrdxCWi4AUg/7J96STLbSsZF0PMmK7lX+/uPzGq88BgbfgtgZGDjApwcu0kX7s7eGb14zTZow1qdpdnAyzA5z9fz6VOj1NdrJjftG5nyNwHAweF9qjCCbeTsHbJPH+eajhjVHbPKg4Ze2f50+5VCgWPfng8HAFO7tqTJWehTeFlAyQVPr+hx9KkieSHaqsSMHnqCPQ05EMkyhiWIAIXHep5YwkeDkupwAO/404mc30ZSuJ0YKAcZBPI5+lZ7SeW7EACPocirErc5PRRnbngEdKLopcRhdoDLxx6+1PR6mdrOxnXcwyN+SxHynPWq7w7kdz0/h/2j6/TtTp3PmMu7hQfm46D/AOtTPtDpAhYZjbgdwTjFCtuEkZTSPu+bld2CSe9FSrbqnmSDcxJ6Z/l6/SioszKVmz6yjwwbZgjtg9Kljlww3cDOMGoI4vKPcEELUuxWfoCeuemK3WiIdrlyI5XLZxjqKaGOSW24A9e1JGN5XuAOSOmKcUYc/wAPPXnNUZ27AE4+UjJ9BTCm1y4BOTjr3PrT9xQ8Jx6e9LkEgHp1HtSsLUgK5PJPy8DjJp6yZbawJ44B5FPUAplvvZ5pCoYAqxGecGnYd09ySRVZBsJwfukdfypsTFG4yScjHr71Kc8ZA+YenQetQyIysDv5HBPaqsQn0G+Y+SrjcR1PoO1WzEG+6cDggZzg1TkiDHKL82MZxjiraOqqmSOOOOn50LzCW2grRkHnIyecNk1BEWV8jdkDnHAIqVdwyH5znORTWxgkBueA2elMSHtgk7Qo4wwxnNV5WTz1BAC45fpj8Kf86BiGwG5K/wCNIygMAo6DB/wBpXHHRla6UqN5wJMcH7xx07VAvzjoCg4GccA9DjoasuyNHjeAynoFHPvmqhRVdsAgnkY6E/56UzaN7ajZlIDKcfLkZAOR9cVQlQH7wQjJILHAIzxitRydgIJSTomOcHPI4/rVc7PJET7MvwBgMEPp9aemxrB2RmXMLykRzIwyCT5uCq+2eoPH61kXyF7pGWMoRwzKu0H3Hv681tTSyh5BbkM4PzISSCO2R1B/lVW9niSNGdfLOD8hIbDHAxksB7/zoR005O+qKkmnRXsQe6XyiCGE3l8s3bYeAT7npj1q2tnEtszzpI7BOoOQ0mdqn174PuaIIxcBViErHadzhw3HfPHHpnNSsZHkZwI1KEqXC52n2PYD61pFkylJrlvsVrm0nhmMc8mXTAKu25hj+E4zj1A7cd65HxLo6TRQXthE8N1bblKxjaBn+Jl6kZyD3xmu3tEiULclovJjO0KCEBbPALe+OvNBtYb/AFKN9L8zzFQq0x/v9Se24YJHYcVNSnGquVhSrujO/b7jitL8QXElkba/SCNBhWWNB5LMAB8w6jI65P0q1qV+0tzMLOSMSrHsTyVO1eOAD3+vU967P+yLPU7a8t7zT4XkwRv3Abun7xWBxnpg57Yqm2k6fp1yiX8ssDRqECyKRgHoQ33e2a8urg68mkpaG6xdLmbUbPsctJpNxqpijhuZ1AiRnZ2OdxxuGP4RkHpnj3ro9M0aKysvJsd8svOJenXk89M9fzrXnjaGJJYDtsyA8bI65cdyScjPXj865rVNfdobmO0muDCyH92FBBG7uRwOM120sJCjaT3M3XqV7Qjt/W5Dq9/N5UEULo7Bt4KnJG0HI4yfu5/Cq1laQmB57dmxGQ5eOMhQD3Ockn34qnZ28QwhtEZpjwZtzEcdQMgLkY6itO1ilkt9pllZuC4LbU6cDHTj1qpSvudSXLG0WPje3nuGMEKgY2Mdu5iPX0HTHFaPzNtSEl4VBUEHp64qvZW644wVznhuSMcYz1P+FacaI8Q82RmmB4jAwMevtS6GFSST0CKRoh8jKEfIYAZJ46Z/wq1BE84LOxIXoT1A7cn+lRiMcEEqCccetOeJZpYHbKiImQEErnI28jvx2NK5zSfYszJGP3a4ZgcYB4Htnv3qrLj5flwmMFWbleP6U6YbmYkqp24wT19OBTYlwEaQ4TPG8Y/TvRZsS0WjGumccHywSMjoD0yB3FRQwH59wHPrz36e9WZ1RWVY2Q8ZPGf06ZqtLNJsClh90KcHgen0oaSGndaFaR0jkKr8/JXJ6H0I/wDrVHEzMhVCojORhR39KkLEgKnUnHC/d9cUZH8GSQPvDuf6UadC0+iK88csRV2AyvOSeT7n3pII2L55ZlPX1GKbdS+apBIYKRls8A980sc4DBYnQ84BPH1qXqx62HFGVzx5b46EknB/karTQuQmxl2tgHIwPqOeatl942uucc56E/j1qsyCQ7V3AHoQeW/z0o0EnYa0Mscf7x/MAyAwAGO44HpUQm2OTJhRtyXUcim3F0PLCKPMydpVRkf54qhercRuxUqSvfqemf1pSemg0m9y3LNEMyquFB53DJqIzK6Mdy464B4H+FZ8N/F5eyVCjjGQWyNv+FNvL61XaT5as+Mcfn07VLsynTe1iZpI8oE2nkYzwAxzxT7lfMicLIwQDPXrnisuCcMkhyGB4XPQE9wO1WpIn8jf5oXCYx3NJK+gShZmb5awTFfMBibkgc+2BU0hjEYVQVzxjGQRnt6VXu51yrHBYAcDrVm2BlLbSu3qNo5Y4ojFbIuV7XYyPaWII68fN1z6f/XqKa1lZlJT5W9D0+lT71l34DFFJHyjGGHH8+Ki88eWsbNktwVPY9/0osjN36EckIg+VizEY3MOcY96jup5VQJ85GcKCcnk8irksUkkRZU6djyOneqTgD5i25mbqOuKb01Rle5n39rJFJvQY78DrVJS8sioDgZJJHc1ryjCM0h4Hvnb7VmybCS23BxjPqT2pW1C7aKE0WyUhwQOpz/L6VXl/eq4xtUjgA5574q2rNIxz1B596SWIRD90pJb+InpT3WhPM09TPllZYFUqOTnnrxRSsC/ztkL/L14op2uZn1PC6sdxA3DtmnlSCzAEe+OKhdTkcgEccd6lRwflXrxwataia7E0JKON5ypNWmZN33u3HNVYyRJnIBUZIB5qfAIDf3uB71SMnqSjaV2nkEdKdk8BRwOR61UWQYPy4cHA54Jp4c7jtOGPUnkD/PrQmTyi5J3Dng9R0zRCzDPB5xweo44GKMEOeCCevHWpoipB2dv0NPQJOyAv83OcHsD1+hpFYEADbu9cU1htfHbH4UqDIcA7SBjLc8/XvTFYcp6AdgcZ4zQcEbgBkDIP9Kd8q8HIycD2OPX0prYG4fLjGf/ANX+FUShYmG/BUE56Z6fj/SlZsLnGH9h2JqEMEYgLhOpp0gx0AHYE9/wpehVhXPyk52EetRMFaMDOT0HqKeq7xgjBHPOMfjTAio5+bDEcdifxo6AhhjO/J6jkj+96/TNQSgDJJ25wAT/AJ6VcLAAg55x17YqkxG/AXajHGc8/T8aNi4tkaKTtAYAZ9O/r/k0MPNilG3hiFII6/480r5UMVX5B3znNVZpkA6psBwWIGPrkelGxsk5ETpsdhhgXGMH/E1m3FtayTGSSMNHs5YvnHPQjvj8a096yAI285T7+clT2J/KoX8nCSuMeWMsR3PI5749KaszeMmjJtxPbF/JmjcD5Dn5hj2yCR19ua3LScNGwuYI/LZQoePBCDGMAk9Opzn8DWFbyYYsG5BJA3g7QT+tWpY0ZAAGZpMMWU7QMdSR3P1NEZW2NK0ObRk811B+/uAkk0yyZEoAkQAgZGTgZzkjAFVzNFNLJ9mUTM0eG6soUrzuH9enNMuLVZyZMNsDEeflvL/3UXHP1qvFDdWsdxcWds4s1ISZPLO/rgkDq2CecdPSlzPqSoRtoLDqJtrl7l7mNVbKPFsPyqf9jhXU/X6VXTU54RJDLPHNB1VSfNUDrjnp6gjkVVvHukdxPFIybtwO1gUJ6ZUj9RTGsYpAs9swjI5aMMTg+qn19RQqjOqFKG8ivf6nau6nyZoCx3fuW3ru7ZB71StpJGuFdY9ijh5ASOvfP+HSrracsmTIwRyRkHgN74HNXLCztrSIC23PMwBVj90nPYfWs7yerNbwhHQdbW+0yBCTGzBmaQBuPfJ5NacUahmD4zwrYB3EY7+3ao44Hlk82VgjuRlpCR+AyM8dKewihblzgAZbOOaLnPKV9CZYYm3gDa4A/iz9alCeUSEB39B/CaajqCpSQkr/AHxz9c+tOlkUMwRmPPDdM9c5p2MbsliEmGZ2KHIJGBnPr9KmeTarIQjcZwp69uo6dKz5UzsQsApIwc7AM0m7aPKQphQPur8v0yaV+gnBMtFiCSV4HIZP1Oe+KXYoiWXeyqR95z96lXy/IO9wpK5znOPasqeIvOjbScfdbljj6DpUNuPQcUpeRedw5C5AHU4HBP8AjSrHiNjtBCtwD2/L+tVhIHzkbeO4ycentTnmfaFZvl5JBPB+v86pJdBSXQJNzSs2N/sxIOfTpVXyAZdz7trHDZbB+lIZDIFVQVIGdo5ycUSyI8YO5so2OfUenr2pMd2iIBYUYCPMaEYK46fT/Go2dcgkpICdzHPQnt+VLNIZUcKQW98EdfTpz71BJI6NGXQjB5w2cj0FFi1djpJYCvmecUkI6McjHpUaNLMzfM0aZ6so5/8ArVCJ/ky8YUeoPQev9KlivQIl8yMYAxg8Y9uaEl1BppaERY7M4LImDwduT71DNbM2SzBXAGct2Hqc807zzMQVKIN205P+cUsrZQoihG5BJOSf8D71k2tgd0Ywt0dyScOOSzHkn6VDcxqxKQ7Q3Xn6c1auwGkG9flIxvVdpH/1qoxsUZuScHdgjPA7ZqErrU3Wuo6O3/dCRy24EZPp/jTJHYHMkuCQdo5yT7DvVl5UKEtlMcNjpx3+hqldMEKtj7ny5B3Y/wAK0aUdCE23qVw0jGQv8qqdzcAY+h9atRKI42ciQei5wRx0qgqNHOpdcjHAJ+56fhVmWWWYKHL7RlQo9c9c96nmXQc0IZHh3ttcQsfNLk58o98+x/TnNQXLx2sHmgnOBj5/9YT0UfU+lXrYKMhlbaODjOAT/Wqk8drFIRDEoLA5YIAy/j2pvbUxbeqRYS+KA79yk4BTPQ9/61FIQWGflCjPBxyfWqaCQ72DqVUgkd89sGnyO4jBcgkgAkDt/jTTIlGxpSTxtAFZdqkcj1rHmiyAoAHOQParDy/LkEEnGF7D/wCvSPEsMZ+76j5umff+lU3zGHwlCa2EQO5Spzkd93t/Os+YN5gwQcDb61a1GZ5JAUYHnHJ/lUIICMGyBnqOoHFCtsg1SuzPupAoYrldoxg+v1opLpVDnncvY570VLUuhKsfV4QEEPwAM49KWCLH3SCCMfSkBXk846Y701ZCrD5eD1Nb6bmer2JJAybWGOv41KkjL3wM5+lNdyYySo3YwQKjJ2ocEYPqe9K+ot1ZlglWy/QdcAfnTQBjCA46iq2cHqRzgkdR71YVznGcDA6djS63G1bYfGcYzk4x/n3qwm3Y3bJ5Iqq/BPHI/hNO8wEnOeRjJ4Ix71V9SLXRJuTywHJHPGB/n86en7pmIHGeMev9aiUkpuDEsD3GKeHynQnb/Fjr9aeqE0MchmJT0+n4e1JGCsuS3yjlSV4HvTpFw+WbORkYo2MUA6FTyQOntVLUOgrMCdpxtB5PQH8aaxBfILbuucZz9aGK4C4564x2+tPjAC5KDjP1H40MNhwKurYBLE87eOaaVYDIYD3x/Sm5xjJVSOenIpQ5KgZYjsDzj/61BIxIyBgcEnrjr+FQupwQxXjknHB9qsTAbcAEnOeTzVOR5QeACoGcr7+1I0hd7FS4cIMnDDdxwc59z3qvJl3R8gtnCjZ94d+asuHYOwwMgYPr/XNQxFEjUqeuSOOc5xj8ae+p0xemm4klvI7rs272B+VujY9T2+lRskflqso8pnb5yyk++R+VTybZNqqvUnDMMZ9QR/WolAVSJIgzIoGCSee3ektNRqTe5gaqPKvPPiKKX+VljYEMO2QBVyBg0azKqHIBIdeRx3HQ/wCNVtRgVhtRnR1+fcpDKe2fUHtWaqYkdmWRxuBUFgB1wRz6dcdKV7PQ7lFSgvI1o9Uuo74TxTyXFwygiMLvBIPBbHpjp0qh4iOpXyj7VOYXBG4CQ4J7A7eM49KW4kHlssYKHoVTqfXPvWSnlJcxjDIhPKFsg+/1qKjdtRwpxT5khQZ42jlj1K5eVRhhdlpEbHQZzu+nBxQbu5lnYyCNJARmRDgt25qO7tnlkRp1JzklfT049foaZukztKFh935hkfhUpWWh1RjGxrK32gKiOxxkEg52+pFaEIKqSIwhHV1+7/8AWrJsgN6neNn3VUJt2j0A7nFdNEkZ3ZkAGM/d5H07Va1VjlrtR0CFAWQjzMZOcnH5d6V40Mf3C2DluPfI/wD11KuGkEgjdhjlpTkknoR2/CkklkxhyMA/NngH8uKVkcl3fQqFYw52jYfUn9PeneWrBvmUEE4xycU2fGwv5afKMgEDA56cUTu0hRgoOeABxj3x2otoW2yZ2Q4DRhiTjJHIGOwqC6gCbZGTJz8uDnn3/Cl2BixwV7fh68fSpGZEUZDM5HAOQAf8aNyL22IFJAA3DaRzxjNLs24jV1SP1XOCcUjYwSvzLnlvX1xULgkMYkaQAnAJxu/HsKlF3JTENqSLKDt6jrj/ABqMxj5eS3Pc5596Y7EFQzEZHVe3NKHZpFHAHY4xmndMl3JhAJgF5wDz6fpVackjBO3ORle307VaLxyYUgqx/HI+lQunzdGLPz7Ch6bEpvqUSkfkqI3brwAOCcd6RZVMbr5W9R3Xt+NackJ8kPtLDGOTgVRZcqhjHyE/IfX8Km1mUpXKRAVC5O/GMFVIGO/HeqMjW8twxfynYLhSRnB/pxWnIJodoZkZmHO4Z/QdqqLIGQKsbbyD95cDHfjt9e9RsaKXUoXUBtw1zaPvj25ljLdVPUj/AAqCG5E8eFK+aSCM9MeuKslAxQOWBJzgjikvLZDHnghRnO3BH1NO6exbktpbkct9BFGI5biMseMN1BzxnFUZ7pJXAXBfIwQPw/lQqRMXG3dHnpjIJ9queWsVvuSEbSMKFHU/41PN2G3GPqUViHGCOThVbqfTPpTHiKZDoQ3II/wqy6mYAk9Tg7eSRSTI4VWBCrznA/8Ar5obvqiXLUzZHIBjDqzZ+7j+tS24aOFklUpkkqQf1zRCoEjCY7g2e/X0xT72ExhfKJK/7X8Q9AKUe45SXwlY3BKMqg46tx/X9agZjghQACeTntTrd3UhnQsDwe3HXGalunjYy+QGCPjaSe49aN9SG7aGbbgGUSMMA5IB4DAVZmdJowIkYYHfofpTI1JlxJkw7ePf3qbaUjwoYjOEJ64//XVxehFRq+pTd9syH5MHoB/IU29kldog3yiMfMq8Bs9yPUU+OMPcDg7QeBwcH/Oahu0YSMC3BPyHvj3pp6GehVvNkgXym+bOcMOBVad2jfM3IB6fh1pwJScuwJI6DaP8mq17cs6M5U7cYGfSku5LTI5mE0pAAwFwTiis97hYSquGbdxlcdqK0i3YxlF33PrGS5KuMMeTgdx9Kto2EG7HPQ5rPkiUgbmGCalWZiRzxxyB2o5rM0cU0rF8NyMk/KM8UsmCV4O3piooz6NkdSe1SeYQCVHy+p9Kq9zK2ugFQMLgZU9PT3p6fLhsnHbnv3qMkSIGOGOOM8Z+lNT5D3z6daTY9yyQWwewHPP8+1MDbmXcMEDHGeD/AJ5pVAA++R6lTwP8ak8vcNwOc9u9Nmd7Dt46KcduVp8bhWGfoaaAqJgjhicbcgj6U5FXpneOmcZxVEslwrrkH8KDlQq4BHHJHFJgLjHSnBizHA6c9MYNNakETJnCtgD1Azn60iq5QDIYZwDipHycnsOn1qMKQcHlTyM9PxpjWwpGRjPIHPpVVSolJPU/L6g1cbjBwOCQP8BVaU/veVzjoMZIPoKGhxYAjccA9OOD0ppImUtgja3BYd6kiHzncfXGTilYlWCkg+vHX6mpt3He2xVZOSuAWI7jkevNUZ4o5I2+XkjAYjJH4+1aLxHLEsCDwAOCP8aFXoF8sqeoYdKOhrGdkZkYKnLRt6cN/D6/SmSSbZyQPlBIwxBx1/pWlIhVtwBBJ5CjpxULQMAd2MYyVHWh3NFUW7MWaBZGzOpRiu1SpwQvYe/rWTeRrbxkyMflOAVHOe3FdPdWsjJklWXkEdc+g/8Ar1k3sZaIRNwoO0gj+tKV7HXRqX0OKvLqXAUEhQwI4wSD/M01JmlwsnzR7sKWGAD6+pxXVNHb+XsvrWOVwDl4gI3cYwMt7cduayGgskcrDczRMMBkMOS2f6fjWfKnq2d0Kqeli1LcXElrAyvbvFGm3dGqqw55z3Y/Ws77XJJcYhD8H7xbBz9PSrcccK8sYwST8xBBP1zVcRPHOMszruyFJNOb1Jp8q0NCyd2kSXHz5z05Oev4fyrchYAfKoO7rx8xI96zYoFY7hkDOShbJPrV+3SS3cfKBH97B5P1NK+py1GmPEshdkbCgcAYJz69OtTSkCPL7RuOcFuv0UdKppdGSRyVcMoOfm6j1A7U51yA0StvIzkDB+uaE1YzlF3JZXO7y0LbjgjcelVI94YcS+UCflPAH4fWnAHBDS4G489c+uTVi0IRRIOQ/AJPJ/r6U1ZibsG8uzjjjqOQTUBVzJwzAdFOcjin3LNKxDsQSOCo+9+NBGfmOTjgZbik3qStgeAwEk7GA6hTk89fxpsWxsqzBccA9T9eKc67n4zg85x+lI8bxfL/AKsH+JTg9MU3pqF09xjjy/nAJIGenaomlLNuCBioz8vBA+tNBKEklsMeopETBy4IUnBO79aXM2V6kiqsj5K7S3Hy8ZP9aR/LRjtYM2On+elSyAFBsk3E8bQOfxqAsNg2YDNgYxkZoehK1BptpCqh44HOcCs+SVjc7nY5ZuAByR65rQWPbbsQUyeCW4/IVTmhQHYWZecnjrUyuVFxQ4kYzIh2kcsOufeqF6zAuIy4zg7iMHHStCZCsLPuBjBGSw5HvWJNe7m8kE85w+OufpUTdtBwTbuhCyxTFVx5RA5B5NQ38oEXmQSOqjk5GRzUwjCwh8KuwcADp2/Gq05QsQGC7c4y3Oe/44/nUu9jRWvcrQkMsZ+Z19B149qlmkkZj8jjABAHHeoZJArPsjdeBhm6Glt5POOQ6jHynceD7frSVxvuWo5rdFYMjMCPvA4P1/CmRqHj27wAwwMgGqd3KLVgzyKWXhRgtn0AqmmoOxPm20zZyRnpWsYkcjeqNBESDO4AsvK7TjcT+nekw0hZgCxPPttGaow3m92aRWyW24cfNx71aV1wnGCh6LkZ9ifXFBMr7sozEbhGN+PvAY4xTIDHOMucEZwrDAHtSysZzIxQlcdc4P49zUYkWHd8u7jPIwfrUg22QmUkyLtOPQYHtxU3mB4pFeQAryR2/wDr1E+0q/LI+ce4oIBDrtVerYAwcexprRkNJjC0uWcjYqnoB1P0qCWaG5EizMPlzk54+v51YmlXyiEU5B9fT3qg6RrCS77JM8Z6t/jVPyI3d2UZi2eWLBeh9eKpahdMqKp+UZ6Y5I9KuABgMDcrE/L6DpVPUYMSAMBtYZ49Pel0bG2UJD5jh1IDY7foaKluDs2JtURngDvRVpmTPq6NWKttYdeAR3/wp6IIznYcD+HPaood6529D+NWFkDHJyegz/nrTsDbEZuPQkdPT8e1JGS7sCT/ALo704xgtwRgnvUfzxy8BhnpgY/H6U3pqCtsXUwMZxwTz7UrfK3ORnpjtSR/vBgZ9c5znmnb9p3MCex54NNPsZse37lVIQ4bngcD6UQyKOSAy9/UUxyQdwbcvHHYe/8A9am7FcLjORyAO/rR1E1pqXQoJyGwBkHPYUkSlWPz7ufl7fhUEMjjBbI7HinNIqnA4bPJ9ad0Q1rYsMCGBVgRjGeuM0I20ED34IqKE8/Pyw6+3pUr8KMgEZyKpEvew4EBjyM+lNkY/INv1JGQBSJhccn1z6+9M8wbyCAR25pvzElqEakkDJHp7/jTkTOVyCeoJzTSSwBUZJzggUhym4KeSeDnFLXYrcHZVDDofr271EhZueAOeSOaU7cKSBgZBz3OO9OSPCjOTuHrQxqyHRsokUA5x2IzSueFIbDAdT0NNcoeSfzHNRszeZkAEA8Y9Palew99RTuxn0GcA8mqswbqkbrnngYqdhuxhvfjHFIw3L5cmWB4Ab/Cla407FYNvZtxTjsCQf1rO1CDeRufbnPP3v8APpWjLGIpWYRjJwNwPp9ap3B2hjGGHXOBjPvRdHRTet0ZE1uFC4ILDJOTgZ9qyb+zDpgKoLckuOQfUfpW5LERIGCBT7jqKivLZ3haE8A84HWo5E9juhUaa1ObiLRMInIJ2ErKRx/npWtawlyrsjsScEiltrVYmACjklQzZGfpVlgpKrASAcHOOWNKMEkVOpzaItiNQo/eK2OBj6emKYxXzFUtkHGTggilEZGMAgd84P49ajdJJjsRDxkj1PPT/wDVT+Rzrcmkto8DMqnBzhRkk+vvUgYKCSSA3Rev/wBaq6RsCQQFkB5Xpj86ljYNHgueO+M9aSZDbtuSxoCc7YxtPcZ/+sDRdLsCFZQcklgPmPHqKgaVg45zx1PH1qrPLNJcgqQ4HBbdxSckTa7LLSYi2HYeOoGSaiR9hweQ3brRMZEcAREcYOKZIQqnaML23Hr9SPeqYicOpbCsSegyMHrxTGBMjLyCDzjoD25qrAzSMM/KB7D+X0qa7ZhGxQqyjnIPA/Gpe1xrTQeZImiwxbPpx1qJ2cBM/M5znpx+VRK3mZYMHIxjb2pYVDEEghFyF7A56n3pL3kO1iVI1kCs0nOeuOv4UkiqhKj58DqB29P0pZ2C4ZTujA+mDUZUmRg7AgHnb90/402raCvcakWHzu4xwT0X6VFdqQ+wEH+6T19jVtwkMY2kSHrtB6VnXb7Y2fJ3Dog4/Wk7JWGndleRpZS0SsSFHIA+9WXdQiIgEHefm4Iz7jHpV1p/s0oEan5j6njvULs8jKeeOCcZz7jPesZO6N02vQqz3UgtgjNsQ9OMkVVabdtQARsOmRnNW7gJk/ekIPIJ6f41j6jcNHMAxCAnnd1/HFTd9TSCUtES3JZD5RYDB3Hjrj1qutyvlN5Z+fO4Z/Hjis+KXzLsREZL9gcAjPGT6VpW4gaEgABcD3NNPuVOPKrDLK28yUzT5eVuFOQdvsKs3MTQks8Z2n7vfIPpTUYFkEI3yMQAAenvS3cp3tu+XaB15qlLQxbdxIII3l3yHDfdx0/Okm2RkrFJvUfdI4IqSMhIy8ZzjjOP0qPdG0ZMnBbkEf1rRNyMpPqU0mSNywPz5zuUZ6f04qhdzBrxmUOAx4+bJY1oom8tuIAHIUngH+v41QuFRSAdoJB+Ydf/AK9G6Q09dAgkTLJLy33uP0/CmpI5Vl3qWxknGc//AFqhtrdi0jIOh65PPFOV4YuWG/P5ipTb1ZMrE8gAti7Alk7dR6c+tY0PmyTyrOuMjIA647CtGWTJYDcQxGQxyB7Cqkx2yFQPvDAAHNU1dIzV1oNBCcDCnGHBIPfoKyrqQb8SM2epBGc+9TzOwI44XgL0rLvhJHc73Y/MOM9B+FF9AsJevHI58snH04oqF5E8p3QndnIbsfaii9gUWfXu0FBg8cgZ4BpwBCbVIJwAueooZv4gMp7noaVW5Y44xk+4rUyuxCrBgckZ6kfpTXVm4x17npU5Kke57+tKgJXGQB2zT3EpdRlu2CFwQR94Hip3YgEjkHpx2phVSoAXBB4p+w7ckdOOtCQnK46B0eL5hnPPv1qQAEhlXPXkGmrFiPn9KRGKoCT9cjirsQ/IndkI7YxjB600hjJy29ehJ6gVGcMSV+vWkBdcAcHpjtmj1Eo2JW45PJHPv7UqTFwcAEg9TxzTN6sjDc2/rgnH+eaawTaGz82TwBQKyJPNdWJDZHAHqaQOuQHPPselRttkfI4wOnr9KkYKYsAAHGR70gaAOwXHUYznPNMZ1bCgkdyDTmTemcKPU9qRo+hIb8/607FJoZGhH8RbPUE4qXO/JDLgcAbaWPaAC2OATzTJM54Ix06Y60WB6jQdpOWwrNj2oEZK5U54weKCAF3Kw3Dg/wD6jQHKxlSGK9AMY5oS7hr0EMmCBzznhuPrQ4Y7y27d69Me9RS9NynHPp2+tIr8YbI4/OpKtpdEcwYZHPGeQMkc1RljZXwmSW5OT3FaMhB3eXk4HORtx/8AWqhJJFbuGeIlGHADdB9e9KTS3NqbHLHhB91W7svX6VVuIjFIXYqXDZ3AkEelOjlQjEbN5eM8g+vXiolcmUuy/KD8uOcHvQmjWKaZWljLcksxzkK4qSPbtBbKjoWz/OrBIVsKcBh8xxjj8Kal2Y2yAVUYA5zkVLa6ju+hDNGVC7VO0dScevYUsYwNr4fHIOcmpdowXP8AEc8nPHrTC8jNhWKFvvKQMEf5/nUsi+g2QYTLMpQDI7ke1MIJKAkDLAYx098dqexAHzYIY/8AfVNd/PiC7GJzjOaasRdsJImVBIyhlx6dKr5WOTcmST90+tLLEYSdzZJIHc4/AfjSrHtYly6c5HTimrAr2FeVsFXYv6sD1psMLyKQi4OM/hSgMN0i5zz/AA5J9/8A69M5ZS28k4GAOcj1xTuuoldEEbkLhlOclenHHf3pWRmJIUCP361MUXcSwIwRz1qZcrEN2CcEjNSknoac1iKCLAKKqHAIIJyf8+9AR0G2RkBzxtPHSkDhGGcnnA4xu5zxirTqccsTxg4HCihaicmijuDmXZ8xTrkHJpkUboMeaMrnIPXp+lSxoIDtR8lmznH54FKwV38xhlhxkDpUctynK2xC6l1y5KnPQHj261kXbXDsFMm4J19B64rZMka7hImT1z1wfrWfO0eSW4bsCO2Kipp1HCVmUU2NGAkhD9NuM5z3BqJ/MiYSbyPlwCRkn606Zi+dwIUkY4xj/wCtUqyAAq5w2D1/qalamr0RQvZpAGLkF156dR6GudvH89hkNvJ+Rl65roblgc53PjjJrKubIMzMVJVsbgO/sf8A61EtTajJR1ZiSxAiJflBQHDDkAn2qa1d5Idx4Ucbcct7/hUU9vMJPLiJIJ3ZfqQO369as2Vu6LscNhCQSRj8qzk03odNRrlumXUdvvRgk9D6/U06RWydwLOT1z3pjusSECTAzwMc9KrvcsVCIPMB5JHG0Z6ZrSK6M42ncvrcRwRkSqryEEKFzVNQ5BZv3Yxwp5x9fepLW2IMklxgyDI45x7CpJmZ4tufkHTP0rZWsZOyehVaYp8ysDt5ZTxk/XvVGTzJJGYqqjGemfpj0NSXwMIDSfdBrPtJD5YfCqD8zLzz70m9BqOl0TrLMiuI1JDHGTxz/wDq7VCJEaZllyABnHTPqa0GeOUboyxx95SOn+RVaH5pGY4JU5AbnPpmlYV1rcg3BhiMgBTgZOCOe59aZqOS2xPkYDJYcEjrzUTIEd2kIG7+70PP/wCqmTnDF0YMEHQnmlGWmpDSTKU+EzIcfNz0wPyqpPGs0bEk8A4U9ScVauXaSIKOC2Mt2x6VmzeZuAAwq8gjvTUkDWhDcROFEZAUD7wbpmipZ237iR84HX+popcz6E6n1tuA+8Qp7N/Q02PcqgkhgDwfUVAlyhmKSfIw454x9KtRfLu6kda1TTIfuosQ7Sigk8dcnmnhwp6fSq6kA5CjB/WpQQx44yetUmZtEwbIGeSf88U8ElDnOKZnGdxB46GmOSY+Dz0Iqr2JtqTqxKYBIBP4UgbnJ5BOcfSmKxYKcHOMcdqQhw5I+77dD9abYraj1QLkgn3qTdzgMO2M02Mtn5euMfjSFioIAODzQS7sSUqHJHQjkAZxTIwCwY9+mR0p5kyMY6Z59aAhyM/MvbNBd7IbIpVN5Q47Y70sEiyIGVgN3qMUrhyVH8Gc8HoagSFld2JGR0I4GP61N5X0Fo46lpGwRlueg9DUm8/ddcEjA28Cq2DgeYvHfmnCT5drdCepq0yWh2d3XsPpTLkMyERnaPUZIqBFaK4c5yjj1z+QqztXnYxGegB61N7rUd+VoYhJGGHbgn3p7RgH5i2D7f1qIkg5AG7qQTSM7KORkEcA9Pahsq2tyUqAAGBPbBxzUJRU3BWwB2yOPanEtu2sRyOnQUgKKeGUk9OKLhqRoNxG7JBHQ859qintgFAZR5I569Pp71YkAJDblx65xz6VDKRnkgjPPH6VLWmqKi3e6Kf2VcgqW6fdBPWoJ0dWj2RyNlsMQQNgx1x3Gfr1q7IS23HUZHp/+uosBgDtALcscfnUvTY3jLuRmVdo3AM+OvpUAG1wzYIYjGBnH41aeEMg2sh7AHlqjKSlcqZOGHy9QB70ajTQyaJxs2DcrjPXg+2ab5WMMgAY8HJq0YJAh25HIGDztqLaRtwuU7ds89Pagi/YPLTygm9WK8AcZP6c01Vxz5u8Lz0/lT2Vk55+YdxgCo1wxKFwvQjI/pQtyF3CRQWBUjdt2lRk8etMltyqDzFYDP3mzyfpUibmILEAevrz+tOLzRIVyCSDuCkYbn1oW2o720GqkKkFmxjpgZx9c9/aqs8cSN8jIUP8WMVMEEsbK3JGPc1WPEgRRz6dT0obsC1epFIfl2gAlT/F1z1zUnntJEF+8oPTp1qwsLeYxjKKcZ5xz+dVjEVjHm8Hk8CjUd1sQkoCDzgdh+lWJH8zCg5Azxz/AJ61EVwcKc7TwBx+YpJ5nG3ouTjHapvoU9dh0mSN275xzjH5nNVvPBCho9gyRgHrUsWGUnac9hjGaoXLuUkTBG3jHfrUyb3Q0ruwt1JIIjJEW2D0xk/T0zWWsoZ/YnIAP6f/AK6JJJAcOwLYAA6AY/8ArUs9viFWAUK3LZ659hWTuzaMVHRkVxNDMQQhDdCxPBHcVn6pPMBH5B2jqeM5GPT8avySK0CKI0yOh/wxVSWQjeAVVGXHJ6f/AFqiUdLIuGjKNnK829JJd0asCvbH1PerfkMxzDkAdQPSq8hZYAtqgC9NpOPyPpU0ck8Mal3GMbu3+fWiK0tIqXdFO6hXdgLgn+LNQDz9pXO9Oh9/xq00cmfOk2Yxjkc802WWPbjDBhyPU/Smkg5jP8mJ9pZmxnnnnp0NSyweUpC48tvlBHQfU02OD7pKnOc7Tzznv6mkml3N5chycYAwRnmqUhSdyYzt5DKqo24c9uPWoZmCRgMB83OSfakdEiZpCPm+6ABkClyJZC0uNuBgkYxmtFd6GTsZWpmWZW2OAjDChueP51E8ckKANxk9T0Hf/wCtV+eIeY4jZehPXHHYVVcyQwk5PltwBjOfz4ol5lqWlkRxSFIWByWY7eBUcTZYDuxI6GoZZhujZcYAGQABk1JNMuxWjfO4cjOMEn9KlBJfiSXCxNkK2cnkg8D2qvephU8og9mHp71IyAws5DBgd23nI/8A1VVmCSv88i4VQTx0FUZWKJmjEmXyzYxjPSoGPmyGRixVuNq4BzS3iq02UJDZ2jA6j19qhfBCBFJY9PQULzG0mLcbmjcKFyD+Qoqt+9IzJnOTtA5zzRRa5Gx9bzwLJOJONy8jtmrancD0xjqPSoHkDBkJP1HpT4htVlByD0I71olbYyd5KzLCgEHnjFPXhyeuKrozK4yThh3PT2qaMDHpnjpWi1IloOHzkhcKc96fGPmAXnPY1H0yD909fapD1BHzD1FCJdxgwHwchhTy+1QHBYevrTSBnI+6DTwyqGGOPp0oQACWJAIZvTFJvBGOefTtTRjdn24PcVKgOD057MKpa7A7DXwh69RwfSljdTnLEN19BTJF2ll4A+ufyqJA6MTkhT3zSu0Fronbse33v/rVIIwwBYLgHH0qsnmckEbc88ZqXuR1x1yaSdyWugPhXyoPBIOKazr8x2sNvB9qTcyzYcZQdDnilYEPwMjqOfemndXQ2kNdy6hkYce2PzpxZlJX7wxncTx+lAJ252Be/HY0oxvwSwHb5RxTtcG+hGI/NBSU/MPukmlWPYMD5j3ycmlYBmwGzjkc9frTeQMEjB7H+lToh9Bs/wAkYVR15OOgpu4kDDYJOMe3rUp2heeCexFQsDt+Q45/AUtb6FRHcbdzEZznB7YpmN0m1MdMgjjP4etKEMiqvf6j9Kj3MisXzwe39KXN3KXkBOCVwxcdARkj60k0alA2AD1AA6+4pp8xiW35cf3uvWgjqd3PRsZ60XKtYiLmOQNzgAHGcfgabNcoQWfKyMdueMCnzRqcgHdg8Ej9RTYoy44KqN3cdPeld7FWW4whkBCFSMd/rSgbgTkHHpzz/SnOiAgR55+ZiRjBqJGZZyUABz1YcUOwtyRZyICu8Mc9M/1quu9WIUhx1BzTiAucAJxngcdemKWTDpjaw54cUPUVrDWjOzOD5eOQO1MO0qQSMjtjgCkbODlmBx0GcfUioZJORjI7Z65/+tS8xrUnbMbnGS45zu4NQ+ZI0uT8voVGFqGSXy2A5UHvjjFPR8EFNpIPTqD65pc3Rgl1ZO0ijackgj5iTgVHJGfOHmfMPvdsfSoEuRIhO8MGZhzjqGIx+B4pJJSzHAAAHWncSiyWT91ggKx6YzUEhLO52BV9j2qSJg7Ylbgk9OR+VVLk7XwD8i98Y4pSelxx3GTysg+9syM5B5+mKrTPBKBtuSZI+HGeVOM8+9WJisgGQS459R9KpvEWclvk2g4X0rKRql3K5i8w/K21DnHHNRuNvlmOMuQ3Q8c//qq+u5A6KcKw/wBXkc/Wqd3MCzIQvTBx2980OKSK5m3Ypu6ySsqR454x7+lMkEbHacHbkqTz9c+lXoFhKO24rIo5BHUdhVcRPsIZCSevoc1LTZSkuhlP81wXBwB0BHGDUgiIUMu3DHduYZPt9Ks3EYRfKddrOcdO9NkcmLywAFGcMOtSluW5XSInDSoUJXqFAHU1BJaCKNQSVX8iKlyscmXJXptJzxn0zTppAFAYOe3Izgd8VpGKZDbWiK6KiqwJYsAGJXIK/wD6qo4RnIyd24jaTnmrchBkAVgIu/HP41C0CRlJwCOCFfI45/lRygZmo3EyxhQCcE8KDg4qIyTSJHGpyyj5mA6exq2XG8lwxiPLE9BgdarSCPCvA5aF1EikAqSDzyD/AF6U0uoXS0sCbxG7vkgjBPSqd7qKhNnUYwMEcGlnld5dkYIQMBg85qvLbq9wFjB2/eyeWJ96Oa+iLjC2rGT7PJIwGXoB3Oe+PSmz/uooyoAJ/izTmVPLYuQhB5GOhzxVK6Wa4t3xHgBscHt65oSBklzcKkDEytnJ6dz6VWXzZMNs2Oy9xye9PgtRI+yTGQnQcc0shJfaGLMvTvkelMl2WxXMe2dzKwUsMGoYkEMj7TuB9Tz+f4VadVurpQ+MY655J/wqs6NHclTjahw2fX1oe+hF7lVslC+AFBznuB6UUt+6xKdp/dsPTv6YopxTZJ9YQMGBJBzjnNWFIIKkY4yDVRGAbDNz3z2qYOHQbuMgZx0rRIwZZV/kCsN2etTxSABcjI6DvVCP5SMsQOTk+lTRFgMc46j0NNCaTRdDBhjH5/ypYgEwidOxziokyFyMbscgdM0jSM23gDp0qrrchRJ2O1uDzjOAKV8Htj8KrLIxAxwKsOMAEHPrzihO+qFa24JzGcZ5NOUB8qVGMc03eoUYXnnBBpQ4ydv4j9aYmxFRgCAcE9c0qk4OARk4wOhpd27Azj60rAKCA3NAr9xgUAspHSnrjPB5J/Km8twcccAUhztZQ+1v4WAzQNq49iAfkHH4daJRn5Bj/eFQwoyoDnt1qRcuDhs8evNO4tmNckJjHJHIHelUb+FBx16fpTF3qw4OexFAkKkYGCOvpUprqVbsAyOOPfmpH5AIGW7/AEphk3EjHHfNG8fdz3qkwtcT7zZ5KntjmiVcqSBnOR6Z+lRSsUYEA4PqME80qsWw2FZu59PpUvsOz3IiGV/mHy443daTPmIFfbjrkjFSXDFRhhgEdQeDUPkCeM9uMHIpWtoWrbscx2EccgAEn0qKSdnJKqo28bh1JqJQVAG1+Oozzn1qcKdocgBe+Tn9Km/QuyRHC6v8zFsDgZ4UU5pgAVZckEYOcUwtsclcMT6nj8qiLMQ33RnnB+vX2pajsmyVsfIASD2qSML1kYcHnj9RUGSgDFSc8+namuwIXawXB43UW1JeuhZZIpUIVA/tnBqjKPJGA2efXt6VKSQD8hOehBxmq7yAqy4wD60PuJIbNJuI/hU9wev41Wkw8OY8Eg4bJyKmudpXb8pRvTtVRY3STbDMVHdSOD9TUtvY0VhjlmVMtgDjBH6UiHYc5O489KkZfmcncpIyc/yqJhvCscK44wDWXdlXQy2iWKF4/LCLvZweuQxLZP4k8UGTblWjyCMgk4NBIPMe5j6E4xTJpkjQuQ4A9ecU03uK3QbHPMSRJhJBjHOeKcxLZKna3fiqj3ZZCFCcHAYYBPt70yOeeNyQNqjoT0Jx2pcxTXyLkSBI2aXcxA3KT0HsajYAsNw/PtUcdyhk2yMFVs7ieKkljw3A3MvI2+tO/MiG3cZLFGpWTfGRx8o9fpVGSSJiQEPUgEr0q8gEm7erCMDO4jn6io2gjyeVVD29cU3G+o1K2hQuhJG/ADGQja2c8f40RJIFy7NjOABx7Zq9dxKbfe6qyEjt/OqqM6SB0zydoHUcUuWzL57rQjmiPAbLAcck/wCTUUSF8hpAi54yMjPr61JcNKzfwjuR0qKFCiH+9yQx5GPahpN6DTdtRkwDnYW+507/AEqs8nkqqgpubjDdSKW6kdCrFDtY4NUNShaSSMwspIXPpg027Ipb67EccREzbWEjMN25j0+lQXJlSJxAABnkE+4yf54HrU9lZrJvDMd+fvHjmnuERxEyrkkZ96FsU5K9iq1uRDuxuBG4bm4Hp9arTRlGAxl/4iTnH0q67PFEUIGAMkHnAqrlhJGQdseMMRRdMVyvMFDlrc7zwGJqBZJ2m/cKFI4LMef881aMfzPFEFI4AIqsgaKUSMu/HBye31pXsxkM1sLhvmAyuCPU/wCfSqzM0KtC/A3YXt+lW7uR3kjETj2xzt+nrxVaVUifEgJbOQc/kadxPzE2GFnf7pfncD0HaqmwLIHyQp6kdPrU9xOrxNJISwHyqBwKrNcSLCkIG4NznOOPejRGZCZESXdyWJIxjr6CopYz5zgKdxx9Ks38SgK5I4IwAcc4qAlsiRyOBzz19h7Ur20FfqjNuGczlSm0dcHHAoqTUGTywMkyZ+5jH0oq0kyG2fV8luDiUcsO/t/jTVD8lCQB6jODViTnA6EHueKi+cOcqMDGDWjRnF6BEzMd3WrEcgZBxhR1zUCgYXHA71ITj5mAK+1HQG0WVkH3hj3AqRSMA5+gPFUsKm3IIxn5s1Ytn39OooJaJ/l6jJ5xzUhCKpbOHHQdarMTksMAg8VIp8w9QFGDxVp9CXsTrtA5Xj0oUIwBPBIzUUTgSkSDAH6VIWy2MdOn0pktCqRkYGGHU0m5mIHVsce1KWUEg8Y6HHT3pV25yB7g+vpRa4XExk9AO3Xp9ab84IztwOhxSu4MhAU9Oo701iGib5vlxRcaBsIRvGB65pI5FdiY+nfjkULkoo3BgBgGkRNgbjHqRQwshzKSAcHAPXvTMqcAjL9MZ54p/mcEIeOhz2NIvCZAyTxmkwXmIRtdiTg9DmoGJ/usrDnOKk+dyT94gdupppjYfcJD46Ghvqi0Ekm+IBlO4dfSoipiOSSV7dsVYaNSOBg46VGzLFxtyD05yc/Speo0+iGvISpI+4RjBPvQkmSxZkBxnn+tI68A7gSPlA9KQRFpG2KwwOSAKQ9BHO0jGNxGAo5qOR9zMvqOe5pB5n3RkYPf9KjkGHPyA/QY70rlJXARGRSS33eSPU0jzLgApliN3rTdjCTDjpnao75qMuPmLAj2A7UnoVa4k1yXjXdnb1C/1o8pXUPkHoe4yKexjdQuMHHQLyRULM0UgKc4HTOeKY+mhKZVJKhW+UAY9fpUA+eMtgkg8g9cVG7EtxznoRz26Z7VHFABMyrvJJ3csc/h7CjcVlYkBDkDDHIz9aGUuwRNuTwfem5IlY4Y+hPSleRWcv8AKh9BSWpLGuCyqjjAXoD1qBwzhsY3DkccUjSfMyB+CM5UdKRzsyQ3yHupqXrqNJkTIyIQQD6HOMVWdNyEyqCvcA/zqWWRmA2khW6dsjtSTorwbydpXOV6ZrK12aJ2K/2aOXbJsjMcZ3HjG1uxGe/+NEk8Tx+WFBU8HHBFV3YjcB8pPykAZ5z6U5Gim/eMwU8D1/Cld7IbjfVkJO6VwRnIBwo2/Q1OpXeGBYg8deKrPOiSbUJOMglR0z6U6G4WRirsflIHA6jrQtGOS6lyTy9gIbI7L3+lVnchVzjqPl7+lTCRFmZWD7x0I9++Kro6zNhzs+bPHc/WrbM0h9zcblEUjOA2MqQfTvUU6bGKYGMZGDwRU81uoxhSeOuSf1qk24BQoXH3fnbGPxp67DVuhI0qRApIuQ3AJ5OagjKncWbcoPWqV48i5DYLYycEHv61BHKxtg0bbXPUnv8A0qVLoWoaXLWrLF+7ETM+CC5UgYqG32q7BlCADOW7n/Cqxk3PhsqNwJDc5/xp8yh4+ZFcg5PtTvdtou1lZi3CSmfajDaWyNvXA/lQfJTkYLdsjv61DHJ9mdprglkOMfNnFMuJY3dpY2KpjCqOeKrzJt2Gwt5bbZED7s5LDOT7CoTGZHZTwyg4BqN5QIyZMmYvhjk8D2qeWRSsZVkC9WIHNSgehnwD7PelnO+NuevPFQXLh7ogA/N74xVohZA8jygIinBAyfcAdqqMFkO1D+8APTt/9ek9EVpe4y5kWCRco3yjg559zVO7ciMiQZDjhyM7c1dQMV/0gKWxhVPH+fWqXmJEpDkkjPB9KTBlKOVpCsQVjAMEsw6+gqSKZEYpKFJAyMjpVSKdUf8Adl927d9P8KgkcyTsjYBB+Ysc8U7vcJRuXZVWW3kkJJUnjnH5VWLx7CM52DgetMEylp9si+X0wDgA+lMjlSTy1AXYgx7n1yaGmZNWINQiDxrOuA+eAOv40Ut5nbwoYIcn6e9FaR2EfXLrhTtP6VGp3RnoCOKKK0Zg9hrgdcAgZGCOg9qMll256dKKKXQcBHnKgqeTnj2pxVotoB+90Pf8aKKGBJEXXarkN1Ap8coDkYOQeDRRSvoJ72JVfc3AG71p5+RGLEn2ooq0JrQcsjA/NgjGaeSS0e043c80UVS1RLQkhIJzjPsKDtlxvGRjp2/KiigUtAU5fbgBR0xTHbyuRgkZPTGaKKT0Ra3GuxZlPQ4yKkjUknngDNFFHUUtiORipPUZ6gUh+cBiScE8Z9qKKS3GOMhQkLxhQcVHgyKemRzyOlFFTuD0I/MZMtgccUrTboyRkHPrxRRTH0uDMF2s27cOOD15qKUqHG5Adh5wcZoooe4LcrtJgbX+ZuefemnAJLZDjByDRRTWpptsJGxYugAAGDnvTbtEV9q5zwQenFFFT0B6NEcO1WwRnHABFNuW3SfKACOc4oopN6B9ogb5dg6l+M+nGahn6AN9726UUVL2QdSrcKFXcxO5m2qR1z61WvJJIIY3RhslYgrj0oopT0jdF03eSTIXmYhmwCBk4qUzmVFDKAT70UVmnqi5JEAjyzFiSR82Tzn60252sSCgDbdqleMetFFHQG9Si1uYyJg3UEev6U2Isib1OVB5VqKKRd24tsnnuSyIcfNkZJ9DUM67QjADbjJoopS6kxG2t1Iz4kkYqCQOM0B2dXEh3Dr6cUUU02VZFMbdu7nrjHUZ6024VvLVlICEZxjmiinBKwdSBYvlCNghjkE8kf4VXlR3kaPcBGV7DFFFJ6FXdxs+/cschBG0ZwOtFkrSyPuKqnXAFFFPqTJ6Db+MB9oChS3GKhtA1xKIyADjC4OOKKKdtfmJP3Rt0hhkCrgc5471TU7Jt4BMp4Bzxiiik9xrXcqTysVBJbcrEkk5zzWfqkybUKR/MTtJPr60UUR2ZdtUZU0phcbQPNdeG7AelZ16zCZ13sx6knqaKK1gDWhJYBpshiNnXb2J9asx27SR7lKhl5Ynvk9qKKU/iM5DJyGc9fLHUDjNFFFBB//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Ulcerative lesion on the breast caused by",
"    <em>",
"     Blastomyces dermatitidis.",
"    </em>",
"    Note the distinct and raised borders.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Bradsher RW, Bariola JR. Blastomycosis. In: Essentials of Clinical Mycology, 2nd ed, Kauffman CA, Pappas PG, Sobel JD, Dismukes WE (Eds), Springer, New York City 2011; with kind permission from Springer Science + Business Media B.V. Copyright &copy; 2011.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_55_23414=[""].join("\n");
var outline_f22_55_23414=null;
var title_f22_55_23415="Processing proteins PD";
var content_f22_55_23415=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F72207&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F72207&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 588px\">",
"   <div class=\"ttl\">",
"    Cellular processing of proteins involved in the pathogenesis of Parkinson disease",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 568px; height: 464px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Model of dopaminergic cell death and possible sites for therapeutic intervention in PD. Studies on inherited forms of PD have led to the identification of genes that, when mutated, lead to dopaminergic cell loss. These genes are involved in a variety of cellular processes that include protein ubiquitination and degradation via the proteasome, response to oxidative stress, protein phosphorylation, mitochondrial function, and protein folding. Potential points of therapeutic intervention are highlighted: gene silencing therapies to reduce synuclein levels",
"    <strong>",
"     (i)",
"    </strong>",
"    ; inhibitors of synuclein aggregation and/or processing",
"    <strong>",
"     (ii)",
"    </strong>",
"    ; interventions to downregulate toxic substrates or upregulate parkin or proteasomal function",
"    <strong>",
"     (iii)",
"    </strong>",
"    ; interventions to enhance mitochondrial function with factors such as CoQ10, DJ-1, or PINK-1",
"    <strong>",
"     (iv)",
"    </strong>",
"    ; free radical scavengers and antioxidants",
"    <strong>",
"     (v)",
"    </strong>",
"    ; kinase inhibitors to block LRRK2 activity or interventions to increase PINK-1 function",
"    <strong>",
"     (vi)",
"    </strong>",
"    ; and other therapies using trophic factors such as GDNF, survival genes, or fetal/stem cell replacement that would protect or replace susceptible cells",
"    <strong>",
"     (vii)",
"    </strong>",
"    .",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Savitt, J, Dawson, V, Dawson, T. Diagnosis and treatment of Parkinson disease: molecules to medicine. J Clin Invest 2006; 116:1744. Copyright &copy;2006 American Society for Clinical Investigation.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_55_23415=[""].join("\n");
var outline_f22_55_23415=null;
var title_f22_55_23416="Management of healthcare workers exposed to hepatitis B virus or hepatitis C virus";
var content_f22_55_23416=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Management of healthcare workers exposed to hepatitis B virus or hepatitis C virus",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/55/23416/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/55/23416/contributors\">",
"     David J Weber, MD, MPH",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/55/23416/contributors\">",
"     William A Rutala, PhD, MPH",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/55/23416/contributors\">",
"     Joseph Eron, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/55/23416/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/55/23416/contributors\">",
"     John G Bartlett, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/55/23416/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/55/23416/contributors\">",
"     Allyson Bloom, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?22/55/23416/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 3, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;More than 30 different pathogens have caused documented occupational infection following exposure to blood or body fluids (BBF) in healthcare workers (HCWs) or hospital laboratory personnel (",
"    <a class=\"graphic graphic_table graphicRef69942 \" href=\"UTD.htm?6/35/6717\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23416/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Many other pathogens have been transmitted via needlesticks in research laboratories or during veterinary care [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23416/abstract/2\">",
"     2",
"    </a>",
"    ]. The most important of these are hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV).",
"   </p>",
"   <p>",
"    The epidemiology of needlestick injuries and exposure to bloodborne pathogens, and the preexposure prophylaxis and postexposure management of HCWs exposed to blood or body fluids contaminated with HBV or HCV will be reviewed here. The management of HCWs and others exposed to HIV is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/47/7930?source=see_link\">",
"     \"Management of healthcare personnel exposed to HIV\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Postexposure prophylaxis also may be warranted for HCWs who are exposed to a variety of infections that are not bloodborne. These include hepatitis A, measles, influenza A and B, varicella zoster, pertussis, and invasive infection with N. meningitidis. Recommended regimens are discussed in the appropriate topic reviews for each pathogen.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY OF BLOODBORNE EXPOSURES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Statistics on exposures",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Occupational Safety and Health Administration (OSHA) estimates that 5.6 million workers in the healthcare industry and related occupations are at risk of occupational exposure to bloodborne pathogens. The National Institute for Occupational Health and Safety (NIOSH) has estimated that 600,000 to 800,000 needlestick and other percutaneous injuries occur annually in hospitals in the United States. The estimated combined medical and work productivity costs in 2004 were $188.5 million [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23416/abstract/3\">",
"     3",
"    </a>",
"    ]. Worldwide it has been estimated that in 2000 alone, percutaneous injuries led to 16,000 cases of hepatitis C, 66,000 cases of hepatitis B, and 1000 cases of HIV [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23416/abstract/4\">",
"     4",
"    </a>",
"    ]. The cost of managing one postexposure evaluation after HCV exposure has been estimated at $650.00 per event [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23416/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The International Health Care Worker Safety Center at the University of Virginia has gathered data on needlestick injuries from 29 cooperating healthcare facilities in the United States [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23416/abstract/6\">",
"     6",
"    </a>",
"    ]. Data from 2007 demonstrated that the overall rates for percutaneous sharp object injuries was greater in teaching hospitals than in non-teaching hospitals; the top three sites where exposures occurred included the operating room, patient rooms, and the emergency department.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Risk by profession",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nurses report the most frequent exposures (34 percent), followed by physicians who are residents or fellows (18 percent), attending physicians (14 percent), surgery attendants (6 percent), phlebotomists (5 percent), and non-laboratory technologists (4 percent). Long work hours and sleep deprivation among medical trainees result in fatigue, which is associated with a threefold increase in the risk needlestick injuries [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23416/abstract/7,8\">",
"     7,8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A survey performed among 699 surgeons in training at 17 medical centers found that the mean number of needlestick injuries increased according to the postgraduate year (PGY); by the final year of training, 99 percent of residents had a history of needlestick injury [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23416/abstract/9\">",
"     9",
"    </a>",
"    ]. Furthermore, more than half of the most recent injuries had not been reported; the most common reason for not reporting the exposure was lack of time.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Devices associated with exposure",
"    </span>",
"    &nbsp;&mdash;&nbsp;The two most common devices involved in injuries included disposable syringes and suture needles. The purpose of the sharp devices was most commonly for suturing, injections, or drawing venous blood.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Minimizing risk",
"    </span>",
"    &nbsp;&mdash;&nbsp;Minimizing risks to HCWs for acquisition of bloodborne pathogens should be an integral part of the infection control and occupational health programs in all healthcare facilities [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23416/abstract/10\">",
"     10",
"    </a>",
"    ]. All healthcare facilities are required by OSHA to undertake measures to reduce the occupational exposures to bloodborne pathogens including the use of engineering controls that minimize the risk of sharp injuries (eg, needleless intravenous medication systems, blunted suture needles) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23416/abstract/11-13\">",
"     11-13",
"    </a>",
"    ]. Key measures required by OSHA include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      All HCWs with \"reasonably anticipated\" exposure to blood or blood contaminated body fluids must receive yearly education on the epidemiology of bloodborne pathogen transmission and means of minimizing such risks.",
"     </li>",
"     <li>",
"      All at-risk HCWs must be offered hepatitis B immunization at no cost to the employee. HCWs who refuse immunization must sign an OSHA mandated declination form.",
"     </li>",
"     <li>",
"      Healthcare facilities must provide certain engineering controls proven to reduce exposure to risk, such as leakproof secondary containers for transporting blood and impervious needle disposal containers.",
"     </li>",
"     <li>",
"      Healthcare facilities must provide personal protective equipment (PPE) and HCWs must use PPE when performing procedures for which it is reasonably anticipated that exposure to blood might occur. PPE consists of gloves for possible hand contact with blood, and impervious gowns and",
"      <span class=\"nowrap\">",
"       face/eye",
"      </span>",
"      shields when splashes, spray, or spatter of blood or other potentially infectious material may be generated.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    \"Standard\" precautions (formerly called universal precautions) should be used for the care of all patients [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23416/abstract/14\">",
"     14",
"    </a>",
"    ]. These precautions consist of wearing gloves when touching blood, all body fluids including all secretions and excretions (with the exception of sweat), and contaminated items. A mask, gown, and eye protection or a face shield should be worn during procedures and patient care activities that are likely to generate splashes and sprays of blood, body fluids, secretions, and excretions. Healthcare facilities should consider implementing other strategies demonstrated to be effective in reducing blood exposures such as double gloving for high risk",
"    <span class=\"nowrap\">",
"     surgical/obstetrical",
"    </span>",
"    procedures, blunted suture needles, and self sheathing needles, needleless connectors and infusion sets, and enhanced education [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23416/abstract/15-21\">",
"     15-21",
"    </a>",
"    ]. It has been demonstrated that most needlestick injuries are preventable [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23416/abstract/22\">",
"     22",
"    </a>",
"    ] and that use of safety-engineered devices reduces needlestick injuries [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23416/abstract/23-25\">",
"     23-25",
"    </a>",
"    ]. The Centers for Disease Control and Prevention has developed a workbook for designing, implementing, and evaluating sharps injury prevention program that is available on the CDC website [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23416/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     OCCUPATIONAL RISKS OF HBV AND HCV ACQUISITION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risk that a HCW will acquire a bloodborne pathogen as a result of an occupational exposure will depend upon several factors [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23416/abstract/27-34\">",
"     27-34",
"    </a>",
"    ]&nbsp;(",
"    <a class=\"graphic graphic_table graphicRef76403 \" href=\"UTD.htm?38/26/39340\">",
"     table 2",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Prevalence of the infectious agent in the general population [",
"      <a class=\"abstract\" href=\"UTD.htm?22/55/23416/abstract/35,36\">",
"       35,36",
"      </a>",
"      ] and within the patient population served by the healthcare facility",
"     </li>",
"     <li>",
"      Frequency of exposures capable of transmitting the infectious agent",
"     </li>",
"     <li>",
"      Nature of the exposure and efficiency of transmission for that exposure (ie, exposure via percutaneous, mucosal, or nonintact skin)",
"     </li>",
"     <li>",
"      Which virus(es) are present in the contaminated fluid and the titer of virus (viral load) in that fluid",
"     </li>",
"     <li>",
"      Availability and efficacy of pre- and postexposure prophylaxis",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     HBV infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prior to the widespread use of HepB vaccine among HCWs, the prevalence of HBV markers was higher among HCWs than the general public. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/31/4602?source=see_link\">",
"     \"Epidemiology, transmission, and prevention of hepatitis B virus infection\"",
"    </a>",
"    .) The frequency of markers of hepatitis B infection correlated with the number of years spent in healthcare and the degree of exposure to blood. In 1991 OSHA required that all HCWs with reasonably anticipated exposure to blood be offered HepB vaccine. Recent studies suggest that this strategy has been highly successful in reducing HBV infection among HCWs with a 95 percent decline in the incidence of hepatitis B infection among HCWs between 1983 and 1995 [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23416/abstract/37\">",
"     37",
"    </a>",
"    ]. This decline is 1.5-fold greater than the reduction in incidence in the general United States population. However, a recent survey demonstrated that only about 75 percent of HCWs have been vaccinated against hepatitis B [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23416/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    HBV is the most infectious of the three bloodborne viruses discussed here. HBV has been transmitted by percutaneous and mucosal exposures and human bites. HBV has also been transmitted by fomites such as finger-stick devices used to obtain blood for glucose measurements, multi-dose medication vials, jet gun injectors, and endoscopes [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23416/abstract/39\">",
"     39",
"    </a>",
"    ]. HBV can survive on counter tops for seven days and remain capable of causing infection [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23416/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     HCV infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prevalence of HCV infection among HCWs is similar to that of the general population and thus, routine testing of HCWs for this virus is not recommended [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23416/abstract/41\">",
"     41",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/7/2169?source=see_link\">",
"     \"Epidemiology and transmission of hepatitis C virus infection\"",
"    </a>",
"    .) Testing of HCWs for HCV should be performed after needle sticks, sharp injuries, mucosal, or nonintact exposure to HCV-positive blood.",
"   </p>",
"   <p>",
"    The average incidence of seroconversion to HCV after unintentional needle sticks or sharps exposures from an HCV-positive source is 1.8 percent (range, 0-7 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23416/abstract/41\">",
"     41",
"    </a>",
"    ]. A study from Japan reported an incidence of HCV infection of 10 percent based upon detection of HCV RNA by reverse transcriptase polymerase chain reaction (RT-PCR) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23416/abstract/42\">",
"     42",
"    </a>",
"    ]. No incidence studies have documented transmission after exposure of nonintact skin. Transmission of HCV from blood splashes to the conjunctiva has been described. Hepatitis C virus has been demonstrated to survive on environmental surfaces for at least 16 hours but not four or seven days [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23416/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     PREEXPOSURE PROPHYLAXIS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Hepatitis C",
"    </span>",
"    &nbsp;&mdash;&nbsp;Currently preexposure prophylaxis for HCV is not available.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Hepatitis B",
"    </span>",
"    &nbsp;&mdash;&nbsp;Preexposure prophylaxis for HBV using",
"    <a class=\"drug drug_general\" href=\"UTD.htm?26/36/27207?source=see_link\">",
"     hepatitis B vaccine",
"    </a>",
"    is safe and effective [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23416/abstract/27,30,34,41\">",
"     27,30,34,41",
"    </a>",
"    ]. The Advisory Committee on Immunization Practices (APIC) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23416/abstract/44\">",
"     44",
"    </a>",
"    ] and the Hospital Infections Control Practices Advisory Committee [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23416/abstract/45\">",
"     45",
"    </a>",
"    ] recommend that all HCWs with potential exposure to blood or blood products be immune to hepatitis B.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Dosing schedules",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approved schedules include the following: Engerix-B (Smith-Kline) &mdash; 1.0 mL (20 mcg) at 0, 1, and 6 months or 0, 1, 2, 12 months, or Recombivax-HB (Merck) &mdash;1.0 mL (10 mcg) at 0, 1, 6 months.",
"   </p>",
"   <p>",
"    The 0, 1, 2, and 12-month schedule was designed for persons who have or may have been exposed to HBV; seroconversion has been documented by the third month after initiation of immunization in the vast majority of patients receiving this schedule, according to the package insert.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Follow-up testing after immunization",
"    </span>",
"    &nbsp;&mdash;&nbsp;Following a primary series, HCWs should be tested for hepatitis B surface antibody (ie, anti-HBs) using a quantitative test, one to two months after the final vaccine dose.",
"   </p>",
"   <p>",
"    HCWs whose anti-HBs titer is &lt;10",
"    <span class=\"nowrap\">",
"     mIU/mL",
"    </span>",
"    should be tested for HBsAg and if positive, be evaluated for chronic HBV hepatitis. If HBsAg negative, they should receive up to three additional doses of vaccine and have their anti-HBs titer repeated. HCWs with a titer &lt;10",
"    <span class=\"nowrap\">",
"     mIU/mL",
"    </span>",
"    after the second series of three doses of vaccines should be considered vaccine nonresponders and provided",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/49/28437?source=see_link\">",
"     hepatitis B immune globulin",
"    </a>",
"    (HBIG) for documented exposure to HBsAg positive blood. It is not necessary to perform serologic testing prior to immunization, unless the healthcare organization considers screening cost-effective.",
"   </p>",
"   <p>",
"    Vaccine-induced antibodies decline gradually with time; as many as 60 percent of those who initially responded to vaccination will lose detectable antibody by eight years. However, booster doses of vaccine are not recommended for immunocompetent HCWs, because persons who respond to the initial vaccine series remain protected against clinical hepatitis and chronic infection even when their anti-HBs levels become low or undetectable [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23416/abstract/27,41,44\">",
"     27,41,44",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     POSTEXPOSURE PROPHYLAXIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Well-defined protocols have been established to assess HCWs potentially exposed to bloodborne pathogens.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Definition of exposure",
"    </span>",
"    &nbsp;&mdash;&nbsp;The CDC has defined \"exposure\" to blood, tissue, or other body fluids that may place a HCW at risk for HIV infection and therefore requires consideration of postexposure prophylaxis (PEP) as [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23416/abstract/41\">",
"     41",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      A percutaneous injury (eg, a needlestick or cut with a sharp object)",
"     </li>",
"     <li>",
"      Contact of mucous membrane or nonintact skin (eg, exposed skin that is chapped, abraded, or afflicted with dermatitis)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Body fluids of concern include: semen, vaginal secretions, or other body fluids contaminated with visible blood that have been implicated in the transmission of HIV infection, and cerebrospinal, synovial, pleural, peritoneal, pericardial, and amniotic fluids, which have an undetermined risk for transmitting HIV. In addition, any direct contact (ie, without barrier protection) to concentrated HIV in a research laboratory or production facility is considered an \"exposure\" that requires clinical evaluation and consideration of PEP. This definition should also be used for providing postexposure evaluation for HBV and HCV.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     OSHA requirements",
"    </span>",
"    &nbsp;&mdash;&nbsp;All physicians providing postexposure evaluation should be aware of OSHA requirements [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23416/abstract/11-13\">",
"     11-13",
"    </a>",
"    ]. In brief, OSHA requires that following an exposure incident, the employer shall make immediately available to the exposed employee a confidential medical evaluation and follow-up, including at least the following elements:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Documentation of the route(s) of exposure, and the circumstances under which the exposure incident occurred.",
"     </li>",
"     <li>",
"      Identification and documentation of the source individual, unless the employer can establish that identification is infeasible or prohibited by state or local law.",
"     </li>",
"     <li>",
"      The source individual's blood shall be tested as soon as feasible, after informed consent is obtained in order to determine HBV, HCV and HIV infectivity. If consent is not obtained, the employer shall establish that legally required consent cannot be obtained. When the source individual's consent is not required by law, the source individual's blood, if available, shall be tested and the results documented. When the source individual is already known to be infected with HCV or HIV, testing the source need not be repeated.",
"     </li>",
"     <li>",
"      Results of the source individual's testing shall be made available to the exposed employee.",
"     </li>",
"     <li>",
"      The exposed employee's blood shall be collected as soon as feasible and tested after consent is obtained. If the employee consents to baseline blood collection, but does not give consent at the time for HIV serologic testing, the sample shall be preserved for at least 90 days.",
"     </li>",
"     <li>",
"      Postexposure prophylaxis should be administered when medically indicated, as recommended by the United States Public Health Service.",
"     </li>",
"     <li>",
"      The employer shall obtain and provide the employee with a copy of the evaluating healthcare professional's written opinion within 15 days of the completion of the evaluation.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     General guidelines",
"    </span>",
"    &nbsp;&mdash;&nbsp;These general guidelines are based upon current CDC recommendations [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23416/abstract/41\">",
"     41",
"    </a>",
"    ]. Healthcare facilities are required by OSHA [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23416/abstract/11-13\">",
"     11-13",
"    </a>",
"    ] to provide employees with care consistent with recommendations.",
"   </p>",
"   <p>",
"    All potential exposures to blood or contaminated body fluids as defined above should be promptly evaluated. The following information should be obtained by trained medical personnel:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Name and identification of the source",
"     </li>",
"     <li>",
"      Time and date of the exposure",
"     </li>",
"     <li>",
"      Nature of the exposure (ie, nonintact skin, mucosal, or percutaneous exposure, human bite); type of fluid (ie, blood, blood contaminated fluid, or other contaminated fluid)",
"     </li>",
"     <li>",
"      Body location of the exposure and contact time with the contaminated fluid",
"     </li>",
"     <li>",
"      Infective status of the source (ie, HIV, HCV, HBsAg), if known, including date of test",
"     </li>",
"     <li>",
"      When the source is HIV positive, selection of the postexposure prophylaxis regimen should consider the comparative risk represented by the exposure and information about the exposure source, including history of and response to antiretroviral therapy based on clinical response, CD4 cell counts, viral load measurements, and current disease stage (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?7/47/7930?source=see_link\">",
"       \"Management of healthcare personnel exposed to HIV\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      For percutaneous injuries, a description of the injury (depth of wound, solid versus hollow needle, sharp use in source patient)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The injured HCW should be questioned about the circumstances of the exposure (activity, time, device type, availability of PPE). The following information should be obtained from the injured person and verified from their",
"    <span class=\"nowrap\">",
"     medical/occupational",
"    </span>",
"    health record:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Dates of hepatitis B immunizations",
"     </li>",
"     <li>",
"      Postimmunization titer, if known",
"     </li>",
"     <li>",
"      Previous testing (if available) for HIV, HBV, and HCV",
"     </li>",
"     <li>",
"      Tetanus immunization status",
"     </li>",
"     <li>",
"      Current medications",
"     </li>",
"     <li>",
"      Current or underlying medical conditions that might influence drug selection (eg, pregnancy, breast feeding, renal or hepatic disease)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    All information should be recorded on the injured HCWs",
"    <span class=\"nowrap\">",
"     medical/occupational",
"    </span>",
"    health record. Many healthcare facilities regard information obtained on HCWs as confidential and place it in a separate medical record accessible only to the occupational health physician or nurse. Use of code numbers instead of names for all laboratory tests and medical prescriptions will aid in protecting confidentiality.",
"   </p>",
"   <p>",
"    All source cases should be tested for HBsAg, HCV, and HIV, unless the source is known to be infectious. If feasible, a system should be devised to allow HIV test results to be obtained possible (ie, within 24 hours). The rapid HIV test may be used to make an initial determination of the source patient's HIV status, and has the advantage that results are available in less than 60 minutes. All positive tests should be confirmed by Western blot. Negative tests do not require confirmation. Determination of HBsAg status should be obtained as soon as possible, but not later than 7 days. Local and state laws regarding consent and counseling prior to HIV testing should be followed.",
"   </p>",
"   <p>",
"    Testing the injured employee is based upon the results of the source patient tests (see below).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     HBV infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Postexposure prophylaxis with HBIG",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    vaccine should be used when indicated (eg, after percutaneous or mucous membrane exposure to blood known or suspected to be HBsAg positive) (",
"    <a class=\"graphic graphic_table graphicRef59736 \" href=\"UTD.htm?20/39/21116\">",
"     table 3",
"    </a>",
"    ). Needlestick or other percutaneous exposures of unvaccinated HCWs should lead to initiation of the",
"    <a class=\"drug drug_general\" href=\"UTD.htm?26/36/27207?source=see_link\">",
"     hepatitis B vaccine",
"    </a>",
"    series regardless of the HBV status of the source patient. Postexposure prophylaxis should be considered for any percutaneous, ocular, or mucous membrane exposure to blood in the workplace and is determined by the HBsAg status of the source and the vaccination and vaccine-response status of the exposed person.",
"   </p>",
"   <p>",
"    If the source patient is HBsAg positive and the exposed person is unvaccinated, HBIG also should be administered as soon as possible after exposure (preferably within 24 hours) and the vaccine series started. The effectiveness of HBIG when administered more than seven days after percutaneous or permucosal exposures is unknown. If the exposed person had an adequate antibody response (&gt;10",
"    <span class=\"nowrap\">",
"     mIU/mL)",
"    </span>",
"    documented after completion of an HBV vaccination series, no testing or treatment is needed, although some experts would consider administration of a booster dose of vaccine. When the source is unavailable but is at high risk for HBV infection (eg, current or former injecting drug user), some clinicians would assume that the source is HBsAg positive and provide postexposure prophylaxis based on this assumption.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     HCV infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Healthcare professionals who provide care to persons exposed to HCV in the occupational health setting should be knowledgeable about the risk for HCV infection and appropriate counseling, testing, and medical follow-up. The Centers for Disease Control and Prevention recommends that persons exposed to an HCV-positive source have the following baseline and follow-up testing [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23416/abstract/30\">",
"     30",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Baseline testing for anti-HCV, HCV RNA, and alanine aminotransferase (ALT)",
"     </li>",
"     <li>",
"      Follow-up testing for HCV RNA between four and six weeks after exposure",
"     </li>",
"     <li>",
"      Follow-up testing for anti-HCV, HCV RNA, and ALT between four and six months after exposure",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    However, a National Institutes of Health (NIH) consensus conference recommended that persons exposed to an HCV-positive source should have a baseline immunoblot or HCV RNA assay [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23416/abstract/46\">",
"     46",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    With improvements in test sensitivity, shorter testing intervals are often used [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23416/abstract/47,48\">",
"     47,48",
"    </a>",
"    ]. For a patient presenting following a known exposure to HCV, we obtain the following tests (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/7/18554?source=see_link&amp;anchor=H2#H2\">",
"     \"Clinical manifestations, diagnosis, and treatment of acute hepatitis C in adults\", section on 'Diagnosis'",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Testing for HCV RNA by polymerase chain reaction immediately and at weeks 4 and 12",
"     </li>",
"     <li>",
"      Antibody testing by enzyme-linked immunosorbent assay immediately and at week 12",
"     </li>",
"     <li>",
"      Serum aminotransferases (ALT and AST) immediately and at weeks 4 and 12",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Testing asymptomatic persons for HCV should conform to current recommendations (",
"    <a class=\"graphic graphic_algorithm graphicRef64362 \" href=\"UTD.htm?40/43/41662\">",
"     algorithm 1",
"    </a>",
"    ). When an enzyme immunoassay is positive for HCV antibodies, supplemental testing is recommended to confirm true positivity.",
"   </p>",
"   <p>",
"    Currently, there is no proven effective postexposure prophylaxis for persons exposed to HCV blood or contaminated body fluids. Immunoglobulin (Ig) and antiviral agents are",
"    <strong>",
"     not",
"    </strong>",
"    recommended for postexposure prophylaxis of HCV [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23416/abstract/30,34\">",
"     30,34",
"    </a>",
"    ]. Postexposure prophylactic use of interferon has not been demonstrated to reduce the rate of infection and interferon is associated with many side effects [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23416/abstract/49,50\">",
"     49,50",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    When HCV transmission is identified early, the individual should be referred to a specialist knowledgeable in the management of acute HCV infection, since early treatment is associated with excellent cure rates. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/7/18554?source=see_link\">",
"     \"Clinical manifestations, diagnosis, and treatment of acute hepatitis C in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?18/31/18931?source=see_link\">",
"       \"Patient information: Blood or body fluid exposure (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H117700804\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Worldwide, it has been estimated that in the year 2000 alone, percutaneous injuries led to 16,000 cases of hepatitis C and 66,000 cases of hepatitis B. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology of bloodborne exposures'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The majority of exposure incidents occurred in an operating room or a patient room; nurses report the most frequent exposures. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/55/41849?source=see_link&amp;anchor=H2#H2\">",
"       \"Screening for and diagnosis of chronic hepatitis C virus infection\", section on 'Who should be tested'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The risk that a healthcare worker will acquire a bloodborne pathogen as a result of an occupational exposure will depend upon the prevalence of the infectious agent in the patient population, the nature of the exposure, and the titer of the virus in the infective fluid. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Occupational risks of HBV and HCV acquisition'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      All healthcare workers should be immunized against hepatitis B virus. Preexposure prophylaxis is not available for hepatitis C infection. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Preexposure prophylaxis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Postexposure prophylaxis with HBIG",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      vaccine should be used when indicated (eg, after percutaneous or mucous membrane exposure to blood known or suspected to be HBsAg-positive). Needlestick or other percutaneous exposures of unvaccinated healthcare workers should lead to initiation of the",
"      <a class=\"drug drug_general\" href=\"UTD.htm?26/36/27207?source=see_link\">",
"       hepatitis B vaccine",
"      </a>",
"      series, regardless of the HBV status of the source patient. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Postexposure prophylaxis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Currently, there is no proven effective postexposure prophylaxis for persons exposed to HCV blood or contaminated body fluids. If HCV infection is identified early, the individual should be referred for medical management to a specialist knowledgeable in this area. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Postexposure prophylaxis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23416/abstract/1\">",
"      Jagger J, Hunt EH, Brand-Elnaggar J, Pearson RD. Rates of needle-stick injury caused by various devices in a university hospital. N Engl J Med 1988; 319:284.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23416/abstract/2\">",
"      Tarantola A, Abiteboul D, Rachline A. Infection risks following accidental exposure to blood or body fluids in health care workers: a review of pathogens transmitted in published cases. Am J Infect Control 2006; 34:367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23416/abstract/3\">",
"      Leigh JP, Gillen M, Franks P, et al. Costs of needlestick injuries and subsequent hepatitis and HIV infection. Curr Med Res Opin 2007; 23:2093.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23416/abstract/4\">",
"      Pr&uuml;ss-Ust&uuml;n A, Rapiti E, Hutin Y. Estimation of the global burden of disease attributable to contaminated sharps injuries among health-care workers. Am J Ind Med 2005; 48:482.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23416/abstract/5\">",
"      O'Malley EM, Scott RD 2nd, Gayle J, et al. Costs of management of occupational exposures to blood and body fluids. Infect Control Hosp Epidemiol 2007; 28:774.",
"     </a>",
"    </li>",
"    <li>",
"     Perry J, Parker G, Jagger J. 2007 percutaneous injury rates. International Healthcare Worker Safety Center, August 2009; 1. file://www.healthsystem.virginia.edu/internet/epinet/EPINet-2007-rates.pdf (Accessed on October 05, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23416/abstract/7\">",
"      Fisman DN, Harris AD, Rubin M, et al. Fatigue increases the risk of injury from sharp devices in medical trainees: results from a case-crossover study. Infect Control Hosp Epidemiol 2007; 28:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23416/abstract/8\">",
"      Ayas NT, Barger LK, Cade BE, et al. Extended work duration and the risk of self-reported percutaneous injuries in interns. JAMA 2006; 296:1055.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23416/abstract/9\">",
"      Makary MA, Al-Attar A, Holzmueller CG, et al. Needlestick injuries among surgeons in training. N Engl J Med 2007; 356:2693.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23416/abstract/10\">",
"      MacCannell T, Laramie AK, Gomaa A, Perz JF. Occupational exposure of health care personnel to hepatitis B and hepatitis C: prevention and surveillance strategies. Clin Liver Dis 2010; 14:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23416/abstract/11\">",
"      Occupational exposure to bloodborne pathogens--OSHA. Final rule. Fed Regist 1991; 56:64004.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23416/abstract/12\">",
"      Occupational exposure to bloodborne pathogens; needlestick and other sharps injuries; final rule. Occupational Safety and Health Administration (OSHA), Department of Labor. Final rule; request for comment on the Information Collection (Paperwork) Requirements. Fed Regist 2001; 66:5318.",
"     </a>",
"    </li>",
"    <li>",
"     Occupational Safety and Health Administration. Enforcement procedures for the occupational exposure to bloodborne pathogens. Directive CPL 202.69, issued November 27, 2001.",
"    </li>",
"    <li>",
"     Siegel JD, Rhinehart E, Jackson M, Chiarello L, The Healthcare Infection Control Practices Advisory Committee. 2007 Guideline for isolation precautions: preventing transmission of infectious agents in healthcare settings. file://www.cdc.gov/ncidod/dhqp/pdf/guidelines/Isolation2007.pdf (Accessed on October 05, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23416/abstract/15\">",
"      Tan L, Hawk JC 3rd, Sterling ML. Report of the Council on Scientific Affairs: preventing needlestick injuries in health care settings. Arch Intern Med 2001; 161:929.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23416/abstract/16\">",
"      Alvarado-Ramy F, Beltrami EM, Short LJ, et al. A comprehensive approach to percutaneous injury prevention during phlebotomy: results of a multicenter study, 1993-1995. Infect Control Hosp Epidemiol 2003; 24:97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23416/abstract/17\">",
"      Trim JC, Elliott TS. A review of sharps injuries and preventative strategies. J Hosp Infect 2003; 53:237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23416/abstract/18\">",
"      Trim JC. A review of needle-protective devices to prevent sharps injuries. Br J Nurs 2004; 13:144, 146.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23416/abstract/19\">",
"      Berguer R, Heller PJ. Preventing sharps injuries in the operating room. J Am Coll Surg 2004; 199:462.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23416/abstract/20\">",
"      Mamoun JS, Ahmed MK, Ahmed SM. Preventing sharps, splash, and needlestick injuries in dentistry: a comprehensive overview. Gen Dent 2005; 53:188.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23416/abstract/21\">",
"      Cleveland JL, Barker LK, Cuny EJ, et al. Preventing percutaneous injuries among dental health care personnel. J Am Dent Assoc 2007; 138:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23416/abstract/22\">",
"      Cullen BL, Genasi F, Symington I, et al. Potential for reported needlestick injury prevention among healthcare workers through safety device usage and improvement of guideline adherence: expert panel assessment. J Hosp Infect 2006; 63:445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23416/abstract/23\">",
"      Vaughn TE, McCoy KD, Beekmann SE, et al. Factors promoting consistent adherence to safe needle precautions among hospital workers. Infect Control Hosp Epidemiol 2004; 25:548.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23416/abstract/24\">",
"      Lamontagne F, Abiteboul D, Lolom I, et al. Role of safety-engineered devices in preventing needlestick injuries in 32 French hospitals. Infect Control Hosp Epidemiol 2007; 28:18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23416/abstract/25\">",
"      Whitby M, McLaws ML, Slater K. Needlestick injuries in a major teaching hospital: the worthwhile effect of hospital-wide replacement of conventional hollow-bore needles. Am J Infect Control 2008; 36:180.",
"     </a>",
"    </li>",
"    <li>",
"     Centers for Disease Control and Prevention. Workbook for designing, implementing, and evaluating a sharp injury prevention program. www.cdc.gov/sharpssafety (Accessed on May 12, 2006).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23416/abstract/27\">",
"      Beltrami EM, Williams IT, Shapiro CN, Chamberland ME. Risk and management of blood-borne infections in health care workers. Clin Microbiol Rev 2000; 13:385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23416/abstract/28\">",
"      Goldmann DA. Blood-borne pathogens and nosocomial infections. J Allergy Clin Immunol 2002; 110:S21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23416/abstract/29\">",
"      Alvarado-Ramy F, Beltrami EM. New guidelines for occupational exposure to blood-borne viruses. Cleve Clin J Med 2003; 70:457.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23416/abstract/30\">",
"      Cleveland JL, Cardo DM. Occupational exposures to human immunodeficiency virus, hepatitis B virus, and hepatitis C virus: risk, prevention, and management. Dent Clin North Am 2003; 47:681.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23416/abstract/31\">",
"      Varghese GM, Abraham OC, Mathai D. Post-exposure prophylaxis for blood borne viral infections in healthcare workers. Postgrad Med J 2003; 79:324.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23416/abstract/32\">",
"      Charles PG, Angus PW, Sasadeusz JJ, Grayson ML. Management of healthcare workers after occupational exposure to hepatitis C virus. Med J Aust 2003; 179:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23416/abstract/33\">",
"      Tansley PD, Beresford N, Ladas G, et al. Infection of patients by bloodborne viruses. Br J Surg 2004; 91:395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23416/abstract/34\">",
"      Beekmann SE, Henderson DK. Protection of healthcare workers from bloodborne pathogens. Curr Opin Infect Dis 2005; 18:331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23416/abstract/35\">",
"      Armstrong GL, Wasley A, Simard EP, et al. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006; 144:705.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23416/abstract/36\">",
"      McQuillan GM, Kruszon-Moran D, Kottiri BJ, et al. Prevalence of HIV in the US household population: the National Health and Nutrition Examination Surveys, 1988 to 2002. J Acquir Immune Defic Syndr 2006; 41:651.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23416/abstract/37\">",
"      Mahoney FJ, Stewart K, Hu H, et al. Progress toward the elimination of hepatitis B virus transmission among health care workers in the United States. Arch Intern Med 1997; 157:2601.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23416/abstract/38\">",
"      Simard EP, Miller JT, George PA, et al. Hepatitis B vaccination coverage levels among healthcare workers in the United States, 2002-2003. Infect Control Hosp Epidemiol 2007; 28:783.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23416/abstract/39\">",
"      Weber DJ, Rutala WA. Hepatitis B immunization update. Infect Control Hosp Epidemiol 1989; 10:541.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23416/abstract/40\">",
"      Bond WW, Favero MS, Petersen NJ, et al. Survival of hepatitis B virus after drying and storage for one week. Lancet 1981; 1:550.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23416/abstract/41\">",
"      U.S. Public Health Service. Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis. MMWR Recomm Rep 2001; 50:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23416/abstract/42\">",
"      Mitsui T, Iwano K, Masuko K, et al. Hepatitis C virus infection in medical personnel after needlestick accident. Hepatology 1992; 16:1109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23416/abstract/43\">",
"      Kamili S, Krawczynski K, McCaustland K, et al. Infectivity of hepatitis C virus in plasma after drying and storing at room temperature. Infect Control Hosp Epidemiol 2007; 28:519.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23416/abstract/44\">",
"      Immunization of health-care workers: recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep 1997; 46:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23416/abstract/45\">",
"      Bolyard EA, Tablan OC, Williams WW, et al. Guideline for infection control in healthcare personnel, 1998. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1998; 19:407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23416/abstract/46\">",
"      National Institutes of Health. National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C: 2002--June 10-12, 2002. Hepatology 2002; 36:S3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23416/abstract/47\">",
"      Maheshwari A, Thuluvath PJ. Management of acute hepatitis C. Clin Liver Dis 2010; 14:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23416/abstract/48\">",
"      Maheshwari A, Ray S, Thuluvath PJ. Acute hepatitis C. Lancet 2008; 372:321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23416/abstract/49\">",
"      Chung H, Kudo M, Kumada T, et al. Risk of HCV transmission after needlestick injury, and the efficacy of short-duration interferon administration to prevent HCV transmission to medical personnel. J Gastroenterol 2003; 38:877.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23416/abstract/50\">",
"      Corey KE, Servoss JC, Casson DR, et al. Pilot study of postexposure prophylaxis for hepatitis C virus in healthcare workers. Infect Control Hosp Epidemiol 2009; 30:1000.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3647 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-210.101.131.231-9685F97C73-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_55_23416=[""].join("\n");
var outline_f22_55_23416=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H117700804\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY OF BLOODBORNE EXPOSURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Statistics on exposures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Risk by profession",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Devices associated with exposure",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Minimizing risk",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      OCCUPATIONAL RISKS OF HBV AND HCV ACQUISITION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      HBV infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      HCV infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      PREEXPOSURE PROPHYLAXIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Hepatitis C",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Hepatitis B",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Dosing schedules",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Follow-up testing after immunization",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      POSTEXPOSURE PROPHYLAXIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Definition of exposure",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      OSHA requirements",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      General guidelines",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      HBV infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      HCV infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H117700804\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/3647\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/3647|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?40/43/41662\" title=\"algorithm 1\">",
"      HCV testing algorithm",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/3647|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?6/35/6717\" title=\"table 1\">",
"      HCW infections after stick",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?38/26/39340\" title=\"table 2\">",
"      Risk of HCW acquiring pathogens",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?20/39/21116\" title=\"table 3\">",
"      Postexposure prophylaxis hepatitis B vaccine",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/7/18554?source=related_link\">",
"      Clinical manifestations, diagnosis, and treatment of acute hepatitis C in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/7/2169?source=related_link\">",
"      Epidemiology and transmission of hepatitis C virus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/31/4602?source=related_link\">",
"      Epidemiology, transmission, and prevention of hepatitis B virus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/47/7930?source=related_link\">",
"      Management of healthcare personnel exposed to HIV",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?18/31/18931?source=related_link\">",
"      Patient information: Blood or body fluid exposure (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/55/41849?source=related_link\">",
"      Screening for and diagnosis of chronic hepatitis C virus infection",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f22_55_23417="J point";
var content_f22_55_23417=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F82922&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F82922&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 534px\">",
"   <div class=\"ttl\">",
"    J point",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 514px; height: 394px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The J point is the junction between the end of the QRS and the beginning of the ST segment.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_55_23417=[""].join("\n");
var outline_f22_55_23417=null;
var title_f22_55_23418="Acquired long QT syndrome";
var content_f22_55_23418=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Acquired long QT syndrome",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/55/23418/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/55/23418/contributors\">",
"     Charles I Berul, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/55/23418/contributors\">",
"     Stephen P Seslar, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/55/23418/contributors\">",
"     Peter J Zimetbaum, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/55/23418/contributors\">",
"     Mark E Josephson, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/55/23418/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/55/23418/contributors\">",
"     John K Triedman, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/55/23418/contributors\">",
"     Samuel L&eacute;vy, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/55/23418/contributors\">",
"     Samuel Asirvatham, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/55/23418/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/55/23418/contributors\">",
"     Brian C Downey, MD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?22/55/23418/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 2, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The long QT syndrome (LQTS) is a disorder of myocardial repolarization characterized by a prolonged QT interval on the electrocardiogram (ECG) (",
"    <a class=\"graphic graphic_waveform graphicRef77018 \" href=\"UTD.htm?26/24/27008\">",
"     waveform 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. This syndrome is associated with an increased risk of a characteristic life-threatening cardiac arrhythmia, known as torsades de pointes (TdP) (",
"    <a class=\"graphic graphic_waveform graphicRef53891 graphicRef73827 \" href=\"UTD.htm?3/40/3719\">",
"     waveform 2A-B",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. The primary symptoms in patients with LQTS include palpitations, syncope, seizures, and sudden cardiac death (SCD).",
"   </p>",
"   <p>",
"    The long QT syndrome may be either genetic or acquired [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/6-9\">",
"     6-9",
"    </a>",
"    ]. Acquired LQTS usually results from drug therapy, hypokalemia, or hypomagnesemia (",
"    <a class=\"graphic graphic_table graphicRef57431 \" href=\"UTD.htm?2/48/2830\">",
"     table 1",
"    </a>",
"    ). As will be described below, hypokalemia, hypomagnesemia, and bradycardia can increase the risk of drug-induced LQTS. In addition, some patients with acquired LQTS have an underlying \"forme fruste\" of congenital LQTS. (See",
"    <a class=\"local\" href=\"#H11\">",
"     'Mutations in LQTS genes'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The pathophysiology, causes, and management of acquired LQTS will be reviewed here. The clinical manifestations of acquired LQTS are similar to those in congenital disease and are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/9/2202?source=see_link\">",
"     \"Clinical features of congenital long QT syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     TORSADES DE POINTES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Torsades de pointes (TdP) is a form of polymorphic ventricular tachycardia (VT) that occurs in the setting of acquired or congenital QT interval prolongation [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. Polymorphic VT is defined as a ventricular rhythm faster than 100 beats per min with frequent variations of the QRS axis, morphology, or both [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. In the specific case of TdP, these variations take the form of a progressive, sinusoidal, cyclic alteration of the QRS axis (",
"    <a class=\"graphic graphic_waveform graphicRef53891 graphicRef73827 \" href=\"UTD.htm?3/40/3719\">",
"     waveform 2A-B",
"    </a>",
"    ). The peaks of the QRS complexes appear to \"twist\" around the isoelectric line of the recording; hence the name torsades de pointes or \"twisting of the points\".",
"   </p>",
"   <p>",
"    Typical features of TdP include an antecedent prolonged QT interval, particularly in the last sinus beat preceding the onset of the arrhythmia, a ventricular rate of 160 to 250 beats per minute, irregular RR intervals, and a cycling of the QRS axis through 180 degrees every five to 20 beats [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. TdP is usually short-lived and terminates spontaneously. However, most patients experience multiple episodes of the arrhythmia, and episodes can recur in rapid succession, potentially degenerating to ventricular fibrillation and SCD [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/5,6\">",
"     5,6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PATHOPHYSIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pathophysiology of LQTS is described in detail elsewhere. The proposed mechanism for drug-induced TdP is the development of early afterdepolarizations and triggered activity resulting from prolonged repolarization. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/23/9591?source=see_link\">",
"     \"Pathophysiology of the long QT syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There are thought to be pathophysiologic differences between the acquired and congenital forms of the LQTS:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The polymorphic VT in the acquired form of LQTS is most commonly precipitated by short-long RR intervals. This interval typically is caused by a ventricular premature beat followed by a compensatory pause (",
"      <a class=\"graphic graphic_waveform graphicRef73827 \" href=\"UTD.htm?42/7/43134\">",
"       waveform 2B",
"      </a>",
"      ). Polymorphic VT also can occur in association with bradycardia or frequent pauses; as a result, the acquired form of LQTS is sometimes called \"pause-dependent\" LQTS [",
"      <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/3\">",
"       3",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      The association between bradycardia and antiarrhythmic drug-induced TdP is thought to be related to a property of some of these drugs called \"reverse use dependence,\" which is defined as the inverse correlation between the heart rate and QT interval [",
"      <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/10\">",
"       10",
"      </a>",
"      ]. As a result, the QT interval decreases as the heart rate increases and lengthens as the heart rate slows. This explains why drug-induced torsades de pointes is more commonly seen with bradycardia.",
"      <br/>",
"      <br/>",
"      Reverse use dependence may be mediated at least in part by changes in the extracellular potassium concentration. Virtually",
"      <strong>",
"       all of the drugs",
"      </strong>",
"      that produce LQTS act by blocking the outward IKr current, which is mediated by the potassium channel encoded by the HERG gene [",
"      <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/11-30\">",
"       11-30",
"      </a>",
"      ]. The degree of drug blockade of IKr, the rapid component of the delayed rectifier potassium current that is responsible for phase 3 depolarization, is inversely related to both the extracellular potassium concentration and heart rate [",
"      <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/13\">",
"       13",
"      </a>",
"      ]. Lower heart rates result in less potassium moving out of the cell during repolarization (before subsequent reuptake by the Na-K-ATPase pump), since there are fewer repolarizations. The associated reduction in extracellular potassium concentration enhances the degree of drug-induced inhibition of IKr, increasing the QT interval [",
"      <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/13\">",
"       13",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In contrast to the association with bradycardia and pauses seen in acquired LQTS, arrhythmias often follow a sudden adrenergic surge (due, for example, to exercise or arousal) in some congenital forms of LQTS, particularly LQTS types 1 and 2 (",
"      <a class=\"graphic graphic_figure graphicRef64239 \" href=\"UTD.htm?9/27/9662\">",
"       figure 1",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?2/9/2202?source=see_link&amp;anchor=H9#H9\">",
"       \"Clinical features of congenital long QT syndrome\", section on 'Triggers of arrhythmia'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    However, these distinctions between acquired and congenital LQTS are not absolute. This was illustrated in an observational study of 15 patients with congenital LQTS in which \"pause-dependent\" TdP, which is more characteristic of the acquired form, was noted in 14 [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/31\">",
"     31",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/23/9591?source=see_link\">",
"     \"Pathophysiology of the long QT syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     DRUG-INDUCED TdP",
"    </span>",
"    &nbsp;&mdash;&nbsp;Drugs are a common cause of acquired LQTS and TdP. Many drugs have been implicated, and additional medications continue to be identified [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/9,32,33\">",
"     9,32,33",
"    </a>",
"    ]. The major classes of drugs that prolong the QT interval include (",
"    <a class=\"graphic graphic_table graphicRef57431 \" href=\"UTD.htm?2/48/2830\">",
"     table 1",
"    </a>",
"    )[",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/32,34-38\">",
"     32,34-38",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Antiarrhythmic drugs",
"     </li>",
"     <li>",
"      Certain nonsedating antihistamines (eg, terfenadine and astemizole)",
"     </li>",
"     <li>",
"      Macrolide antibiotics",
"     </li>",
"     <li>",
"      Certain psychotropic medications",
"     </li>",
"     <li>",
"      Certain gastric motility agents (eg, cisapride)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Determining the absolute and comparative risk of the many drugs associated with QT prolongation is difficult, since most available data comes from case reports or small observational series.",
"   </p>",
"   <p>",
"    Some drugs have been taken off the market in the United States and other countries because they increase the risk of TdP (eg, cisapride, terfenadine, astemizole). An internet resource with updated lists of specific drugs that prolong the QT interval is available at the University of Arizona Center for Education and Research on Therapeutics website (",
"    <a class=\"external\" href=\"file://www.qtdrugs.org/\">",
"     www.qtdrugs.org",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Importance of HERG blockade",
"    </span>",
"    &nbsp;&mdash;&nbsp;Virtually all of the drugs that produce LQTS act by blocking the IKr current mediated by the potassium channel encoded by the HERG gene [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/11-30\">",
"     11-30",
"    </a>",
"    ]. In addition, one of the forms of congenital LQTS, LQTS type 2, is due to mutations in HERG. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/0/28681?source=see_link\">",
"     \"Genetics of congenital and acquired long QT syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The relationship between the degree of drug-induced HERG blockade and the risk of ventricular arrhythmias and sudden cardiac death was described in a report from the International Drug Monitoring Program of the World Health Organization [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/39\">",
"     39",
"    </a>",
"    ]. For 52 medications associated with QT prolongation and TdP, the investigators compared the plasma concentrations achieved during usual clinical use, defined as the effective free therapeutic plasma concentration (ETCP), to the in vitro concentration of the drug that inhibits 50 percent of potassium channels (IC50). The ratio of these values",
"    <span class=\"nowrap\">",
"     (ETCP/IC50)",
"    </span>",
"    is considered a measure of the",
"    <span class=\"nowrap\">",
"     therapeutic/toxic",
"    </span>",
"    window. The following findings were reported:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The",
"      <span class=\"nowrap\">",
"       ETCP/IC50",
"      </span>",
"      ratio ranged from 0.00003 for",
"      <a class=\"drug drug_general\" href=\"UTD.htm?12/5/12377?source=see_link\">",
"       nifedipine",
"      </a>",
"      (indicating that drug levels in general clinical use are substantially lower than levels required to block potassium channels), to 29.7 for",
"      <a class=\"drug drug_general\" href=\"UTD.htm?31/35/32311?source=see_link\">",
"       thioridazine",
"      </a>",
"      (indicating that usual drug levels have significant potassium channel blocking activity).",
"     </li>",
"     <li>",
"      Eight medications had a ratio &gt;1, including cisapride, sparfloxacin,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?0/48/777?source=see_link\">",
"       quinidine",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?13/32/13829?source=see_link\">",
"       ibutilide",
"      </a>",
"      , and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?31/35/32311?source=see_link\">",
"       thioridazine",
"      </a>",
"      .",
"     </li>",
"     <li>",
"      There was a linear relationship between the",
"      <span class=\"nowrap\">",
"       ETCP/IC50",
"      </span>",
"      ratio and the reported incidence of a composite end point of cardiac arrest, sudden death, TdP, ventricular tachycardia, and ventricular fibrillation.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Incidence with specific drugs",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incidence of drug-induced TdP is difficult to estimate and may be higher than suggested by documented cases. This possibility was illustrated in an observational study of 500,000 persons in the Netherlands [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/40\">",
"     40",
"    </a>",
"    ]. In this cohort, 775 cases of SCD were identified over a period of slightly less than nine years, and each case was matched to up to 10 controls. The following findings were noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Current use of any non-cardiac QT prolonging drug was associated with a significantly increased risk of SCD (adjusted OR 2.7), and the highest risk was associated with antipsychotic drugs (adjusted OR 5.0).",
"     </li>",
"     <li>",
"      The risk was higher in women and in people who had recently started a QT prolonging drug.",
"     </li>",
"     <li>",
"      Past use of a QT prolonging drug was not associated with SCD (OR 0.9).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Although these results suggest that drug-induced TdP may be more common than documented cases suggest, the absolute number of events is still low and represents a small proportion of SCD events (24 of 775 patients with SCD [3.1 percent] were currently using a QT prolonging drug).",
"   </p>",
"   <p>",
"    The relative frequency of the different causes of drug-induced TdP will vary with the population studied and the drugs that are available (eg, cisapride is not easily available in the United States but is available in some other countries). The range of findings can be illustrated by the following observations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Among 761 cases of drug-induced TdP reported to the World Health Organization Drug Monitoring Centre between 1983 and 1999, the most common drugs were",
"      <a class=\"drug drug_general\" href=\"UTD.htm?21/13/21721?source=see_link\">",
"       sotalol",
"      </a>",
"      and cisapride (17 and 13 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/32\">",
"       32",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a review of 92 patients from the United States with drug-induced TdP, antiarrhythmic drugs were responsible in 71 (77 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/34\">",
"       34",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Among drugs still available in the United States, some of the best data on incidence of TdP come from studies of antiarrhythmic drugs, particularly class IA and class III drugs, and psychotropic medications.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Antiarrhythmic drugs",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?0/48/777?source=see_link\">",
"       Quinidine",
"      </a>",
"      , a class IA sodium channel blocking agent, has been the most frequently implicated cause of drug-induced TdP, with an incidence of 0.6 to 1.5 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/41\">",
"       41",
"      </a>",
"      ]. Most cases occur within 48 hours of initiating drug therapy; associated factors are hypokalemia and excessive bradycardia. The incidence may be reduced by careful attention to correction of hypokalemia or hypomagnesemia before therapy and discontinuation of drug therapy if QT prolongation occurs [",
"      <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/42\">",
"       42",
"      </a>",
"      ]. Although quinidine-induced QT prolongation and TdP (\"quinidine syncope\") often are dose-related, these abnormalities may represent an idiosyncratic reaction, occurring when drug dose and serum concentrations are low. However, even low serum concentrations of quinidine can block the HERG channel [",
"      <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/39\">",
"       39",
"      </a>",
"      ]. Proarrhythmia may lead to increased mortality when quinidine is used to maintain sinus rhythm after cardioversion in patients with atrial fibrillation [",
"      <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/43\">",
"       43",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Although TdP occurs with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/49/35607?source=see_link\">",
"       disopyramide",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/34/36391?source=see_link\">",
"       procainamide",
"      </a>",
"      (also class IA), the incidence is unknown but probably lower than seen with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?0/48/777?source=see_link\">",
"       quinidine",
"      </a>",
"      &nbsp;[",
"      <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/44,45\">",
"       44,45",
"      </a>",
"      ]. With procainamide therapy, it is likely that QT prolongation and TdP result from the major metabolite of the drug, N-acetylprocainamide (NAPA), which has class III potassium channel blocking activity and therefore causes QT prolongation [",
"      <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/46\">",
"       46",
"      </a>",
"      ]. This complication may be more common in patients who rapidly metabolize procainamide by acetylation (ie, rapid acetylators) and have high NAPA levels.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?21/13/21721?source=see_link\">",
"       Sotalol",
"      </a>",
"      (class III) causes QT prolongation and TdP in approximately 2 percent of men and 4 percent of women [",
"      <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/47,48\">",
"       47,48",
"      </a>",
"      ]. Unlike",
"      <a class=\"drug drug_general\" href=\"UTD.htm?0/48/777?source=see_link\">",
"       quinidine",
"      </a>",
"      , these complications usually are related to the dose and blood level [",
"      <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/49\">",
"       49",
"      </a>",
"      ]. As a result, sotalol therapy should be initiated and doses increased in a hospital with facilities for cardiac rhythm monitoring and assessment.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?6/2/6183?source=see_link\">",
"       Dofetilide",
"      </a>",
"      (class III) was associated with TdP in two major trials in 0.9 percent of patients with a recent myocardial infarction and left ventricular dysfunction and in 3.3 percent of patients with heart failure [",
"      <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/50,51\">",
"       50,51",
"      </a>",
"      ]. The majority of episodes occurred within the first three days, the time of peak increase in the QT interval [",
"      <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/51\">",
"       51",
"      </a>",
"      ]. As a result, patients must be",
"      <strong>",
"       hospitalized",
"      </strong>",
"      for a minimum of three days for dofetilide initiation at a facility that can provide measurement of creatinine clearance, cardiac monitoring, and cardiac resuscitation.",
"     </li>",
"     <li>",
"      Proarrhythmia is the most common toxic reaction with intravenous",
"      <a class=\"drug drug_general\" href=\"UTD.htm?13/32/13829?source=see_link\">",
"       ibutilide",
"      </a>",
"      (class III); such arrhythmias include nonsustained polymorphic ventricular tachycardia (2.7 percent of patients), sustained polymorphic VT (1.7 percent), nonsustained monomorphic VT (4.9 percent), and sustained monomorphic VT (0.2 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/52,53\">",
"       52,53",
"      </a>",
"      ]. One study also found an association between sustained TdP and a history of heart failure or low ejection fraction. Sustained TdP occurred in 5.4 percent versus 0.8 of patients with and without heart failure, respectively).",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?22/58/23466?source=see_link\">",
"       Amiodarone",
"      </a>",
"      (class III) markedly prolongs the QT interval. However, in contrast to the other class III antiarrhythmic drugs, amiodarone is rarely associated with TdP, except when used concomitantly with a class IA agent or when hypokalemia is present [",
"      <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/54\">",
"       54",
"      </a>",
"      ]. The estimated incidence of TdP is less than 1 percent overall [",
"      <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/55\">",
"       55",
"      </a>",
"      ] and, in a review of 738 patients in randomized trials of low-dose therapy (&le;400",
"      <span class=\"nowrap\">",
"       mg/day",
"      </span>",
"      for at least one year, there were no cases of TdP [",
"      <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/56\">",
"       56",
"      </a>",
"      ]. Several factors contribute to the rarity of TdP with amiodarone: lack of reverse use dependence; concurrent blockade of the L-type calcium channels; and less heterogeneity of ventricular repolarization (less QT dispersion). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/57/23449?source=see_link&amp;anchor=H6#H6\">",
"       \"Major side effects of amiodarone\", section on 'Cardiac toxicity'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Data are not as readily available on the incidence of TdP with drugs other than antiarrhythmic medications, most of which are used for noncardiac reasons and in much less controlled settings than antiarrhythmic drugs (",
"    <a class=\"graphic graphic_table graphicRef57431 \" href=\"UTD.htm?2/48/2830\">",
"     table 1",
"    </a>",
"    ). Furthermore, patients taking these drugs are less likely to also be taking drugs that produce hypokalemia",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    hypomagnesemia than those with arrhythmias.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Psychotropic medications",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?31/50/32553?source=see_link\">",
"       Haloperidol",
"      </a>",
"      was the topic of a United States Food and Drug Administration (FDA) alert in September 2007, based upon the observation that QT prolongation and TdP have been observed in patients receiving haloperidol, especially when it is administered intravenously or in higher doses than recommended. Because of the widespread use of haloperidol and also the potential confounding influence of other QT-prolonging factors, the magnitude of the risk associated with or attributable to haloperidol cannot be determined from the case reports upon which this advisory was based. However, a direct effect is likely since in vitro studies have shown that haloperidol is a high-potency blocker of the HERG channel that is blocked by virtually all drugs that cause LQTS [",
"      <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/29\">",
"       29",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Importance of HERG blockade'",
"      </a>",
"      above.)",
"      <br/>",
"      <br/>",
"      The FDA observed that, although cases of QT prolongation and TdP have been reported in the absence of other predisposing factors, particular caution should be exercised in treating patients with haloperidol who have any the following characteristics:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Electrolyte abnormalities (particularly hypokalemia or hypomagnesemia)",
"     </li>",
"     <li>",
"      Use of other drugs known to prolong the QT interval",
"     </li>",
"     <li>",
"      Congenital long QT syndrome",
"     </li>",
"     <li>",
"      Underlying cardiac abnormalities",
"     </li>",
"     <li>",
"      Hypothyroidism",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The FDA also recommended ECG monitoring when",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/50/32553?source=see_link\">",
"     haloperidol",
"    </a>",
"    is given intravenously. Furthermore, the FDA observed that haloperidol is approved for intramuscular, but not intravenous use. Off-label intravenous use is common, however, and it is not clear if the route of administration affects the risk of QT prolongation and TdP.",
"   </p>",
"   <p>",
"    Although typical antipsychotic drugs like",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/50/32553?source=see_link\">",
"     haloperidol",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/35/32311?source=see_link\">",
"     thioridazine",
"    </a>",
"    have received particular attention with regard to risk of arrhythmia and sudden death, there is evidence that several atypical antipsychotic medications can prolong the QT interval and cause TdP [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/57\">",
"     57",
"    </a>",
"    ]. In addition, a large retrospective cohort study found that treatment with typical and atypical antipsychotics was associated with similar increases in the risk of sudden death in patients with psychosis [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/58\">",
"     58",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/24/7562?source=see_link\">",
"     \"First-generation antipsychotic medications: Pharmacology, administration, and comparative side effects\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/10/15530?source=see_link\">",
"     \"Second-generation antipsychotic medications: Pharmacology, administration, and comparative side effects\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/57/36761?source=see_link\">",
"       Methadone",
"      </a>",
"      often increases the QTc interval and is a cause of TdP. Concern regarding the proarrhythmic potential of methadone prompted a clinician safety alert from the FDA in 2006, as well as a manufacturer's black-box warning. These issues as well as safety recommendations for prescribing methadone are discussed elsewhere. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/52/29514?source=see_link&amp;anchor=H360270012#H360270012\">",
"       \"Treatment of opioid abuse and dependence\", section on 'Cardiac arrhythmias'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Other medications",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cisapride, which is not easily available in the United States, has been one of the most common causes of acquired TdP not due to antiarrhythmic drugs [",
"      <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/32\">",
"       32",
"      </a>",
"      ]. The proarrhythmic effect of cisapride in children was prospectively evaluated in 35 children (mean age 5.2 years) with gastroesophageal reflux disease [",
"      <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/59\">",
"       59",
"      </a>",
"      ]. Prolongation of the corrected QT interval (QTc) occurred in 11 (31 percent), two of whom (5.7 percent of the whole group) developed TdP.",
"     </li>",
"     <li>",
"      Users of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/29/36304?source=see_link\">",
"       erythromycin",
"      </a>",
"      had a twofold increased risk of sudden cardiac death over nonusers in one report [",
"      <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/60\">",
"       60",
"      </a>",
"      ]. In addition, because erythromycin is metabolized by the CYP3A4 system, medications that inhibit CYP3A4 cause a further increase in risk when used with erythromycin (",
"      <a class=\"graphic graphic_table graphicRef76992 \" href=\"UTD.htm?9/45/9950\">",
"       table 2",
"      </a>",
"      ). In an analysis of over one million patient-years of follow-up data, those using",
"      <a class=\"drug drug_general\" href=\"UTD.htm?12/16/12554?source=see_link\">",
"       diltiazem",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?9/18/9514?source=see_link\">",
"       verapamil",
"      </a>",
"      , troleandomycin, or azole antifungal drugs (all of which inhibit CYP3A4) had a five-fold increase in sudden cardiac death risk when taking erythromycin [",
"      <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/60\">",
"       60",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/47/16119?source=see_link\">",
"       Arsenic trioxide",
"      </a>",
"      is a newer drug used in the treatment of patients with acute promyelocytic leukemia and other advanced malignancies. It appears to be associated with a very high rate of QT prolongation but a lower rate of TdP [",
"      <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/61-63\">",
"       61-63",
"      </a>",
"      ]. In an initial report, all eight patients treated with arsenic trioxide developed QT prolongation and four developed nonsustained ventricular tachycardia requiring treatment with antiarrhythmic agents [",
"      <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/62\">",
"       62",
"      </a>",
"      ]. A lower but still high risk was noted in a much larger series of 99 patients [",
"      <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/61\">",
"       61",
"      </a>",
"      ]. Reversible prolongation of the QT interval to more than 0.50 sec occurred in 38 patients; the risk was increased in patients with hypokalemia, and one hypokalemic patient developed TdP.",
"      <br/>",
"      <br/>",
"      The unusually high incidence of QT prolongation with arsenic trioxide may be a consequence of a unique effect on potassium flux. As noted above, most of the drugs that produce LQTS act by blocking the IKr current. However, arsenic trioxide blocks both IKr and IKs, an effect comparable to the combined effects of genetic LQT1 and LQT2 [",
"      <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/64\">",
"       64",
"      </a>",
"      ]. This effect may be mitigated somewhat because arsenic trioxide also activates IK-ATP, another outward potassium current.",
"      <br/>",
"      <br/>",
"      Labeling instructions for arsenic trioxide recommend that, during therapy, serum potassium concentrations should be kept above 4",
"      <span class=\"nowrap\">",
"       meq/L",
"      </span>",
"      and magnesium concentrations above 1.8",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/61,65\">",
"       61,65",
"      </a>",
"      ]. In addition, serial ECGs should be obtained and the patient should be hospitalized and placed on telemetry if the QT interval is greater than 0.50 sec or the patient develops palpitations or syncope [",
"      <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/61\">",
"       61",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Risk factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although drug-induced TdP is sometimes regarded as an idiosyncratic event, a number of risk factors have been identified [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/11,35,66\">",
"     11,35,66",
"    </a>",
"    ]. Patients with multiple risk factors may face the greatest risk [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/66\">",
"     66",
"    </a>",
"    ]. These factors can be classified as follows.",
"   </p>",
"   <p>",
"    With respect to the drug regimen:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      High drug doses or concentrations of QT prolonging drug (",
"      <a class=\"drug drug_general\" href=\"UTD.htm?0/48/777?source=see_link\">",
"       quinidine",
"      </a>",
"      is an exception);",
"      <a class=\"drug drug_general\" href=\"UTD.htm?31/35/32311?source=see_link\">",
"       thioridazine",
"      </a>",
"      , for example, should be limited to doses &le;100",
"      <span class=\"nowrap\">",
"       mg/day",
"      </span>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/67\">",
"       67",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Rapid intravenous infusion of QT prolonging drug.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Concurrent use of more than one drug that can prolong the QT interval or use of a QT prolonging drug with one that slows drug metabolism due to inhibition of hepatic cytochrome P450 enzymes, such as",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/29/36304?source=see_link\">",
"       erythromycin",
"      </a>",
"      (which also directly causes QT prolongation) [",
"      <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/19,20,24,60\">",
"       19,20,24,60",
"      </a>",
"      ], and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?2/54/2921?source=see_link\">",
"       cimetidine",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/68\">",
"       68",
"      </a>",
"      ]; in addition, concurrent intake of grapefruit juice, which inhibits CYP3A4, can increase the QT interval by two possible mechanisms: slowed metabolism of other drugs and direct inhibition of the IKr channel by flavonoids in grapefruit juice [",
"      <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/69\">",
"       69",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Diuretic treatment may be a risk factor due to its correlation with electrolyte abnormalities and heart failure or due to the direct blockade of potassium current by some diuretics [",
"      <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/66\">",
"       66",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    With respect to ECG abnormalities:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Baseline QT prolongation or T wave lability",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The development of marked QT prolongation (eg, QTc &gt;500 ms), T wave lability, or T wave morphologic changes (such as LQT2-type repolarization: notching, long T peak-Tend) during therapy",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Bradycardia which, as noted above, may be related to a fall in local extracellular potassium concentration, leading to enhanced drug-induced inhibition of IKr [",
"      <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/13\">",
"       13",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Sinus bradycardia, heart block, incomplete heart block with pauses",
"     </li>",
"     <li>",
"      Premature complexes leading to short-long-short cycles",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Congenital long QT syndrome or \"silent\" mutations in LQTS genes (see",
"      <a class=\"local\" href=\"#H11\">",
"       'Mutations in LQTS genes'",
"      </a>",
"      below)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    With respect to metabolic factors:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Electrolyte disturbances, especially hypokalemia and hypomagnesemia and less often hypocalcemia",
"     </li>",
"     <li>",
"      Impaired hepatic",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      renal function",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Clinically silent risk factors [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/66\">",
"     66",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Occult (latent) congenital LQTS",
"     </li>",
"     <li>",
"      Genetic polymorphisms (reduced repolarization reserve)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Other:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Underlying heart disease, particularly heart failure, myocardial infarction, and left ventricular hypertrophy",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Recent conversion from atrial fibrillation [",
"      <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/70\">",
"       70",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Female sex [",
"      <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/71\">",
"       71",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Advanced age [",
"      <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/66\">",
"       66",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Most patients who have drug-induced TdP have one or more risk factors. In a literature review including 249 patients with TdP associated with noncardiac drugs, 97 percent had at least one risk factor, and 71 percent had at least two [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/72\">",
"     72",
"    </a>",
"    ]. These included female sex in 71 percent, a history of heart disease in 41 percent, concurrent use of another QT-prolonging drug in 39 percent, hypokalemia in 28 percent, high drug dose in 19 percent, and a prior history of long QT syndrome in 18 percent.",
"   </p>",
"   <p>",
"    The most frequent risk factor for drug-induced TdP is female sex [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/48,71,73,74\">",
"     48,71,73,74",
"    </a>",
"    ]. In a literature review of 332 patients with TdP associated with cardiovascular drugs, 70 percent were females [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/71\">",
"     71",
"    </a>",
"    ], similar to the 71 percent incidence associated with noncardiac drugs [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/72\">",
"     72",
"    </a>",
"    ]. A female preponderance for symptomatic disease also has been noted in patients with congenital long QT syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/75\">",
"     75",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Compared to males, females have a longer QTc and greater response to drugs that block IKr, potentiating the development of TdP [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/73\">",
"     73",
"    </a>",
"    ]. This may be mediated by the effect of sex steroids on ion channel expression. Estrogen potentiates QT prolongation induced by bradycardia and the development of arrhythmia. In contrast, androgens shorten the QT interval and make it less responsive to drugs.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Mutations in LQTS genes",
"    </span>",
"    &nbsp;&mdash;&nbsp;In some patients, drug-associated LQTS appears to represent a \"forme fruste\" of congenital LQTS in which a mutation or polymorphism in one of the LQTS genes is clinically inapparent until the patient is exposed to a particular drug or other predisposing factor. It has been suggested that there is a redundancy in repolarizing currents that has been called repolarization reserve [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/11\">",
"     11",
"    </a>",
"    ]. This could explain why a given mutation might be associated with clinical disease only when another insult, such as a drug, hypokalemia, or hypomagnesemia, is superimposed. This topic is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/0/28681?source=see_link&amp;anchor=H20#H20\">",
"     \"Genetics of congenital and acquired long QT syndrome\", section on 'Mutations in acquired LQTS'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Summarized briefly, two observations illustrate the feasibility and magnitude of such a relationship:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      One report evaluated nine families with sporadic cases of LQTS; 15 of 46 family members (33 percent) who were felt to be unaffected based upon clinical criteria were gene carriers [",
"      <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/76\">",
"       76",
"      </a>",
"      ]. In such individuals, the LQTS mutations may produce an alteration in repolarizing currents that is insufficient to prolong the QT interval at rest. However, these silent gene carriers and their affected offspring might be at risk for unexpected TdP if exposed to drugs that can prolong the QT interval.",
"     </li>",
"     <li>",
"      Mutations affecting LQTS genes may be present in 5 percent of patients with drug-induced TdP and gene polymorphisms that might contribute to risk may be present in another 5 to 10 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/34\">",
"       34",
"      </a>",
"      ]. It has been estimated that one in 1000 to 3000 individuals may be a carrier of an LQTS mutation [",
"      <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/34\">",
"       34",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Precautions when using QT prolonging drugs",
"    </span>",
"    &nbsp;&mdash;&nbsp;For patients who are treated with drugs that have been associated with LQTS (",
"    <a class=\"graphic graphic_table graphicRef57431 \" href=\"UTD.htm?2/48/2830\">",
"     table 1",
"    </a>",
"    ) (and see",
"    <a class=\"external\" href=\"file://www.qtdrugs.org/\">",
"     www.qtdrugs.org",
"    </a>",
"    ), the following recommendations have been made [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/33\">",
"     33",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Caution should be used when prescribing a drug that prolongs the QT interval in patients with one or more of the risk factors listed above. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Risk factors'",
"      </a>",
"      above.) Decisions regarding use of a QT prolonging drug should be based upon an individualized risk-benefit analysis. Alternative agents should be considered. Use of more than one QT prolonging drug should be avoided, if possible.",
"     </li>",
"     <li>",
"      A baseline electrocardiogram should be obtained prior to the administration of the drug. Electrocardiograms should also be obtained during the course of treatment to detect prolongation of the QT interval.",
"     </li>",
"     <li>",
"      Patients being treated with QT-prolonging drugs should be instructed to report promptly any new symptoms including palpitations, syncope, or near-syncope. They should also report clinical changes that could lead to hypokalemia, such as gastroenteritis or the initiation of diuretic therapy.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     OTHER CAUSES OF TdP",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Hypokalemia, hypomagnesemia, and hypocalcemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypokalemia and hypomagnesemia can predispose to TdP. These disorders can occur together since hypomagnesemia directly causes hypokalemia. Hypocalcemia, alone or induced by hypomagnesemia, is a less common cause [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/77-79\">",
"     77-79",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/37/42580?source=see_link&amp;anchor=H3#H3\">",
"     \"Signs and symptoms of magnesium depletion\", section on 'Hypokalemia'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/37/42580?source=see_link&amp;anchor=H4#H4\">",
"     \"Signs and symptoms of magnesium depletion\", section on 'Bone and calcium metabolism'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The risk for developing TdP in the presence of hypokalemia",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    hypomagnesemia is greatest in patients taking antiarrhythmic drugs [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/34,41,80-82\">",
"     34,41,80-82",
"    </a>",
"    ]. This was illustrated in a report of 32 such patients [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/81\">",
"     81",
"    </a>",
"    ]. Serum drug concentrations were in the therapeutic range in 22 of 26 patients in whom they were measured. However, 20 patients had, either alone or in combination, baseline prolongation of the QT interval, hypokalemia, or hypomagnesemia. In another series of 92 patients with drug-induced LQTS, 27 percent had hypokalemia or hypomagnesemia [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/34\">",
"     34",
"    </a>",
"    ]. Similar findings were noted in a report of 24 patients with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/48/777?source=see_link\">",
"     quinidine",
"    </a>",
"    -induced LQTS: the serum quinidine concentration was well within the therapeutic range in one-half of patients and the serum potassium concentration was below 4.0",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    in 13 [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    As noted above, virtually all of the drugs that produce LQTS act by blocking the IKr current mediated by the potassium channel encoded by the HERG gene [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/11-24,27\">",
"     11-24,27",
"    </a>",
"    ]. The increase in risk with hypokalemia may be related to enhanced drug blockade of IKr [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/13\">",
"     13",
"    </a>",
"    ]. The risk of hypokalemia itself may also be related to decreased IKr activity.",
"   </p>",
"   <p>",
"    Further support for the importance of hypomagnesemia is the beneficial effect of magnesium administration in the acute therapy of TdP. (See",
"    <a class=\"local\" href=\"#H19\">",
"     'Management'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Structural heart disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Heart failure and left ventricular hypertrophy are common risk factors for drug-induced TdP. Antiarrhythmic drugs and hypokalemia",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    hypomagnesemia associated with diuretic therapy may all contribute to proarrhythmia. It is not clear if there is an increased risk of LQTS or TdP with either type of heart disease alone.",
"   </p>",
"   <p>",
"    Polymorphic VT is an uncommon arrhythmia following an acute myocardial infarction (MI) or ischemic episode. When it occurs, it typically is associated with a normal QT interval and with signs or symptoms of recurrent myocardial ischemia (",
"    <a class=\"graphic graphic_waveform graphicRef54538 \" href=\"UTD.htm?7/6/7271\">",
"     waveform 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_waveform graphicRef67322 \" href=\"UTD.htm?31/19/32054\">",
"     waveform 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/83\">",
"     83",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, QTc prolongation may be common during the early phase of ischemia. In a series of 74 patients undergoing serial ECGs during angioplasty, all patients developed QT prolongation during balloon inflation [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/84\">",
"     84",
"    </a>",
"    ]. In addition, some patients with acute myocardial infarction (8 of 434 consecutive patients in one series) develop progressive QT interval prolongation that is maximal at days three to 11 during the healing phase of the infarct [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/85\">",
"     85",
"    </a>",
"    ]. By three months, the QT interval was normal in all but two patients treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?22/58/23466?source=see_link\">",
"     amiodarone",
"    </a>",
"    . (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/48/37641?source=see_link&amp;anchor=H14#H14\">",
"     \"Catecholaminergic polymorphic ventricular tachycardia and other polymorphic ventricular tachycardias with a normal QT interval\", section on 'Polymorphic VT in coronary heart disease'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Bradyarrhythmias",
"    </span>",
"    &nbsp;&mdash;&nbsp;As mentioned above, the likelihood of developing QT prolongation and TdP in patients taking antiarrhythmic drugs is increased by bradycardia due to reverse use dependency [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/13\">",
"     13",
"    </a>",
"    ]. It is less clear whether bradycardia alone causes TdP [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/86,87\">",
"     86,87",
"    </a>",
"    ]. This issue was addressed in a report of 14 patients with complete atrioventricular block, six of whom had a history of TdP [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/86\">",
"     86",
"    </a>",
"    ]. The two groups did not differ with respect to the rate of the escape rhythm; however, the corrected QT interval was significantly longer in those who had experienced TdP (0.59 versus 0.48 sec). After pacemaker placement, the corrected QT interval was again significantly longer in those patients who had had TdP when the pacemaker was set at 60 beats per minute (0.55 versus 0.50 sec) or 50 beats per minute (0.70 versus 0.53 sec).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Stroke",
"    </span>",
"    &nbsp;&mdash;&nbsp;QT prolongation is a common finding in patients with a stroke. In a review of 150 patients with acute stroke, QT prolongation was present in 45 percent of patients overall; and in 71 percent with subarachnoid hemorrhage, 64 percent with intraparenchymal hemorrhage, and 38 percent with ischemic stroke [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/88\">",
"     88",
"    </a>",
"    ]. Occasional patients develop TdP, often in association with hypokalemia [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/89\">",
"     89",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/20/26952?source=see_link&amp;anchor=H4#H4\">",
"     \"Cardiac complications of stroke\", section on 'QT prolongation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21777558\">",
"    <span class=\"h1\">",
"     MONITORING",
"    </span>",
"    &nbsp;&mdash;&nbsp;The 2004 American Heart Association (AHA) practice standards for ECG monitoring in hospital settings include the following indications for QT interval monitoring [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/90\">",
"     90",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Initiation of a drug known to cause TdP",
"     </li>",
"     <li>",
"      Overdose from potentially proarrhythmic agents",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Since the types and amounts of drugs taken in an intentional overdose are frequently not known, monitoring of QT intervals may be prudent in all such cases [",
"      <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/66\">",
"       66",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      New-onset brady arrhythmias",
"     </li>",
"     <li>",
"      Severe hypokalemia or hypomagnesemia",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The 2011",
"    <span class=\"nowrap\">",
"     AHA/ACC",
"    </span>",
"    scientific statement on prevention of TdP suggests a strategy of documenting the QTc interval before and at least every 8 to 12 hours after the initiation, increased dose, or overdose of QT prolonging drugs [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/66\">",
"     66",
"    </a>",
"    ]. If QTc prolongation is observed, documentation of more frequent measurements is recommended.",
"   </p>",
"   <p>",
"    The duration of QTc monitoring depends upon the duration of treatment with the QT prolonging drug and the drug half-life.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The QT interval typically is measured in lead II of a 12 lead ECG from the onset of the QRS complex to the point at which the T wave ends. The QT interval varies inversely with the heart rate; therefore, a correction for the heart rate (or the duration of the RR interval) must be made. A corrected QT interval (QTc) can be calculated from Bazett's formula:",
"   </p>",
"   <p>",
"    &nbsp;QTc = QT interval &divide; square root of the RR interval (in sec)",
"   </p>",
"   <p>",
"    The normal value usually cited for the QTc is &le;0.44 to 0.46 sec (440 to 460 msec) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/1,91\">",
"     1,91",
"    </a>",
"    ]. A QTc of more than 0.44 sec is considered prolonged in men; the normal range generally is extended to 0.45 to 0.46 sec in women [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/92\">",
"     92",
"    </a>",
"    ]. The 2011",
"    <span class=\"nowrap\">",
"     AHA/ACC",
"    </span>",
"    scientific statement on prevention of torsade de pointes in hospital settings recommended that a QTc over the 99th percentile should be considered abnormally prolonged [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/66\">",
"     66",
"    </a>",
"    ]. This corresponds to a QTc of &gt;470 ms for men and &gt;480 ms for women. A QTc &gt;500 ms is considered highly abnormal for both men and women.",
"   </p>",
"   <p>",
"    Among patients with possible acquired LQTS, there should be concern when there is more than a 25 percent increase in QTc from baseline; the risk of TdP does not vary predictably with the QTc but the risk is greatest when the QTc is longer than 0.50 sec [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/91\">",
"     91",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A limitation of Bazett&rsquo;s formula is that it produces overlong QTc values at faster heart rates (particularly over 85 bpm) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/66\">",
"     66",
"    </a>",
"    ]. A detailed discussion of which lead should be used for measurement, how to measure the interval, the method of correction for changes with heart rate, the limits of the normal range, and other factors used in diagnosis are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/6/33897?source=see_link&amp;anchor=H3#H3\">",
"     \"Diagnosis of congenital long QT syndrome\", section on 'QT interval'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19909623\">",
"    <span class=\"h2\">",
"     General measures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients presenting with a possible overdose of a QT-prolonging drug should be evaluated for risk of TdP.",
"   </p>",
"   <p>",
"    The cornerstone of the management of patients with acquired LQTS is addressing the underlying cause by identifying and stopping any precipitating drug and aggressive correction of any metabolic abnormalities, such as hypokalemia or hypomagnesemia [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/93\">",
"     93",
"    </a>",
"    ]. As noted above, correcting hypokalemia may be particularly important because a low serum potassium concentration enhances the degree of drug-induced inhibition of IKr, increasing the QT interval [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/13\">",
"     13",
"    </a>",
"    ]. All drugs that prolong the QT interval (",
"    <a class=\"graphic graphic_table graphicRef57431 \" href=\"UTD.htm?2/48/2830\">",
"     table 1",
"    </a>",
"    ) (and see",
"    <a class=\"external\" href=\"file://www.qtdrugs.org/\">",
"     www.qtdrugs.org",
"    </a>",
"    ) should be avoided because they appear to act by a common mechanism, inhibition of IKr [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/11-24\">",
"     11-24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Mild QT prolongation without TdP or syncope may be tolerated and monitored as an outpatient when it is associated with needed therapy with a drug known to cause it.&nbsp;Specific protocols for such management have not been established, but we suggest intermittent monitoring with ECGs and Holter recordings particularly at times of dose changes.&nbsp;",
"   </p>",
"   <p>",
"    Patients with prolonged QT with syncope (without documented TdP) or ECG signs of instability (ventricular ectopy, T wave alternans, AV block or QRS widening) should be admitted for telemetry observation during withdrawal of the toxic agent (with immediate availability of an external defibrillator), and treatment of arrhythmias if indicated. In addition, admission and monitoring during drug withdrawal is suggested for patients with markedly prolonged QTc (&gt;500 ms) or an increase in QTc of at least 60 ms compared with the predrug baseline value [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/66\">",
"     66",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Acute therapy of TdP",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prompt nonsynchronized electric defibrillation is indicated in patients with hemodynamically unstable TdP [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/5,41\">",
"     5,41",
"    </a>",
"    ]. However, in the conscious patient, a brief trial of medical therapy may be attempted prior to cardioversion. A number of acute therapies are available (",
"    <a class=\"graphic graphic_table graphicRef70083 \" href=\"UTD.htm?29/46/30443\">",
"     table 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/6,41,93\">",
"     6,41,93",
"    </a>",
"    ]. The relative efficacy of these modalities was evaluated in a report of 24 patients with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/48/777?source=see_link\">",
"     quinidine",
"    </a>",
"    -induced LQTS, 20 of whom had TdP [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/41\">",
"     41",
"    </a>",
"    ]. TdP was terminated in all nine patients who underwent ventricular pacing at rates of 100 to 120",
"    <span class=\"nowrap\">",
"     beats/min,",
"    </span>",
"    five of six treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?22/31/23029?source=see_link\">",
"     isoproterenol",
"    </a>",
"    , and only seven of 14 receiving",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/34/35360?source=see_link\">",
"     lidocaine",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    Specific therapy of ventricular arrhythmia in acquired LQTS differs from that in congenital LQTS due in part to pathophysiologic differences between the two forms (",
"    <a class=\"graphic graphic_table graphicRef70083 \" href=\"UTD.htm?29/46/30443\">",
"     table 3",
"    </a>",
"    ). As an example, a bradycardia usually is associated with TdP in acquired LQTS, whereas catecholamine surges trigger TdP in some types of congenital LQTS (",
"    <a class=\"graphic graphic_figure graphicRef64239 \" href=\"UTD.htm?9/27/9662\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Intravenous",
"      <a class=\"drug drug_general\" href=\"UTD.htm?26/25/27031?source=see_link\">",
"       magnesium sulfate",
"      </a>",
"      is first-line therapy, being highly effective for both the treatment and prevention of recurrence of long QT-related ventricular ectopic beats or TdP [",
"      <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/5,6,94\">",
"       5,6,94",
"      </a>",
"      ]. The benefit occurs without shortening of the QT interval and is seen even in patients with normal serum magnesium concentrations at baseline.",
"      <br/>",
"      <br/>",
"      The standard regimen consists of a 2 gram intravenous bolus of 50 percent magnesium sulfate over one to two minutes followed in 15 minutes by another such bolus if required [",
"      <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/94\">",
"       94",
"      </a>",
"      ]. Some patients also receive a continuous infusion at a rate of 3 to 20",
"      <span class=\"nowrap\">",
"       mg/min.",
"      </span>",
"      The bolus dose in children is 25 to 50",
"      <span class=\"nowrap\">",
"       mg/kg;",
"      </span>",
"      there are no published data on intravenous maintenance dosing in children.",
"     </li>",
"     <li>",
"      Temporary transvenous overdrive pacing (atrial or ventricular) generally is reserved for patients with long QT-related TdP who do not respond to intravenous magnesium [",
"      <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/5,6\">",
"       5,6",
"      </a>",
"      ]. Pacing at rates of about 100 beats per minute will decrease the dispersion of refractoriness and the development of early afterdepolarizations (EADs), and may shorten the surface QT interval, especially if there is an associated bradycardia. As noted above, many of the class IA and class III antiarrhythmic drugs that cause TdP have a property of \"reverse use dependency,\" in which the QT interval decreases as the heart rate increases and lengthens as the heart rate slows [",
"      <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/10\">",
"       10",
"      </a>",
"      ]. These changes may be mediated in part by changes in the extracellular potassium concentration [",
"      <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/13\">",
"       13",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      The efficacy of overdrive pacing was illustrated in a report of nine patients with life-threatening ventricular arrhythmias and drug-induced LQTS [",
"      <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/95\">",
"       95",
"      </a>",
"      ]. Acceleration of the heart rate produced immediate suppression of all arrhythmias, with a reduction in the QT interval from 0.65 to 0.50 sec. Similar findings were noted in another small series [",
"      <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/96\">",
"       96",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?22/31/23029?source=see_link\">",
"       Isoproterenol",
"      </a>",
"      (initial dose 0.05 to 0.1",
"      <span class=\"nowrap\">",
"       mcg/kg",
"      </span>",
"      per min in children and 2",
"      <span class=\"nowrap\">",
"       mcg/min",
"      </span>",
"      in adults, then titrated to achieve a heart rate of 100 beats per minute) also can be used to increase the sinus rate and decrease the QT interval [",
"      <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/5,6,97\">",
"       5,6,97",
"      </a>",
"      ]. We favor placement of a temporary pacemaker in the treatment of most cases of TdP that do not respond to magnesium. However, isoproterenol can be used as a temporizing measure prior to pacing.",
"     </li>",
"     <li>",
"      Class IB antiarrhythmic drugs, such as",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/34/35360?source=see_link\">",
"       lidocaine",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/48/35594?source=see_link\">",
"       phenytoin",
"      </a>",
"      , shorten the action potential duration and, based upon small case series, may be effective in the acute management of TdP and ventricular fibrillation [",
"      <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/41,98-101\">",
"       41,98-101",
"      </a>",
"      ]. They appear to be less predictably effective than pacing or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?22/31/23029?source=see_link\">",
"       isoproterenol",
"      </a>",
"      &nbsp;[",
"      <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/6,41\">",
"       6,41",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Alkalinization of the plasma, via the administration of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?0/52/840?source=see_link\">",
"       sodium bicarbonate",
"      </a>",
"      , is useful when TdP is due to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?0/48/777?source=see_link\">",
"       quinidine",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/102\">",
"       102",
"      </a>",
"      ]. Alkalinization drives the reaction",
"      <br/>",
"      <br/>",
"      Qud+ + OH- &lt;-&gt; QudOH",
"      <br/>",
"      <br/>",
"      to the right, thereby decreasing the availability of the active charged form of the drug and shortening the QT interval. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/4/26695?source=see_link&amp;anchor=H8#H8\">",
"       \"Enhanced elimination of poisons\", section on 'Urinary alkalinization'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      An intravenous infusion of potassium may be beneficial in patients with a normal baseline serum potassium concentration. The potential benefit of intravenous potassium was illustrated in a report of 20 normokalemic patients with QT prolongation due to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?0/48/777?source=see_link\">",
"       quinidine",
"      </a>",
"      or heart failure [",
"      <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/103\">",
"       103",
"      </a>",
"      ]. The administration of intravenous potassium (0.5",
"      <span class=\"nowrap\">",
"       meq/kg",
"      </span>",
"      to a maximum of 40 meq) raised the plasma potassium concentration by 0.7",
"      <span class=\"nowrap\">",
"       meq/L,",
"      </span>",
"      reversed QT prolongation and QT morphologic changes (U waves and bifid T waves), and decreased QT dispersion. It is uncertain, however, if this therapy is effective for preventing or reversing TdP.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     ACC/AHA/ESC Guidelines",
"    </span>",
"    &nbsp;&mdash;&nbsp;The 2006 American College of",
"    <span class=\"nowrap\">",
"     Cardiology/American",
"    </span>",
"    Heart",
"    <span class=\"nowrap\">",
"     Association/European",
"    </span>",
"    Society of Cardiology",
"    <span class=\"nowrap\">",
"     (ACC/AHA/ESC)",
"    </span>",
"    guidelines for the management of ventricular arrhythmias and the prevention of SCD addressed the management of TdP in the setting of acquired LQTS [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/93\">",
"     93",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The guidelines stated that the weight of evidence supported the following options in patients with recurrent TdP:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Intravenous magnesium",
"     </li>",
"     <li>",
"      Temporary pacing",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?22/31/23029?source=see_link\">",
"       Isoproterenol",
"      </a>",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Additional therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with eating disorders, nutritional rehabilitation will correct the QT prolongation over the longer term (three to 18 months) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/104,105\">",
"     104,105",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/63/44023?source=see_link\">",
"     \"Eating disorders: Treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A permanent pacemaker may be required in the occasional patient with a chronic bradyarrhythmia (due to sick sinus syndrome or atrioventricular block) who has bradycardia- or pause-dependent TdP (",
"    <a class=\"graphic graphic_table graphicRef80487 \" href=\"UTD.htm?1/47/1788\">",
"     table 4",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/52/27463?source=see_link\">",
"     \"Indications for permanent cardiac pacing\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition to treating the underlying cause, a thorough history and ECG screening of immediate family members is recommended because of the occasional association with congenital LQTS. (See",
"    <a class=\"local\" href=\"#H11\">",
"     'Mutations in LQTS genes'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/6/33897?source=see_link\">",
"     \"Diagnosis of congenital long QT syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with acquired LQTS should be educated about the culprit drugs and other QT-prolonging drugs (including being provided with a list as available at",
"    <a class=\"external\" href=\"file://www.qtdrugs.org/\">",
"     www.qtdrugs.org",
"    </a>",
"    ) and potential drug-drug interactions [",
"    <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/66\">",
"     66",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?19/25/19859?source=see_link\">",
"       \"Patient information: Long QT syndrome (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19910066\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Acquired LQTS usually results from drug therapy, hypokalemia,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      hypomagnesemia (",
"      <a class=\"graphic graphic_table graphicRef57431 \" href=\"UTD.htm?2/48/2830\">",
"       table 1",
"      </a>",
"      ). Some patients with acquired LQTS have an underlying \"forme fruste\" of congenital LQTS. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Torsades de pointes (TdP) is a form of polymorphic ventricular tachycardia (VT) that occurs in the setting of acquired or congenital QT interval prolongation. TdP is usually short-lived and terminates spontaneously. However, most patients experience multiple episodes of the arrhythmia, and episodes can recur in rapid succession, potentially degenerating to ventricular fibrillation and sudden cardiac death. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Torsades de pointes'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Acquired LQTS is commonly associated with bradycardia and pauses, in contrast to some forms of congenital LQTS (particularly types 1 and 2) (",
"      <a class=\"graphic graphic_figure graphicRef64239 \" href=\"UTD.htm?9/27/9662\">",
"       figure 1",
"      </a>",
"      ) in which arrhythmias often follow a sudden adrenergic surge. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Pathophysiology'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?2/9/2202?source=see_link&amp;anchor=H9#H9\">",
"       \"Clinical features of congenital long QT syndrome\", section on 'Triggers of arrhythmia'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Drugs that prolong the QT interval include antiarrhythmic drugs (classes IA and III), certain nonsedating antihistamines (eg, terfenadine and astemizole), macrolide antibiotics, certain psychotropic medications, and certain gastric motility agents (eg, cisapride) (see",
"      <a class=\"external\" href=\"file://www.qtdrugs.org/\">",
"       www.qtdrugs.org",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Incidence with specific drugs'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Risk factors for drug-induced TdP include high concentrations (",
"      <a class=\"drug drug_general\" href=\"UTD.htm?0/48/777?source=see_link\">",
"       quinidine",
"      </a>",
"      is an exception), concurrent use of other drugs that can prolong the QT interval or that slow drug metabolism due to inhibition of cytochrome P450 enzymes, concurrent intake of grapefruit juice, baseline QT prolongation or T wave lability, development of marked QT prolongation or T wave changes during therapy, bradycardia, electrolyte disturbances (particularly hypokalemia and hypomagnesemia), impaired hepatic",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      renal function, underlying heart disease, recent conversion from atrial fibrillation, and female sex. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Risk factors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Alternatives to QT prolonging drugs should be considered in patients with the above risk factors, particularly if the patient is already taking a QT prolonging drug. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Precautions when using QT prolonging drugs'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with prolonged QT with syncope (without documented TdP) or ECG signs of instability (ventricular ectopy, T wave alternans, AV block or QRS widening) should be admitted for telemetry observation during withdrawal of the toxic agent (with immediate availability of an external defibrillator), and treatment of arrhythmias if indicated. In addition, admission and monitoring during drug withdrawal is suggested for patients with markedly prolonged QTc (&gt;500 ms) or an increase in QTc of at least 60 ms compared with the predrug baseline value [",
"      <a class=\"abstract\" href=\"UTD.htm?22/55/23418/abstract/66\">",
"       66",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Prompt, nonsynchronized electric defibrillation is indicated in patients with hemodynamically unstable TdP.",
"     </li>",
"     <li>",
"      In the conscious patients with TdP, we suggest a brief trial of medical therapy (see",
"      <a class=\"local\" href=\"#H20\">",
"       'Acute therapy of TdP'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Intravenous magnesium is first-line therapy, as it is highly effective for both treatment and prevention of recurrence of long QT-related ventricular ectopic beats of TdP. The benefit is seen even in patients with normal serum magnesium concentrations at baseline.",
"     </li>",
"     <li>",
"      Temporary transvenous overdrive pacing (atrial or ventricular) at about 100 beats per minute is generally reserved for patients who do not respond to intravenous magnesium.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?22/31/23029?source=see_link\">",
"       Isoproterenol",
"      </a>",
"      (initial dose 0.05 to 0.1",
"      <span class=\"nowrap\">",
"       mcg/kg",
"      </span>",
"      per min in children and 2",
"      <span class=\"nowrap\">",
"       mcg/min",
"      </span>",
"      in adults, then titrated to achieve a heart rate of 100 beats per minute) can be used as a temporizing measure to achieve a heart rate of 100 beats per minute prior to pacing.",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/1\">",
"      Moss AJ. Long QT Syndrome. JAMA 2003; 289:2041.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/2\">",
"      Li H, Fuentes-Garcia J, Towbin JA. Current concepts in long QT syndrome. Pediatr Cardiol 2000; 21:542.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/3\">",
"      Jackman WM, Friday KJ, Anderson JL, et al. The long QT syndromes: a critical review, new clinical observations and a unifying hypothesis. Prog Cardiovasc Dis 1988; 31:115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/4\">",
"      El-Sherif N, Turitto G. Torsade de pointes. Curr Opin Cardiol 2003; 18:6.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/5\">",
"      Passman R, Kadish A. Polymorphic ventricular tachycardia, long Q-T syndrome, and torsades de pointes. Med Clin North Am 2001; 85:321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/6\">",
"      Khan IA. Long QT syndrome: diagnosis and management. Am Heart J 2002; 143:7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/7\">",
"      Wehrens XH, Vos MA, Doevendans PA, Wellens HJ. Novel insights in the congenital long QT syndrome. Ann Intern Med 2002; 137:981.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/8\">",
"      Camm AJ, Janse MJ, Roden DM, et al. Congenital and acquired long QT syndrome. Eur Heart J 2000; 21:1232.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/9\">",
"      Haverkamp W, Breithardt G, Camm AJ, et al. The potential for QT prolongation and proarrhythmia by non-antiarrhythmic drugs: clinical and regulatory implications. Report on a policy conference of the European Society of Cardiology. Eur Heart J 2000; 21:1216.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/10\">",
"      Hondeghem LM, Snyders DJ. Class III antiarrhythmic agents have a lot of potential but a long way to go. Reduced effectiveness and dangers of reverse use dependence. Circulation 1990; 81:686.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/11\">",
"      Roden DM. Taking the \"idio\" out of \"idiosyncratic\": predicting torsades de pointes. Pacing Clin Electrophysiol 1998; 21:1029.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/12\">",
"      Kupershmidt S, Yang IC, Hayashi K, et al. The IKr drug response is modulated by KCR1 in transfected cardiac and noncardiac cell lines. FASEB J 2003; 17:2263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/13\">",
"      Yang T, Roden DM. Extracellular potassium modulation of drug block of IKr. Implications for torsade de pointes and reverse use-dependence. Circulation 1996; 93:407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/14\">",
"      Ridley JM, Milnes JT, Benest AV, et al. Characterisation of recombinant HERG K+ channel blockade by the Class Ia antiarrhythmic drug procainamide. Biochem Biophys Res Commun 2003; 306:388.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/15\">",
"      Jurkiewicz NK, Sanguinetti MC. Rate-dependent prolongation of cardiac action potentials by a methanesulfonanilide class III antiarrhythmic agent. Specific block of rapidly activating delayed rectifier K+ current by dofetilide. Circ Res 1993; 72:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/16\">",
"      Yang T, Snyders DJ, Roden DM. Ibutilide, a methanesulfonanilide antiarrhythmic, is a potent blocker of the rapidly activating delayed rectifier K+ current (IKr) in AT-1 cells. Concentration-, time-, voltage-, and use-dependent effects. Circulation 1995; 91:1799.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/17\">",
"      Numaguchi H, Mullins FM, Johnson JP Jr, et al. Probing the interaction between inactivation gating and Dd-sotalol block of HERG. Circ Res 2000; 87:1012.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/18\">",
"      Kamiya K, Nishiyama A, Yasui K, et al. Short- and long-term effects of amiodarone on the two components of cardiac delayed rectifier K(+) current. Circulation 2001; 103:1317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/19\">",
"      Daleau P, Lessard E, Groleau MF, Turgeon J. Erythromycin blocks the rapid component of the delayed rectifier potassium current and lengthens repolarization of guinea pig ventricular myocytes. Circulation 1995; 91:3010.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/20\">",
"      Volberg WA, Koci BJ, Su W, et al. Blockade of human cardiac potassium channel human ether-a-go-go-related gene (HERG) by macrolide antibiotics. J Pharmacol Exp Ther 2002; 302:320.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/21\">",
"      Roy M, Dumaine R, Brown AM. HERG, a primary human ventricular target of the nonsedating antihistamine terfenadine. Circulation 1996; 94:817.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/22\">",
"      Suessbrich H, Waldegger S, Lang F, Busch AE. Blockade of HERG channels expressed in Xenopus oocytes by the histamine receptor antagonists terfenadine and astemizole. FEBS Lett 1996; 385:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/23\">",
"      Drolet B, Khalifa M, Daleau P, et al. Block of the rapid component of the delayed rectifier potassium current by the prokinetic agent cisapride underlies drug-related lengthening of the QT interval. Circulation 1998; 97:204.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/24\">",
"      Dumaine R, Roy ML, Brown AM. Blockade of HERG and Kv1.5 by ketoconazole. J Pharmacol Exp Ther 1998; 286:727.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/25\">",
"      Kang J, Wang L, Chen XL, et al. Interactions of a series of fluoroquinolone antibacterial drugs with the human cardiac K+ channel HERG. Mol Pharmacol 2001; 59:122.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/26\">",
"      Anson BD, Weaver JG, Ackerman MJ, et al. Blockade of HERG channels by HIV protease inhibitors. Lancet 2005; 365:682.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/27\">",
"      Schram G, Zhang L, Derakhchan K, et al. Ranolazine: ion-channel-blocking actions and in vivo electrophysiological effects. Br J Pharmacol 2004; 142:1300.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/28\">",
"      Katchman AN, McGroary KA, Kilborn MJ, et al. Influence of opioid agonists on cardiac human ether-a-go-go-related gene K(+) currents. J Pharmacol Exp Ther 2002; 303:688.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/29\">",
"      Katchman AN, Koerner J, Tosaka T, et al. Comparative evaluation of HERG currents and QT intervals following challenge with suspected torsadogenic and nontorsadogenic drugs. J Pharmacol Exp Ther 2006; 316:1098.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/30\">",
"      Suessbrich H, Sch&ouml;nherr R, Heinemann SH, et al. The inhibitory effect of the antipsychotic drug haloperidol on HERG potassium channels expressed in Xenopus oocytes. Br J Pharmacol 1997; 120:968.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/31\">",
"      Viskin S, Alla SR, Barron HV, et al. Mode of onset of torsade de pointes in congenital long QT syndrome. J Am Coll Cardiol 1996; 28:1262.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/32\">",
"      Yap YG, Camm AJ. Drug induced QT prolongation and torsades de pointes. Heart 2003; 89:1363.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/33\">",
"      Roden DM. Drug-induced prolongation of the QT interval. N Engl J Med 2004; 350:1013.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/34\">",
"      Yang P, Kanki H, Drolet B, et al. Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes. Circulation 2002; 105:1943.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/35\">",
"      De Ponti F, Poluzzi E, Cavalli A, et al. Safety of non-antiarrhythmic drugs that prolong the QT interval or induce torsade de pointes: an overview. Drug Saf 2002; 25:263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/36\">",
"      Viskin S, Justo D, Halkin A, Zeltser D. Long QT syndrome caused by noncardiac drugs. Prog Cardiovasc Dis 2003; 45:415.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/37\">",
"      Straus SM, Bleumink GS, Dieleman JP, et al. Antipsychotics and the risk of sudden cardiac death. Arch Intern Med 2004; 164:1293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/38\">",
"      Magnano AR, Talathoti NB, Hallur R, et al. Effect of acute cocaine administration on the QTc interval of habitual users. Am J Cardiol 2006; 97:1244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/39\">",
"      De Bruin ML, Pettersson M, Meyboom RH, et al. Anti-HERG activity and the risk of drug-induced arrhythmias and sudden death. Eur Heart J 2005; 26:590.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/40\">",
"      Straus SM, Sturkenboom MC, Bleumink GS, et al. Non-cardiac QTc-prolonging drugs and the risk of sudden cardiac death. Eur Heart J 2005; 26:2007.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/41\">",
"      Roden DM, Woosley RL, Primm RK. Incidence and clinical features of the quinidine-associated long QT syndrome: implications for patient care. Am Heart J 1986; 111:1088.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/42\">",
"      Maisel WH, Kuntz KM, Reimold SC, et al. Risk of initiating antiarrhythmic drug therapy for atrial fibrillation in patients admitted to a university hospital. Ann Intern Med 1997; 127:281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/43\">",
"      Coplen SE, Antman EM, Berlin JA, et al. Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials. Circulation 1990; 82:1106.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/44\">",
"      Meltzer RS, Robert EW, McMorrow M, Martin RP. Atypical ventricular tachycardia as a manifestation of disopyramide toxicity. Am J Cardiol 1978; 42:1049.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/45\">",
"      Strasberg B, Sclarovsky S, Erdberg A, et al. Procainamide-induced polymorphous ventricular tachycardia. Am J Cardiol 1981; 47:1309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/46\">",
"      Olshansky B, Martins J, Hunt S. N-acetyl procainamide causing torsades de pointes. Am J Cardiol 1982; 50:1439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/47\">",
"      Soyka LF, Wirtz C, Spangenberg RB. Clinical safety profile of sotalol in patients with arrhythmias. Am J Cardiol 1990; 65:74A.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/48\">",
"      Lehmann MH, Hardy S, Archibald D, et al. Sex difference in risk of torsade de pointes with d,l-sotalol. Circulation 1996; 94:2535.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/49\">",
"      Wang T, Bergstrand RH, Thompson KA, et al. Concentration-dependent pharmacologic properties of sotalol. Am J Cardiol 1986; 57:1160.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/50\">",
"      K&oslash;ber L, Bloch Thomsen PE, M&oslash;ller M, et al. Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction: a randomised trial. Lancet 2000; 356:2052.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/51\">",
"      Torp-Pedersen C, M&oslash;ller M, Bloch-Thomsen PE, et al. Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group. N Engl J Med 1999; 341:857.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/52\">",
"      Ellenbogen KA, Stambler BS, Wood MA, et al. Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: a dose-response study. J Am Coll Cardiol 1996; 28:130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/53\">",
"      Stambler BS, Wood MA, Ellenbogen KA, et al. Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Ibutilide Repeat Dose Study Investigators. Circulation 1996; 94:1613.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/54\">",
"      Brown MA, Smith WM, Lubbe WF, Norris RM. Amiodarone-induced torsades de pointes. Eur Heart J 1986; 7:234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/55\">",
"      Hohnloser SH, Klingenheben T, Singh BN. Amiodarone-associated proarrhythmic effects. A review with special reference to torsade de pointes tachycardia. Ann Intern Med 1994; 121:529.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/56\">",
"      Vorperian VR, Havighurst TC, Miller S, January CT. Adverse effects of low dose amiodarone: a meta-analysis. J Am Coll Cardiol 1997; 30:791.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/57\">",
"      Haddad PM, Anderson IM. Antipsychotic-related QTc prolongation, torsade de pointes and sudden death. Drugs 2002; 62:1649.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/58\">",
"      Ray WA, Chung CP, Murray KT, et al. Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med 2009; 360:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/59\">",
"      Hill SL, Evangelista JK, Pizzi AM, et al. Proarrhythmia associated with cisapride in children. Pediatrics 1998; 101:1053.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/60\">",
"      Ray WA, Murray KT, Meredith S, et al. Oral erythromycin and the risk of sudden death from cardiac causes. N Engl J Med 2004; 351:1089.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/61\">",
"      Barbey JT, Pezzullo JC, Soignet SL. Effect of arsenic trioxide on QT interval in patients with advanced malignancies. J Clin Oncol 2003; 21:3609.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/62\">",
"      Ohnishi K, Yoshida H, Shigeno K, et al. Prolongation of the QT interval and ventricular tachycardia in patients treated with arsenic trioxide for acute promyelocytic leukemia. Ann Intern Med 2000; 133:881.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/63\">",
"      Unnikrishnan D, Dutcher JP, Varshneya N, et al. Torsades de pointes in 3 patients with leukemia treated with arsenic trioxide. Blood 2001; 97:1514.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/64\">",
"      Drolet B, Simard C, Roden DM. Unusual effects of a QT-prolonging drug, arsenic trioxide, on cardiac potassium currents. Circulation 2004; 109:26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/65\">",
"      Singer JW. Cardiac toxicity of arsenic trioxide. Blood 2001; 98:1633; author reply 1633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/66\">",
"      Drew BJ, Ackerman MJ, Funk M, et al. Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. Circulation 2010; 121:1047.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/67\">",
"      Hennessy S, Bilker WB, Knauss JS, et al. Cardiac arrest and ventricular arrhythmia in patients taking antipsychotic drugs: cohort study using administrative data. BMJ 2002; 325:1070.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/68\">",
"      Herings RM, Stricker BH, Leufkens HG, et al. Public health problems and the rapid estimation of the size of the population at risk. Torsades de pointes and the use of terfenadine and astemizole in The Netherlands. Pharm World Sci 1993; 15:212.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/69\">",
"      Zitron E, Scholz E, Owen RW, et al. QTc prolongation by grapefruit juice and its potential pharmacological basis: HERG channel blockade by flavonoids. Circulation 2005; 111:835.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/70\">",
"      Choy AM, Darbar D, Dell'Orto S, Roden DM. Exaggerated QT prolongation after cardioversion of atrial fibrillation. J Am Coll Cardiol 1999; 34:396.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/71\">",
"      Makkar RR, Fromm BS, Steinman RT, et al. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. JAMA 1993; 270:2590.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/72\">",
"      Zeltser D, Justo D, Halkin A, et al. Torsade de pointes due to noncardiac drugs: most patients have easily identifiable risk factors. Medicine (Baltimore) 2003; 82:282.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/73\">",
"      Drici MD, Cl&eacute;ment N. Is gender a risk factor for adverse drug reactions? The example of drug-induced long QT syndrome. Drug Saf 2001; 24:575.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/74\">",
"      Drici MD, Knollmann BC, Wang WX, Woosley RL. Cardiac actions of erythromycin: influence of female sex. JAMA 1998; 280:1774.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/75\">",
"      Locati EH, Zareba W, Moss AJ, et al. Age- and sex-related differences in clinical manifestations in patients with congenital long-QT syndrome: findings from the International LQTS Registry. Circulation 1998; 97:2237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/76\">",
"      Priori SG, Napolitano C, Schwartz PJ. Low penetrance in the long-QT syndrome: clinical impact. Circulation 1999; 99:529.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/77\">",
"      Bradley TJ, Metzger DL, Sanatani S. Long on QT and low on calcium. Cardiol Young 2004; 14:667.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/78\">",
"      Eryol NK, Colak R, Ozdo��ru I, et al. Effects of calcium treatment on QT interval and QT dispersion in hypocalcemia. Am J Cardiol 2003; 91:750.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/79\">",
"      Benoit SR, Mendelsohn AB, Nourjah P, et al. Risk factors for prolonged QTc among US adults: Third National Health and Nutrition Examination Survey. Eur J Cardiovasc Prev Rehabil 2005; 12:363.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/80\">",
"      Curry P, Fitchett D, Stubbs W, Krikler D. Ventricular arrhythmias and hypokalaemia. Lancet 1976; 2:231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/81\">",
"      Kay GN, Plumb VJ, Arciniegas JG, et al. Torsade de pointes: the long-short initiating sequence and other clinical features: observations in 32 patients. J Am Coll Cardiol 1983; 2:806.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/82\">",
"      McKibbin JK, Pocock WA, Barlow JB, et al. Sotalol, hypokalaemia, syncope, and torsade de pointes. Br Heart J 1984; 51:157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/83\">",
"      Wolfe CL, Nibley C, Bhandari A, et al. Polymorphous ventricular tachycardia associated with acute myocardial infarction. Circulation 1991; 84:1543.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/84\">",
"      Kenigsberg DN, Khanal S, Kowalski M, Krishnan SC. Prolongation of the QTc interval is seen uniformly during early transmural ischemia. J Am Coll Cardiol 2007; 49:1299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/85\">",
"      Halkin A, Roth A, Lurie I, et al. Pause-dependent torsade de pointes following acute myocardial infarction: a variant of the acquired long QT syndrome. J Am Coll Cardiol 2001; 38:1168.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/86\">",
"      Kurita T, Ohe T, Marui N, et al. Bradycardia-induced abnormal QT prolongation in patients with complete atrioventricular block with torsades de pointes. Am J Cardiol 1992; 69:628.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/87\">",
"      Furushima H, Niwano S, Chinushi M, et al. Relation between bradycardia dependent long QT syndrome and QT prolongation by disopyramide in humans. Heart 1998; 79:56.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/88\">",
"      Goldstein DS. The electrocardiogram in stroke: relationship to pathophysiological type and comparison with prior tracings. Stroke 1979; 10:253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/89\">",
"      Di Pasquale G, Pinelli G, Andreoli A, et al. Torsade de pointes and ventricular flutter-fibrillation following spontaneous cerebral subarachnoid hemorrhage. Int J Cardiol 1988; 18:163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/90\">",
"      Drew BJ, Califf RM, Funk M, et al. Practice standards for electrocardiographic monitoring in hospital settings: an American Heart Association scientific statement from the Councils on Cardiovascular Nursing, Clinical Cardiology, and Cardiovascular Disease in the Young: endorsed by the International Society of Computerized Electrocardiology and the American Association of Critical-Care Nurses. Circulation 2004; 110:2721.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/91\">",
"      Al-Khatib SM, LaPointe NM, Kramer JM, Califf RM. What clinicians should know about the QT interval. JAMA 2003; 289:2120.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/92\">",
"      Moss AJ. Measurement of the QT interval and the risk associated with QTc interval prolongation: a review. Am J Cardiol 1993; 72:23B.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/93\">",
"      European Heart Rhythm Association, Heart Rhythm Society, Zipes DP, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol 2006; 48:e247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/94\">",
"      Tzivoni D, Banai S, Schuger C, et al. Treatment of torsade de pointes with magnesium sulfate. Circulation 1988; 77:392.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/95\">",
"      DiSegni E, Klein HO, David D, et al. Overdrive pacing in quinidine syncope and other long QT-interval syndromes. Arch Intern Med 1980; 140:1036.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/96\">",
"      T&ouml;tterman KJ, Turto H, Pellinen T. Overdrive pacing as treatment of sotalol-induced ventricular tachyarrhythmias (torsade de pointes). Acta Med Scand Suppl 1982; 668:28.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/97\">",
"      Keren A, Tzivoni D, Gavish D, et al. Etiology, warning signs and therapy of torsade de pointes. A study of 10 patients. Circulation 1981; 64:1167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/98\">",
"      Assimes TL, Malcolm I. Torsade de pointes with sotalol overdose treated successfully with lidocaine. Can J Cardiol 1998; 14:753.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/99\">",
"      Takahashi N, Ito M, Inoue T, et al. Torsades de pointes associated with acquired long QT syndrome: observation of 7 cases. J Cardiol 1993; 23:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/100\">",
"      Raehl CL, Patel AK, LeRoy M. Drug-induced torsade de pointes. Clin Pharm 1985; 4:675.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/101\">",
"      Vukmir RB, Stein KL. Torsades de pointes therapy with phenytoin. Ann Emerg Med 1991; 20:198.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/102\">",
"      WASSERMAN F, BRODSKY L, KATHE JH, et al. The effect of molar sodium lactate in quinidine intoxication. Am J Cardiol 1959; 3:294.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/103\">",
"      Choy AM, Lang CC, Chomsky DM, et al. Normalization of acquired QT prolongation in humans by intravenous potassium. Circulation 1997; 96:2149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/104\">",
"      Cooke RA, Chambers JB, Singh R, et al. QT interval in anorexia nervosa. Br Heart J 1994; 72:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/55/23418/abstract/105\">",
"      Mont L, Castro J, Herreros B, et al. Reversibility of cardiac abnormalities in adolescents with anorexia nervosa after weight recovery. J Am Acad Child Adolesc Psychiatry 2003; 42:808.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1043 Version 13.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-61.234.146.186-67DC1C7482-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_55_23418=[""].join("\n");
var outline_f22_55_23418=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H19910066\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      TORSADES DE POINTES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PATHOPHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      DRUG-INDUCED TdP",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Importance of HERG blockade",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Incidence with specific drugs",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Antiarrhythmic drugs",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Psychotropic medications",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Other medications",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Risk factors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Mutations in LQTS genes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Precautions when using QT prolonging drugs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      OTHER CAUSES OF TdP",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Hypokalemia, hypomagnesemia, and hypocalcemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Structural heart disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Bradyarrhythmias",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Stroke",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21777558\">",
"      MONITORING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19909623\">",
"      General measures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Acute therapy of TdP",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - ACC/AHA/ESC Guidelines",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Additional therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19910066\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/1043\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/1043|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?9/27/9662\" title=\"figure 1\">",
"      Trigger event vs LQTS genotype",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/1043|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?2/48/2830\" title=\"table 1\">",
"      Causes of long QT syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?9/45/9950\" title=\"table 2\">",
"      Inhibitors and inducers of cytochrome P450 3A4",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?29/46/30443\" title=\"table 3\">",
"      Rx of torsades de pointes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?1/47/1788\" title=\"table 4\">",
"      ACC AHA HRS prevent tachy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/1043|Waveform\">",
"      <a href=\"#\" title=\"WAVEFORMS\">",
"       WAVEFORMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?26/24/27008\" title=\"waveform 1\">",
"      Prolonged QT interval tutorial",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?42/23/43380\" title=\"waveform 2A\">",
"      ECG Torsades de pointes tutorial",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?42/7/43134\" title=\"waveform 2B\">",
"      ECG torsades de pointes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?7/6/7271\" title=\"waveform 3\">",
"      ECG_1 Polymorphic VT in ischemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?31/19/32054\" title=\"waveform 4\">",
"      ECG_2 Polymorphic VT in ischemia",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/20/26952?source=related_link\">",
"      Cardiac complications of stroke",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/48/37641?source=related_link\">",
"      Catecholaminergic polymorphic ventricular tachycardia and other polymorphic ventricular tachycardias with a normal QT interval",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/9/2202?source=related_link\">",
"      Clinical features of congenital long QT syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/6/33897?source=related_link\">",
"      Diagnosis of congenital long QT syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/63/44023?source=related_link\">",
"      Eating disorders: Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/4/26695?source=related_link\">",
"      Enhanced elimination of poisons",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/24/7562?source=related_link\">",
"      First-generation antipsychotic medications: Pharmacology, administration, and comparative side effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/0/28681?source=related_link\">",
"      Genetics of congenital and acquired long QT syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/52/27463?source=related_link\">",
"      Indications for permanent cardiac pacing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/57/23449?source=related_link\">",
"      Major side effects of amiodarone",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/23/9591?source=related_link\">",
"      Pathophysiology of the long QT syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?19/25/19859?source=related_link\">",
"      Patient information: Long QT syndrome (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/10/15530?source=related_link\">",
"      Second-generation antipsychotic medications: Pharmacology, administration, and comparative side effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/37/42580?source=related_link\">",
"      Signs and symptoms of magnesium depletion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/52/29514?source=related_link\">",
"      Treatment of opioid abuse and dependence",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f22_55_23419="Morbidity LND melanoma";
var content_f22_55_23419=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F79661&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F79661&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Morbidity of node dissection in patients with melanoma",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        Axillary, percent*",
"       </td>",
"       <td class=\"subtitle1\">",
"        lnguinal, percent&bull;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Infection",
"       </td>",
"       <td>",
"        15",
"       </td>",
"       <td>",
"        21",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Edema",
"       </td>",
"       <td>",
"        12",
"       </td>",
"       <td>",
"        21",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Wound necrosis or separation",
"       </td>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        20",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Seroma",
"       </td>",
"       <td>",
"        17",
"       </td>",
"       <td>",
"        12",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pain or disability",
"       </td>",
"       <td>",
"        4",
"       </td>",
"       <td>",
"        34",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Other major",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\">",
"        Overall",
"       </td>",
"       <td>",
"        44",
"       </td>",
"       <td>",
"        50",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     * Data from Shaw, JH, Br J Surg 1990; 77:760.",
"     <br>",
"      &bull; Data from Smith, TI, SSO Cancer Symposium, 1998.",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_55_23419=[""].join("\n");
var outline_f22_55_23419=null;
var title_f22_55_23420="Fungal skin infections OLT";
var content_f22_55_23420=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F55662&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F55662&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Fungal skin infection after liver transplantation",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Fungi",
"       </td>",
"       <td class=\"subtitle1\">",
"        Comments",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Opportunistic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Candida albicans",
"       </td>",
"       <td>",
"        Quite frequent in recipients of liver grafts (20 percent). The cutaneous lesions can result from direct inoculation or from seeding from hematogenous dissemination (Aspergillus fumigatus). Protean clinical manifestations. Appear as isolated or multiples subcutaneous nodules that are violet, and can be necrotic, forming abscesses. Voriconazole might be an efficient alternative to amphotericin B.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Aspergillus flavus",
"       </td>",
"       <td rowspan=\"13\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Aspergillus fumigatus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Candida parapsilosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Candida tropicalis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Chromoblastomycosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Chromomycosis (Alternaria, Exophiala jeanselmei)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Cryptococcus neoformans",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Fusarium spp",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Histoplasma capsulatum",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Mycoleptodiscus indicus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Paecilomyces lilacinus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Scopulariopsis brevicaulis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Zygomycosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Trichophyton rubrum or mentagrophytes",
"       </td>",
"       <td rowspan=\"3\">",
"        Dermatophytosis are more frequent in patients living in tropical regions. Intertrigo and more unusual manifestations such as folliculitis, inflammatory plaques, invasive lesions, pseudotumoral lesions, abscess may be seen.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Microsporum canis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Epidermophyton floccosum",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Malassezia furfur",
"       </td>",
"       <td>",
"        Tinea versicolor can be found in 10 to 20 percent of recipients of a liver graft. Localization is commonly on the face and buttock. Lesions can be extensive sometimes hyperkeratotic.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     <p>",
"      &nbsp;",
"     </p>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_55_23420=[""].join("\n");
var outline_f22_55_23420=null;
var title_f22_55_23421="Immunosuppressive agents used in heart transplantation";
var content_f22_55_23421=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F50962&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F50962&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Immunosuppressive agents used in heart transplantation",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Drug",
"       </td>",
"       <td class=\"subtitle1\">",
"        Dosing",
"       </td>",
"       <td class=\"subtitle1\">",
"        Target levels",
"       </td>",
"       <td class=\"subtitle1\">",
"        Major toxicities",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\">",
"        Calcineurin inhibitors",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Cyclosporine",
"       </td>",
"       <td>",
"        4-8 mg/kg/day in 2 divided doses, titrated to keep target 12-hr trough levels",
"       </td>",
"       <td>",
"        <p>",
"         <strong>",
"          0-6 months:",
"         </strong>",
"        </p>",
"        <p>",
"         250-350 ng/mL",
"        </p>",
"        <p>",
"         <strong>",
"          6-12 months:",
"         </strong>",
"        </p>",
"        <p>",
"         200-250 ng/mL",
"        </p>",
"        <p>",
"         <strong>",
"          &gt;12 months:",
"         </strong>",
"        </p>",
"        <p>",
"         100-200 ng/mL",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         Renal insufficiency",
"        </p>",
"        <p>",
"         Hypertension",
"        </p>",
"        <p>",
"         Dyslipidemia",
"        </p>",
"        <p>",
"         Hypokalemia and hypomagnesemia",
"        </p>",
"        <p>",
"         Hyperurecemia",
"        </p>",
"        <p>",
"         Neurotoxicity (encephalopathy, seizures, tremors, neuropathy)",
"        </p>",
"        <p>",
"         Gingival hyperplasia",
"        </p>",
"        <p>",
"         Hirsutism",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Tacrolimus",
"       </td>",
"       <td>",
"        0.05-0.1 mg/kg/day in 2 divided doses, titrated to keep target 12-hr trough levels",
"       </td>",
"       <td>",
"        <p>",
"         <strong>",
"          0-6 months:",
"         </strong>",
"        </p>",
"        <p>",
"         10-15 ng/mL",
"        </p>",
"        <p>",
"         <strong>",
"          6-12 months:",
"         </strong>",
"        </p>",
"        <p>",
"         5-10 ng/mL",
"        </p>",
"        <p>",
"         <strong>",
"          &gt;12 months:",
"         </strong>",
"        </p>",
"        <p>",
"         5-10 ng/mL",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         Renal dysfunction",
"        </p>",
"        <p>",
"         Hypertension",
"        </p>",
"        <p>",
"         Hyperglycemia and diabetes mellitus",
"        </p>",
"        <p>",
"         Dyslipidemia",
"        </p>",
"        <p>",
"         Hyperkalemia",
"        </p>",
"        <p>",
"         Hypomagnesemia",
"        </p>",
"        <p>",
"         Neurotoxicity (tremors, headaches)",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\">",
"        Cell cycle agents",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Azathioprine",
"       </td>",
"       <td>",
"        1.5-3.0 mg/kg/day, titrated to keep WBC &sim;3K",
"       </td>",
"       <td>",
"        None",
"       </td>",
"       <td>",
"        <p>",
"         Bone marrow suppression",
"        </p>",
"        <p>",
"         Hepatitis (rare)",
"        </p>",
"        <p>",
"         Pancreatitis",
"        </p>",
"        <p>",
"         Malignancy",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Mycophenolate mofetil",
"       </td>",
"       <td>",
"        1000-3000 mg/day in 2 divided doses",
"       </td>",
"       <td>",
"        Mycophenolic acid (MPA): 2-5 mcg/ml",
"       </td>",
"       <td>",
"        <p>",
"         Gastrointestinal disturbances (nausea, gastritis, and diarrhea)",
"        </p>",
"        <p>",
"         Leukopenia",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\">",
"        Proliferation signal inhibitors",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Sirolimus",
"       </td>",
"       <td>",
"        1-3 mg/day, titrated to keep therapeutic 24-hr trough levels",
"       </td>",
"       <td>",
"        5-10 ng/mL",
"       </td>",
"       <td>",
"        <p>",
"         Oral ulcerations",
"        </p>",
"        <p>",
"         Hypercholesterolemia and hypertriglyceridemia",
"        </p>",
"        <p>",
"         Poor wound healing",
"        </p>",
"        <p>",
"         Lower extremity edema",
"        </p>",
"        <p>",
"         Pulmonary toxicities (pneumonitis, alveolar hemorrhage)",
"        </p>",
"        <p>",
"         Leukopenia, anemia, and thrombocytopenia",
"        </p>",
"        <p>",
"         Potentiation of CNI nephrotoxicity",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\">",
"        Corticosteroids",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Prednisone",
"       </td>",
"       <td>",
"        1 mg/kg/day in 2 divided doses, tapered to 0.05 mg/kg/day by 6-12 mo",
"       </td>",
"       <td>",
"        None",
"       </td>",
"       <td>",
"        <p>",
"         Weight gain",
"        </p>",
"        <p>",
"         Hypertension",
"        </p>",
"        <p>",
"         Hyperlipidemia",
"        </p>",
"        <p>",
"         Osteopenia",
"        </p>",
"        <p>",
"         Hyperglycemia",
"        </p>",
"        <p>",
"         Poor wound healing",
"        </p>",
"        <p>",
"         Salt and water retention",
"        </p>",
"        <p>",
"         Proximal myopathy",
"        </p>",
"        <p>",
"         Cataracts",
"        </p>",
"        <p>",
"         Peptic ulcer disease",
"        </p>",
"        <p>",
"         Growth retardation",
"        </p>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Pham MX, Chen JM, Berry GJ, Rose EA, Schroeder JS. Surgical Treatment of Heart Failure, Cardiac Transplantation, and Mechanical Ventricular Support. In: Hurst's The Heart, 12th ed, V, Fuster R, O'Rourke R, Walsh P, Poole-Wilson (eds). McGraw-Hill, New York 2007. Copyright &copy; 2007 McGraw-Hill Companies Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_55_23421=[""].join("\n");
var outline_f22_55_23421=null;
var title_f22_55_23422="Rx bacterial arthritis";
var content_f22_55_23422=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F77858&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F77858&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 537px\">",
"   <div class=\"ttl\">",
"    Treatment of nongonococcal bacterial arthritis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 517px; height: 296px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Algorithm for the initial treatment of nongonococcal bacterial arthritis illustrating the main components of therapy: parenteral antibiotics and joint drainage.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_55_23422=[""].join("\n");
var outline_f22_55_23422=null;
var title_f22_55_23423="Uncircumcised penis PI";
var content_f22_55_23423=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F69361&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F69361&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Uncircumcised penis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 283px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of David G Weismiller, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_55_23423=[""].join("\n");
var outline_f22_55_23423=null;
